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1 Summary 
Proteins are the workhorses of the cell. They are involved in the collective of processes 
required for life. Together, the proteins of the cell constitute the proteome, and can 
number from 10 000 to 20 000 proteins. Increasing cellular complexity is associated with 
more complex proteomes. For cell survival, it is of paramount importance to preserve 
proteome integrity when challenged by outside stressors such as heat, oxidation, changes 
in pH and the presence of toxic elements. The term proteostasis (protein homeostasis) is 
used to describe a cell’s ability to keep its proteome stable and functional in spite of such 
outside insults. To achieve this, cells have developed a proteostasis network of interacting 
proteins. Chaperones represent the majority of nodes in the proteostasis network. They 
help proteins to fold, assemble into oligomeric structures, maintain their structure, repair 
them and prevent them from aggregating. 
The aim of this thesis was to investigate protein folding, assembly and repair by molecular 
chaperones. The chaperone system GroEL/GroES was used as a model to study in detail 
the mechanism of assisted protein folding. Rubisco, the enzyme that incorporates 
atmospheric CO2 into the five carbon sugar ribulose-1,5-bisphosphate (RuBP) in the 
Calvin-Benson-Bassham cycle (CBB cycle), was used as a model substrate for studying 
chaperones of protein assembly and conformational repair. 
The first article to which this thesis contributed, addressed in detail the mechanism by 
which GroEL/ES folds a model substrate called double mutant maltose binding protein 
(DM-MBP). GroEL and GroES form a nano-cage for a single protein molecule to fold in 
isolation. By using a single-molecule fluorescence approach to exclude aggregation during 
folding, we demonstrated that GroEL/ES plays an active role in DM-MBP folding, 
enhancing its folding rate up to 8-fold. Next, we showed that repetitive binding, 
conformational stretching and release of DM-MBP are not required for assisted folding 
since a single-round encapsulation event by GroES also resulted in accelerated folding. 
Lastly, we established that the environment of the GroEL cavity is crucial for catalysing 
DM-MBP folding, thus demonstrating that GroEL/ES is not a mere aggregation prevention 
device but an active folding catalyst. 
In the second article, we investigated the conformational cycle of GroEL/ES. In the 
canonical description of the cycle, GroEL binds GroES on one side only, forming an 
asymmetrical complex (GroEL:GroES) that functions as a two-stroke machine. Under 
certain conditions, however, it is possible that two GroES molecules bind to GroEL, 
forming a symmetrical complex (GroEL:GroES2). A single molecule fluorescence approach 
using two differently labelled populations of GroES allowed us to measure the amount of 
symmetrical complexes under a variety of conditions. We showed that GroEL:GroES2 
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complexes are formed only in presence of non-foldable substrates, such as α-lactalbumin 
(α-LA) and α-casein, but not when challenged with foldable substrates like Rhodospirillum 
rubrum Rubisco, mitochondrial malate dehydrogenase (mMDH), mitochondrial 
rhodanese (mRho) or DM-MBP, or in the absence of a substrate. Additionally, we found 
that physiological ratios of ATP/ADP decrease the amount of symmetrical complexes. 
Taken together, we concluded that the asymmetrical complex is the prevalent form under 
physiological in vitro conditions. 
The third article describes the structure of the assembly chaperone Rubisco accumulation 
factor 1 (Raf1), and its role in assembly of the Rubisco holoenzyme. Rubisco consists of 
eight large subunits (RbcL) arranged as a tetramer of antiparallel dimers capped by four 
small subunits (RbcS) on each side. We demonstrated using biochemical methods that 
Raf1 acts downstream of chaperonin assisted folding of RbcL. Additionally, X-ray 
crystallography, chemical crosslinking and single-particle negative stain electron 
microscopy (EM) allowed us to conclude that Raf1 in its dimeric functional form binds to 
RbcL, releases it from the chaperonin, facilitates formation of RbcL2 antiparallel dimers, 
and drives the assembly of a RbcL8:Raf14 complex. In the last step, RbcS replaces Raf1 and 
forms the Rubisco holoenzyme (RbcL8:RbcS8). 
In the fourth and final article we looked at yet another type of a chaperone, which is 
involved in metabolic repair. We investigated the interaction and remodelling activity of 
red-type Rubisco activase from the bacterium Rhodobacter sphaeroides (RsRca). RsRca is 
a homohexameric AAA+ protein that uses energy derived from ATP hydrolysis to exert 
force on inhibited Rubisco in order to conformationally remodel it, leading to metabolic 
repair. A combination of various techniques, ranging from standard biochemical methods, 
hydrogen/deuterium exchange coupled to mass spectrometry (H/DX-MS), chemical 
cross-linking and single-particle cryo-EM led us to propose a model where Rca transiently 
binds to the corner of inhibited Rubisco, contacting both RbcS and RbcL. RsRca then 
interacts with the RbcL C-terminal tail to open a multi-layered active pocket and release 
the bound inhibitor. Moreover, we were able to show that RsRca acts locally on one active 
site and does not globally destabilize or unfold Rubisco. 
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2 Introduction 
Along with lipids, nucleic acids and carbohydrates, proteins are the major 
macromolecules present in nature. Proteins provide a structural framework to give cells 
shape and are involved in a plethora of metabolic reactions, the products of which allow 
cells to grow and divide. Proteins also help to protect cells and organisms against outside 
invaders as part of highly sophisticated immune systems. Even the synthesis of proteins, 
which as explained by central dogma, proceeds from DNA to RNA to protein through the 
events of transcription and translation, is orchestrated by proteins in combination with 
nucleic acids. DNA replication, the hallmark of cell multiplication, is regulated and 
executed by proteins. Since function and structure are intimately connected, most 
functional proteins must attain a specific three-dimensional structure in a process called 
protein folding1. 
2.1 Protein structure 
Proteins are polymers which consist of a genetically determined linear sequence of amino 
acid residues. An amino acid is an organic molecule with a chiral carbon (Cα) atom to 
which hydrogen, amino, carboxylic and side chain groups are attached. In nature, amino 
acids occur primarily in their L- enantiomeric form. Depending on the physicochemical 
properties of the side chain, amino acids can be divided into 7 groups: simple aliphatic, 
hydroxy, aminodicarboxylic and amides, basic, sulfur containing, cyclic and aromatic 
amino acids. Amino acids polymerize via a condensation reaction. The amino and 
carboxylic groups react, forming a peptide bond that connects Cα atoms through three 
covalent bonds in a trans configuration (in respect to NH and CO groups); Cα-N-C-Cα 
(Figure 1)1. 
 
Figure 1: Schematic representation of a sequence of peptide bonds. 
In the polypeptide chain depicted, bonds N-Cα and Cα-C can rotate around torsion angles phi (ϕ) and psi 
(ψ) to a certain degree, whereas the peptide bond C(O)-N(H) is planar (shown as plane). Distances 
between atoms, amino and carboxyl terminus are indicated (reproduced from Nelson et al.1). 
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Due to partial overlap of the carbonyl π orbital with the lone electron pair on the nitrogen 
atom, the peptide bond has a partial double bond character and is essentially planar. Cα 
atoms on both sides, however, have single bonds Cα-N and C-Cα which can rotate through 
torsion angles phi (ϕ) and psi (ψ), respectively. Combination of torsion angles are 
visualised in the so called Ramachandran plot (Figure 2)2. Due to steric constraints, there 
are two major combinations of angles that can be realized and are termed α and β. The 
exceptions to this rule are glycine, where the side chain is a lone hydrogen atom that 
allows larger span of angles, and proline, where the NH group is part of a ring which 
renders many torsion angles inaccessible2. 
 
Figure 2: Ramachandran plot for L-alanine.  
Combinations of phi (ϕ) and psi (ψ) angles as x and y axis, respectively, are shown on a 2D plot. 
Favourable combinations are shown as dark green regions. Light green regions show borderline 
possibilities. Structures on the left are in favourable conformation. Structure on the right is disfavoured. 
(reproduced from Berg et al.3). 
The linear sequence of amino acid residues determines the primary structure of a protein. 
In relation to primary sequence, the term motif describes amino acid sequence patterns 
that have biological significance. Secondary structure is the local arrangement of amino 
acid residues into α-helices and β-sheets4 which are formed by backbone hydrogen bonds 
between amine hydrogen and carbonyl oxygen. Analogous to linear motifs, structural 
motifs represent connectivity between secondary structure elements (super-secondary 
structure). Once these local elements are packed together and stabilized by π-π, π-cation, 
hydrogen, ionic and van der Walls interactions we use the term tertiary structure to 
describe them. Additionally, the expression ‘fold’5 describes how the elements of 
secondary structure are arranged relative to each other in space. Furthermore, several 
identical or different independent tertiary structures can be combined into quaternary 
 
 
  Introduction 
5 
 
structure. Proteins can fulfil their biological role after reaching their native structure in 
the intricate process of protein folding. 
2.2 Protein folding 
The question of how proteins fold to their final three-dimensional state, and with it the 
related issue of predicting the three-dimensional structure from the linear sequence, still 
awaits a complete answer. In a seminal experiment by Anfinsen in 1962 it was shown that 
denatured Ribonuclease A refolds and attains enzymatic activity upon removal of 
denaturant and reducing agent6,7. Therefore, all the information required for the protein 
to attain its three-dimensional form is encoded in its linear sequence of amino acids. 
Anfinsen's finding led him to suggest that the folding mechanism is pathway independent. 
Proteins would fold by random search through all the conformations in vast 
conformational space. However, it was not long before Levinthal opposed this view by 
calculating that for a protein of 100 amino acid residues, ~1000 years would be necessary 
to try out all possible conformations8. Since this is in stark contrast to the time of 5 
seconds for a functional protein of 100 amino acid residues to fold at 37°C, and the fact 
the E. coli cells divide on average every 20 minutes, protein folding cannot be a random 
trial-and-error process. These opposing arguments are now known as Levinthal's 
paradox.  
In order to resolve Levinthal's paradox, proteins have to achieve a stable structure (global 
energy minimum) on reasonable time scale (kinetic control). This could be achieved by 
following one specific pathway or having an option between several defined pathways. In 
recent years several folding models have been proposed which try to satisfy both global 
energy minimum and kinetic control conditions. 
2.2.1 Diffusion-collision model 
In the diffusion-collision model9 the protein is considered to be composed of several parts 
– elementary microdomains - each short enough for all conformational alternatives to be 
searched rapidly, as compared with the time scale of the entire folding process (Figure 3). 
Overall folding would occur in a stepwise manner starting from an extended or a more 
collapsed state, and leading to a backbone structure close to the native state. This latter 
state can be described as a molten globule, which has secondary structure elements 
formed but lacks elements of three-dimensional structure. In the last step, the exact 
tertiary structure is formed by coalescence of secondary structure elements upon 
diffusion and collision9. 
2.2.2 Nucleation-condensation model 
Nucleation-condensation model10 postulates that neighbouring residues form native like 
contacts in turn forming a nucleus around which further secondary structure forms and 
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propagates in direction out of nucleus. As a result of secondary structure formation, 
tertiary structure forms concomitantly (Figure 3).  
2.2.3 Hydrophobic collapse model 
In the hydrophobic collapse model11 the molten globule state with a hydrophobic core 
forms early in the folding pathway, followed by the correct positioning of secondary 
structure elements in space (Figure 3). 
 
Figure 3: Classical folding mechanisms. 
Diffusion-collision model states that microdomains which represent transient elements of secondary 
structure diffuse and collide thereby forming more stable and folded structure. In the framework model 
(nucleation-propagation and nucleation-condensation) initial nucleus is formed followed by outward 
structure formation. Hydrophobic collapse model posits the formation molten globule with hydrophobic 
core followed by correct positioning of secondary structure elements thus reaching a native tertiary fold 
(reproduced from Nickson et al.12). 
2.2.4 Folding funnel model 
The folding funnel model13 is the latest in the arsenal of folding models and the most 
general. It describes folding as a process of native-like contacts formation causing the 
reduction in entropy and free energy of the polypeptide chain. Rearrangement of amino 
acid side chain contacts during the folding process drives the polypeptide chain along the 
folding landscape down the funnel towards the unique three dimensional structure with 
lowest free energy (Figure 4). 
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Figure 4: Folding funnel model. 
Folding funnel model describes protein folding in an ensemble approach. At the beginning of folding a 
vast conformational space is available to protein molecules which then funnel into one unique state with 
a decrease in entropy and enthalpy (reproduced from Radford et al.14). 
All of the folding models described above, except for nucleation-condensation, predict 
folding intermediates. Intermediates differ in flexibility, stability, and the number of 
native contacts15. Some intermediates can be on-pathway, and act to reduce the number 
of attainable states and can fold to the native state16. On the other hand, some 
intermediates can be kinetically trapped and unable to complete productive folding on 
their own. According to the folding funnel model, they represent local energetic minima 
on a rugged free energy folding landscape. In absence of external factors17, and due to a 
substantial amount of exposed hydrophobic residues, such intermediates can accumulate 
and aggregate18. 
2.3 Methods for studying protein folding in vitro 
To completely describe a biological process, one needs both structural information and 
rates of the interconversion of all the species. The complicating factor in studying protein 
folding is the short lifetime of folding intermediates. Nevertheless, in recent years many 
methods that allow the observation of protein folding have been developed. In order to 
approach a complete description of the folding mechanism, several of these methods have 
to be used in combination. Methods most commonly used in the field are summarized in 
Table 1.  
Technique Timescale Description 
Fluorescence 
Intrinsic fluorescence ms Local environment of Trp 
and Tyr residues 
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ANS binding ms Exposure of hydrophobic 
areas 
FRET  ms Distance between labelled 
positions 
Substrate/Inhibitor 
binding 
 Formation of native 
contacts 
Anisotropy  Dynamics of protein chains 
Circular dichroism 
Far UV ms Secondary structure 
formation 
Near UV ms Tertiary structure 
formation (local 
environment of aromatic 
residues) 
Other spectroscopic methods 
Small-angle X-ray 
scattering (SAXS) 
ms Overall shape and 
dimensions of a protein 
Absorbance (near UV)  Local environment of 
aromatic residues 
Hydrogen exchange 
Native exchange  Global stability of a protein 
Pulsed hydrogen exchange 
NMR  
 Rate of hydrogen exchange 
on backbone and amino 
acid side chain 
Pulsed hydrogen exchange 
ESI MS 
 Rate of hydrogen exchange 
in folding population 
Additional methods 
Atomic force spectroscopy 
(AFM) 
 Rates of folding and 
unfolding events 
Solution-state NMR  Changes in environment of 
amino acid side chains 
Table 1: List of commonly used methods in protein folding studies (Modified from 
Brockwell et al.16 and Radford et al.14).  
Abbreviations: ANS: 1-anilino naphthalene sulphonic acid; FRET: Förster energy 
resonance transfer; UV: ultraviolet; ESI MS: electron spray ionization mass spectrometry; 
NMR: nuclear magnetic resonance. 
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Of particular importance are the methods that allow us to study changes on short 
timescales, such as stopped-flow, quenched-flow and microfluidics combined with a 
biophysical method of choice. For example, fluorescence intensity, lifetime and anisotropy 
(on ensemble or on single molecule level) measurements provide information on the 
amount of structure, chain dynamics, inter-residue distances, changes in environment 
around the probe and kinetics of both local and global folding. Circular dichroism can be 
used to monitor the extent of secondary (far UV range) and tertiary structure (near UV 
range) either as steady state or kinetic measurements. In recent years, the method of 
hydrogen/deuterium exchange mass spectrometry (HDX MS) has provided us with an 
unprecedented amount of temporal and spatial information of folding processes. Nuclear 
magnetic resonance (NMR) and UV absorption (albeit with low resolution) are used to 
describe the environment around the amino acid side chain or aromatic residues, 
respectively. Small-angle X-ray scattering (SAXS) can be used to gain low resolution 
structural information on polypeptide shape and dimensions. Finally, the method of 
atomic force microscopy (AFM), especially when used on a single molecule level, reveals 
valuable information on folding and unfolding rates. 
Protein engineering as realized in the method of ϕ value analysis19 is a method of choice 
if one would like to interrogate the role of specific residues in the folding process. In this 
method, several different amino acid residues are most commonly replaced by alanine. 
From the change in folding and unfolding kinetics caused by such a perturbation, one can 
infer the degree of native-like structure around this position in the transition state or 
folding intermediate. Usually, ϕ values range from zero to one. When the value is close to 
one, it implies that this position plays significant role in stability and kinetics and that it 
is close to the native form. The opposite is true for values close to zero. 
2.3.1 Single molecule methods in protein folding  
Most of the methods listed above are used to observe folding events at an ensemble level. 
In an effort to gain higher resolution and describe the folding of single protein molecules, 
two distinct single-molecule approaches were developed: fluorescence spectroscopy and 
force spectroscopy. Single proteins are isolated by immobilization on a surface, trapping 
between optical tweezers or working at high dilution (< 100 pM). 
Single molecule fluorescence spectroscopy experiments are carried out on a confocal 
laser microscope. Such a setup allows one to observe single protein molecules that pass 
through a small confocal volume (~1 fL). Proteins have to be labelled with fluorescent 
dyes in order to be detected. Labelling is achieved via coupling reactions of cysteine or 
lysine with maleimide or N-hydroxysuccinimide-ester (NHS-ester), respectively. Other 
methods of labelling include coupling of a fluorescence probe to N- or C-termini. Another 
possibility is the introduction of non-natural fluorescent amino acids. Depending on the 
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information one would like to obtain, different fluorescence spectroscopy variants can be 
employed20,21,22. 
Single molecule Förster resonance energy transfer (smFRET) is radiation-less energy 
transfer between a suitable pair of donor and acceptor dyes (overlap integral) (Figure 
5)20. Energy transfer or FRET efficiency is defined as the ratio of either fluorescence 
intensity or lifetime of the excited donor fluorophore in the presence and absence of the 
acceptor, and it occurs on distances of 2-10 nm. Energy transfer is highly sensitive to 
changes in distances between labelled positions (E~r-6) and is thus suitable for detection 
of local properties that define different conformational states or folding intermediates. 
FRET measurements on a single molecule level have an advantage of obtaining 
quantitative information on different species present in the process which would 
otherwise have been averaged out in ensemble measurements. 
Fluorescence correlation spectroscopy (FCS) is a method that depends on measurements 
of fluorescence intensity fluctuations (Figure 5)20. Fluctuations arise due to changes in the 
number of molecules that pass on a timescale of microseconds to milliseconds through 
the observation volume over a certain measuring time period. From the analysis of 
measured fluctuations the autocorrelation function, which is defined as the self-similarity 
of a signal as a function of time, can be constructed. The appropriate fit for the 
autocorrelation curve is then used and several parameters such as rotational diffusion 
time, blinking events, translational diffusion time and number of molecules, can be 
extracted23. FCS is commonly used to monitor events on nanosecond to hour time scale 
and can detect changes in size and conformation and thus has been widely used in protein 
folding studies24. Since FCS is a fluctuation method it is limited to concentrations of 1 pM 
to 200 nM. Below 1pM there are too few events that occur which leads to poor statistics. 
Going above concentrations of 200 nM however, results in reduced sensitivity to 
fluctuations in the confocal spot. 
Photoinduced electron transfer (PET) is a photo-physical event where an electron from 
the indole ring of tryptophan is transferred to the fluorophore, thereby quenching the 
fluorophore (Figure 5)21. For this event to occur, tryptophan and the fluorophore have to 
be in van der Walls contact (<2 nm). In combination with FCS (PET-FCS) the transition 
between dark and bright states (blinking) can be observed as an additional exponential 
decay in the autocorrelation curve at short correlation times (µs). PET-FCS was used to 
observe fast protein chain dynamics22, early folding events25 and transitions between 
conformational states26. 
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Figure 5: Comparison of single-molecule fluorescence methods. 
Spectroscopic methods implemented in confocal microscopy for observation of single molecules. In 
smFRET, distance between labelled positions is determined from ratio of either donor/acceptor 
fluorescence intensity or lifetime. FCS measures fluorescence intensity fluctuations and associated 
processes. Most commonly, diffusion coefficient is obtained from diffusion time and the size of a confocal 
spot. PET-FCS is based on quenching of oxazine dye by tryptophan residue(s) when in distance of van-
der-Waals contacts. Information on conformational changes or chain dynamics is obtained from such 
experiment (reproduced from Gupta27). 
2.3.2 Single particle transmission electron microscopy 
Single particle transmission electron microscopy (EM) is a structural method that has 
recently gained substantial attention28. Instrumental29, and data processing progress30 
resulted in a 'resolution revolution' that now enables determination of atomic31 or near 
atomic resolution of protein structures. In EM, electrons are released from an electron 
gun and focused on to the specimen by a set of condenser lenses. Emitted electrons are 
scattered by electrons and atom nuclei in macromolecules of the sample. Scattered 
electrons are refocused by the objective lens system resulting in the formation of an image 
of an object. The image is then further magnified by an intermediate lens system and 
finally projected by the projector lens system. A micrograph is recorded either on a 
photographic film, a scintillator-based digital camera or the recently developed direct 
electron detection camera32 (Figure 6). Specimens for EM are prepared by applying a 
solution of macromolecules to an EM grid. The solution is then removed and the specimen 
can be either negatively stained (negative stain-EM) or plunge-frozen into liquid ethane 
(cryo-EM) (Figure 7).  
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Figure 6: Simplified representation of an electron microscope. 
Electrons are released from the electron gun and are focused by the condenser lens onto the specimen. 
The objective lens is responsible for image formation and magnification of the object. Aperture stops the 
electrons that are off-axis or off-energy. Further magnification is achieved with system of projector lens. 
Finally, the image is projected onto a plane (reproduced from Orlova et al.32). 
 
 
Figure 7: Sample preparation for electron microscopy. 
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Two approaches of sample preparation: a.) Negative staining where the sample solution is applied to the 
grid, stained with heavy metal stain and dried. b.) Freezing with liquid nitrogen where the sample is 
applied to the grid and plunge frozen into liquid ethane. Example of cryo-EM image is shown. (reproduced 
form Orlova et al.32). 
The structure of a protein is determined computationally by combining images of many 
macromolecules33. On a micrograph, particles that are 2D projections of a molecule can 
adopt a wide range of orientations. Six geometric parameters define the position and 
spatial orientation of the particle: two in-plane coordinates (x,y), three Eulerian angles 
(φ, θ, ψ), and a defocus (z), which is assumed to be the same for all the particles on the 
micrograph. After image alignment and 2D classification which resolves compositional 
and configurational heterogeneity, an initial 3D model can be built. Subsequent 3D 
classification allows for an additional in-silico purification step. Finally, in the 3D 
refinement, Eulerian angles are more accurately determined and a 3D model can be built34 
(Figure 8). 
 
Figure 8: EM workflow. 
Overview of cryo-EM single particle reconstruction. After data collection, particles are extracted and 2D 
classification is performed. After initial model generation, additional 3D classification can be performed 
to attain more conformationally homogeneous classes. Refinement results in the 3D model which can be 
used for de-novo model building or fitting of know structures(reproduced from Skiniotis et al.34). 
Cryo-EM was previously used principally for analysing large macromolecular complexes. 
However, with the recent development it is possible to obtain atomic structures of smaller 
proteins, such as y-secretase (170 kDa)35. Furthermore, it is now possible to dissect 
various conformational states of macromolecular machines along their mechanistic 
cycles36. Cryo-EM has also become the method of choice for studying complex assemblies 
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such as the spliceosome, which are highly dynamic in nature and resist crystalization37. 
Another advantage of EM is the small amount of material that is required for the 
experiment (micrograms of protein). Since it is possible to capture short lived, dynamic 
complexes, EM can also be used to study chaperones that are involved in the assembly of 
protein complexes. Intermediates that form along the assembly process can be 
structurally characterized. Due to the dynamic nature of intermediates, one has to take 
into account the compromised resolution in the final reconstruction. Nonetheless, the 
resulting envelope of electron density still allows for docking of X-ray determined 
structures (hybrid approach) and determination of the general architecture of a complex. 
2.4 Protein folding in the cell 
In contrast to dilute in vitro solutions, the environment in the cell is highly concentrated, 
with an estimated macromolecular concentration of ~300-400 mg/ml38 (Figure 9). The 
term of macromolecular crowding was coined to describe this property. Such high 
concentrations cause macromolecular crowding39, which results in a substantial excluded 
volume effect and has a profound effect on protein folding, stability, and catalysis as well 
as binding affinities inside a living cell40,41. 
 
Figure 9: Macromolecular crowding in E. coli cell. 
Environment in the cell is highly concentrated, with concentrations of macromolecules reaching up to 
300-400mg/ml, resulting in substantial excluded volume effects. Approximated amount, shape and 
density of macromolecules inside E. coli cell are shown. (reproduced from Ellis et al.42). 
In such an environment, non-specific interactions are more likely to occur. In particular, 
aggregation is favoured when partially folded proteins expose hydrophobic regions, such 
as the case of ribosome bound nascent chains or folding intermediates.43. When 
aggregation is faster than folding, oligomers and sometimes aggregates can form, which 
can have detrimental consequences for the cell44. Indeed, the presence of aggregates is a 
hallmark of many neurodegenerative diseases, such as Alzheimer's, Parkinson's, 
Huntingtin's and Creutzfeldt-Jakob's disease, as well as amyloid lateral sclerosis (ALS). 
However, it is still a matter of active debate whether oligomeric species or aggregates are 
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responsible for toxicity45. For all the above listed diseases, so called amyloidoses, a 
common form of amyloid-like aggregates are formed that are characterized by cross-beta-
sheet structure. It is therefore clear that for in-cell folding to be productive, additional 
factors have to be at play43,44,46. 
2.4.1 Molecular chaperones 
A molecular chaperone is a protein that helps in folding or unfolding of another protein 
without being a part of its final structure47. The crucial property which gave name to 
chaperones is that in the act of chaperoning any unproductive/unwanted interactions are 
prevented. Chaperones are important in all branches of protein homeostasis 
(proteostasis), from biosynthesis (folding and assembly), to maintenance and 
degradation44. 
Many of the molecular chaperones are upregulated upon heat shock, and have since been 
recognized as heat shock proteins (Hsps)48. They are classified according to their 
molecular mass or function. They can act as holdases, which stabilize non-native 
conformations; foldases, which assist folding; or unfoldases, which unfold misfolded 
species or extract proteins from aggregates49. In general, chaperones recognize and bind 
exposed hydrophobic patches on a substrate protein. Binding affinities of the substrate 
are regulated in two markedly different manners: ATP dependent, or ATP independent. 
Most chaperones hydrolyse ATP (Hsp60, Hsp70, Hsp90, Hsp104 and Hsp110). ATP 
hydrolysis drives the chaperone through different conformational states, which remodels 
the substrate and modulates substrate binding affinity50. Examples for regulation of 
substrate binding affinity in an ATP independent manner include post-translational 
modifications such as phosphorylation (small Hsps)51 and a reduction in the amount of 
stress-unfolded proteins, which can shift the equilibrium between the bound and 
unbound states of the substrate (Spy chaperone)52. 
Molecular chaperones act in combination with co-chaperones, which enable chaperones 
to interact with a broad array of substrates (Hsp40), modulate chaperone ATPase activity 
(Hsp40, Hsp10) and expand the number of processes in which chaperones can be 
involved49. 
2.4.2 Molecular chaperone network 
Different molecular chaperones within the cell are organized into a complex network 
(Figure 10)53. In all three domains of life, bacteria, archaea and eukarya, proteins are 
synthesized on ribosomes. An average protein, while being synthesized on the ribosome, 
stays in a non-native state for around 15 seconds54. As a first adaptation to prevent early 
unwanted interactions, ribosomes adopt a pseudo-helical organization in polysomes55, 
allowing ribosome exit tunnels to point in opposite directions. During and immediately 
after translation the protein enters the flux of a highly sophisticated chaperone network. 
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It first encounters ribosome associated chaperones56. Then, it is transferred downstream 
to Hsp70/Hsp40 system57. While some proteins can fold after passing through this node 
of network, others, require additional chaperones such as Hsp90 and barrel shaped 
chaperones with a central cavity (chaperonins)58. 
 
Figure 10: Chaperone network in all domains of life. 
Chaperones are organized in sophisticated network in a.) bacteria b.) archaea and c.) eukarya. During 
translation protein chain encounters ribosome associated chaperones. Upon completion of biosynthesis 
some protein can spontaneously fold whereas others need assistance of downstream chaperones such as 
Hsp70, Hsp90 and Hsp 60. Percentages indicate the amount of proteins either independent or dependent 
on different chaperone systems (reproduced from Kim et al.46). 
Some proteins, despite the help of a folding network, might not be able to fold due to 
mutations or changes in cellular environment46 (Figure 11). To prevent unproductive 
cycling through folding chaperones, they have to be transferred to and degraded by either 
the ubiquitin/proteasome system (UPS) or autophagy/lysosome pathways. On the other 
hand, larger aggregates that have already formed, can be cleared by autophagy or can be 
remodelled and disaggregated by chaperones in cooperation with the UPS or lysosome 
pathways. Overload of UPS or lysosomes pathways can cause 'choking' of these systems 
and leads to build up of misfolded proteins and further aggregation44. 
 
 
  Introduction 
17 
 
 
Figure 11: Proteostasis network. 
Proteostasis network components are involved in synthesis, maintenance and degradation of a proteins. 
After the protein is synthesised on a ribosome it forms a folding intermediate which can have different 
fates. It can fold to native state, misfold or aggregate. These states can interconvert by assistance of 
proteostasis network components (reproduced from Kim et al.46). 
The life and fate of a protein inside the cell does not depend only on foldases, but also 
chaperones which maintain its structure and at the later stage successfully transfer it for 
degradation(Figure 12)43,44,46. 
 
Figure 12: Components of the human proteostasis network. 
Chaperones represent ~200 components of ~1400 factors comprising the proteostasis network. 
Proteostasis network includes proteins involved in biogenesis, conformational maintenance and 
degradation (reproduced from Hipp et al.44). 
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2.4.3 Ribosome-associated chaperones 
Protein synthesis on the ribosome proceeds in a vectorial fashion from the N- to C- 
terminus. Only after the complete chain emerges from the ribosome exit tunnel can long-
range interactions form. It is characteristic of nascent chains to expose hydrophobic 
patches prone to aggregation. 
Bacteria have evolved the ribosome-associated chaperone Trigger factor (TF) to prevent 
early misfolding and aggregation events (Figure 13)58,59. TF is a conformationally dynamic 
~50 kDa protein, consisting of three domains60. The dispensable peptidyl-prolyl-
isomerase (PPI) domain might serve as additional substrate binding site and adds to the 
chaperone activity. The C-terminal domain, which bears the main chaperone activity, and 
the N-terminal domain are crucial for ribosome binding and chaperone function. TF binds 
to the ribosomal protein L23, thus positioning TF close to the ribosomal exit tunnel and 
allowing for interaction with the nascent chain. TF does not have a single substrate 
binding site but interacts with the nascent chain with its entire inner, cavity-forming 
surface. According to the structural model, the cavity formed between TF and ribosome 
could accommodate a protein domain of 14 kDa in size possibly allowing co-translational 
folding61. It is interesting to note that the action of TF delays the folding process62. The 
concentration of TF in the cell is ~50 µM and is in excess over ribosomes at ~20 µM. TF 
binds transiently to vacant ribosomes with an apparent KD of 1-2 µM and koff of 10-15 
seconds. The KD is decreased to 40-700 nM (2-30 fold) in the presence of the nascent 
chain. This allows TF to differentiate between vacant and translating ribosomes59. TF 
dissociates in an ATP independent manner. After dissociation it hands the nascent chain 
to downstream chaperones57. Due to the excess of TF over ribosomes, it was speculated 
that TF might be involved in other functions. Indeed, TF may function as ribosome 
assembly factor59. 
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Figure 13: Trigger factor from E. coli – ribosome associated chaperone. 
a.) Domain organization of TF. TF has N-, C- and PPIase domains. b.) Crystal structure of TF (PDB: 1W26) 
shown in ribbon representation. N-terminal domain (red) has a signature motif (GFRxGxxP) important 
for ribosome binding. Peptidyl-prolyl cis-trans isomerase (PPIase) domain (green) is connected to N-
terminal domain via flexible linker. C-terminal domain (blue) is in the middle and forms two arm-like 
protrusions. N-domain and arm-like protrusions form a cavity for nascent polypeptide chain. c.) 
Distribution of positive (blue) and negative (red) charges shown in space filling model. d.) Structural 
model of TF bound to ribosome exit tunnel. Contact sites include the signature motif of N-terminal 
domain of TF (red) and ribosomal L23 protein (dark grey) (reproduced from Preissler et al.59). 
TF is not present in archaea and eukarya, but is substituted by the ribosome-associated 
complex (RAC) which is composed of a specialized Hsp70/40 based system 
(Zuo/Ssz/Ssb) or nascent-chain associated complex (NAC), respectively58,63,64. 
2.4.4 The Hsp70 system 
The Hsp70 chaperone family is the hub in the centre of the cytosolic chaperone network65. 
It has been recently shown in E. coli that Hsp70 interacts with ~700 proteins. A subset of 
~180 aggregation prone proteins are especially dependent on this system57. 
Hsp70 is a ~70 kDa protein. It has an N-terminal nucleotide-binding domain (NBD) and a 
C-terminal substrate-binding domain (SBD), connected by a flexible linker important for 
allosteric regulation (Figure 14)49. The NBD has two large globular subdomains divided 
into two small subdomains. Between the subdomains there is a cleft where nucleotide 
binds. For efficient nucleotide binding, one Mg2+ and two K+ ions are required. The SBD is 
subdivided into an N-terminal β-sandwich subdomain and a C-terminal α-helical 
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subdomain. The latter functions as a lid to close over bound substrate after ATP 
hydrolysis. 
 
Figure 14: Structure of Hsp70 in open and closed states. 
Hsp70 consist of nucleotide-binding domain (NBD) and a substrate-binding domain (SBD) connected via 
conserved, flexible linker. The structure of a closed state (left) (PDB: 2KHO) shown in ribbon and space 
filling representation was solved by hybrid approach using solution NMR and crystal structures of 
individual domains. In this structure ADP (violet) is bound to NBD and the α-helical lid is closed over the 
peptide (red) bound to SBD. Α-helical domain of SBD, linker, and subdomains (IA; IB; IIA; IIB) of NBD are 
indicated. The open state (right) is represented by crystal structure of ATP-bound Sse1 (PDB: 2QXL). In 
this state β-sandwich domain contacts IA subdomain od NBD. α-helical lid contact IA and IB of NBD 
(reproduced from Kim et al.46). 
Non-native proteins bind to Hsp70 via a hydrophobic stretch of 5-7 residues flanked by 
positively charged amino acid residues (Figure 15)49. Hsp70 can then either keep the 
protein in an unfolded state acting as a holdase or functions as a foldase, thus helping 
substrate proteins to fold66. In the latter case, after binding of the substrate and 
subsequent conformational changes of Hsp70, the substrate is released into free solution. 
As the protein collapses upon release, it can kinetically partition to the correct pathway 
and fold67. In an alternative explanation of its foldase activity, repetitive binding and 
release induce local unfolding and help overcome kinetic barriers for folding to the native 
state. When several cycles of repeated binding and release cannot drive the substrate to 
its native state, Hsp70 fulfils its role as a holdase and transfers the substrate in a non-
native state to downstream chaperones46. Moreover, as part of a proteostasis network in 
yeast, Hsp70 in combination with Hsp104 can function as a disaggregase. Higher 
eukaryotes however, lack Hsp104; instead a combination of Hsp70 and a mixed J-protein 
complex is involved in disaggregation processes68. 
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Figure 15: Hsp70/40 reaction cycle. 
Hsp70 and Hsp40 are shown in cartoon representation. Hsp70 nucleotide binding domain is in yellow, 
Hsp70 substrate binding domain is in green. Hsp40 is in blue. Substrate protein is in ribbon 
representation coloured dark blue. Hsp70 with bound ATP is in open state allowing for substrate binding 
which is recruited by Hsp40 additionally Hsp40 stimulates Hsp70. Hsp70 with ADP bound is in closed 
state with α-helical lid over the bound substrate which effectively decreases on and off rates. In the last 
step NEFs stimulate ADP release and subsequent ATP binding causes substrate release (reproduced from 
Kim et al.46). 
Additional roles attributed to Hsp70 are mediating the transfer of substrates across 
membranes and in regulating the σ32  heat shock transcription factor. Interestingly, Hsp70 
also plays a role in the disassembly of clathrin coats, viral capsids and the nucleoprotein 
complex. Hsp70 can take part in such diverse tasks due to a plethora of associated co-
factors69. 
In the context of proteostasis, Hsp70 has two main co-factors. The co-chaperone Hsp40 
and a nucleotide exchange factor (NEF) which drive the Hsp70 conformational cycle69. 
During cycling, Hsp70 switches between ATP and ADP states which differ in substrate 
binding affinities. Hsp70 with bound ATP is in the 'open' state with low affinity for 
substrate and high on- and off-rates. By delivering the substrate protein to Hsp70, Hsp40 
stimulates the ATPase activity of Hsp70 by more than ~1000 fold70. Substrate alone can 
stimulate the ATPase activity up to 2-10 fold as well, but this is not sufficient for effective 
cycling. ATP hydrolysis causes the closing of α-helical lid, thereby 'locking'-in the 
substrate. The 'closed' state is characterized by high binding affinity and low on/off rates. 
The NEF accelerates the release of bound ADP, causing opening of the lid and release of 
the substrate. 
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2.4.5 The chaperonins 
Chaperones with cavities formed within each of two rings stacked back to back are called 
chaperonins. These are ~1 MDa large complexes which can bind and encapsulate non-
native proteins43. Chaperonins act upon ~10 % of cytosolic proteins and are 
indispensable for cell viability71. The cavity of each ring is an active site where substrate 
protein is bound, encapsulated, folded in isolation and released. These steps are part of a 
complex cycling mechanism driven by ATP hydrolysis. 
Chaperonins are classified into groups I and II. Group I is present in bacteria and 
organelles of endosymbiotic origin (mitochondria, chloroplasts), whereas group II is 
specific to archaea and eukarya43. Both types of chaperonins have cavity-forming rings 
stacked back to back. Chaperonins of group I have seven identical subunits which form 
the ring. Group II chaperonins, on the other hand, have eight to nine subunits (either 
identical or up to three different types) as it is the case for archaeal chaperonins, or eight 
different subunits within the ring, which is characteristic of eukaryotic TRiC/CCT. 
Chaperonins of the first group work together with lid-shaped co-chaperone GroES. Group 
II chaperonins do not need any external co-chaperone since they have a built-in lid in a 
form of an α-helical protrusion extending from the apical domain. 
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Figure 16: Structure of group I and II chaperonins. 
Chaperonins consist of two rings stacked back to back. First column shows crystal structures of 
chaperonins in open and closed states in ribbon representation: GroEL(PDB: 3E76), GroEL/ES (PDB: 
1AON); open (PDB: 3KFK) and closed (PDB: 1A6D) states of thermosome, open (PDB: 2XSM) and closed 
(PDB: 3IYG) states of CCT/TRiC in side views. Equatorial and intermediate domains forming inter- and 
intra- ring contacts, respectively, are coloured light green. Apical domain is coloured dark green. Rest of 
the chaperonin structures is in grey (GroEL), blue (thermosome),violet (CCT/TRiC). GroES is in orange. 
Middle column shows and compares isolated pair of inter-ring interacting chaperonin subunits in open 
and closed states. Last columns shows chaperonins in top view for open and closed state (reproduced 
from Yebenes et al.72). 
Substrates bind the chaperonins via the apical domains of the open ring. Upon 
encapsulation, the substrate is given a chance to fold within the cavity. In the case of Group 
I chaperonins, folding starts after ATP binding and displacement of the substrate protein 
into chaperonin cavity by the co-chaperone. For Group II chaperonins, ATP hydrolysis 
triggers the closure of a built-in lid and the release of the substrate into the cavity73. 
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2.4.6 The chaperonin system GroEL/ES of E. coli 
GroEL/ES is the most studied chaperonin system thus far. EM66, and X-ray studies74,75 
showed that GroEL consists of two heptameric rings stacked back to back (Figure 17). 
Each ring is composed of seven identical subunits and forms a cavity where assisted 
folding occurs. Each subunit, ~56 kDa in size, has three domains. The apical domain 
(residues 191-376) is required for the binding of a heptameric co-chaperone GroES and 
non-native substrate. More specifically, substrates are bound by amino acid residues on 
helices H (233-243) and I (255-267)66. Moreover, it has been shown that at least three 
apical domains are required for successful substrate binding76. The intermediate domain 
(residues 134-190) transmits allosteric signals and contains two pivot points (Gly192 and 
Gly375) around which large en-bloc movements occur66. The equatorial domain (residues 
6-133 and 409-523) has a nucleotide binding pocket where ATP binding and hydrolysis 
occurs66. The majority of intra- and inter-ring contacts are formed between equatorial 
domains. 
The height of the double ring complex in the apo state is ~146 Å and the width ~136 Å 
(Figure 17)50. The volume of the cavity is estimated to be 75.000 Å3. Upon ATP and GroES 
binding, the dimensions of the complex increases to ~183 Å in height and ~150 Å in width 
(Figure 17). The volume doubles correspondingly to approximately ~150.000 Å3 and can 
accommodate a substrate up to ~60 kDa in size. 
 
Figure 17: Structure of GroEL and GroEL/ES complex. 
a.) Isolated GroEL subunit from apo GroEL (PDB: 1SS8). GroEL subunit is composed of apical (yellow), 
intermediate (blue) and equatorial (grey). Helices H and I important for substrate binding are in red. 
Hinge residues (Gly192 and Gly375) and residues forming inter-ring contacts (Ala109, Arg452, Glu461 
and Val464) are shown in space-filling representation. N- and C- termini are indicated. 23 residues long 
C-terminal tail is modelled and shown as dots. Gly-Gly-Met repeats are indicated. b.) Side view of apo 
GroEL tetradecamer (PDB: 1SS8) c.) Top view of apo GroEL tetradecamer. d.-f.) GroEL/ES complex (PDB: 
1PF9) in equivalent views and colouring as in a.-c.). GroES is shown in ribbon representation and 
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coloured green. ADP is shown in space-filling representation. Grey arrows indicate conformational 
changes upon nucleotide binding. (reproduced from Hayer-Hartl et al.50). 
The GroEL rings exert allosteric regulation77. Within the rings there is positive allostery 
which results in concerted binding of ATP by all seven subunits. Between the rings, 
negative allostery decreases the binding affinity for ATP of the second ring, therefore 
allowing only one ring to function in the low to mid-range ATP concentrations78. The basis 
for allosteric regulation are formation and breakage of salt bridges between the subunits 
within the rings and the subunits between the rings79. 
GroEL and GroES work together in a complex multi-step cycle driven by ATP binding and 
hydrolysis (Figure 18). 
 
Figure 18: GroEL/ES reaction cycle. 
In this figure, the starting state of the cycle is the apo GroEL tetradecamer where both rings are tense (T) 
state (blue). Upon substrate and ATP binding to GroEL cis ring it proceeds to relaxed (R) state (red). 
GroES (dark blue) binds and causes the release of the substrate protein into the cavity (dark red). Time 
required for ATP hydrolysis is ~10 s which allows the encapsulated protein to fold in isolation. Upon 
completion of ATP hydrolysis in cis ring (yellow) ATP binding to trans ring causes GroES and substrate 
to be released from the cis ring. Former trans ring becomes cis and the cycle repeats (reproduced from 
Clare et al.79). 
Upon binding of ATP to the binding pocket of the equatorial domain, large rigid body 
movements occur. Conformational states along the pathway have been observed by 
fluorescence80 and cryo-EM79. In the apo-state where both of the GroEL rings are in the 
tense state (T), ATP binding to the cis-ring causes the transition to the first relaxed state 
(Rs1) (Figure 19). In this state an en-bloc, 35° sideways tilt of the apical and intermediate 
domains around the lower hinge occurs. As a consequence, the ATP binding pocket closes. 
Additionally, the salt bridges R197-E386 and E255-K207 between the intermediate and 
apical domains, and between the equatorial domains are broken, respectively. New salt 
bridges are formed: K80-E386 and E255-K245 in adjacent equatorial and apical domains, 
respectively. Next, in the second relaxed state (Rs2), the upper hinge bends and the apical 
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domain undergoes an additional lift without breaking the newly formed salt bridges. 
Finally, after breakage of the newly-formed salt bridges, the apical domain moves radially 
outwards and elevates for 20° to form the third relaxed state (Rs-open). This radial 
movement and elevation can stretch a bound substrate. As an effect, certain kinetically 
trapped intermediates may be resolved. Moreover, it is in this state that GroES, via its 
mobile loops, can bind to the GroEL apical domains. In the final step after GroES binding, 
the apical domains rotate 100° clockwise and complete their elevation and thus reach the 
R-ES conformation. This large rotation is thought to be responsible for the release of the 
captured substrate into the cavity, which has changed in character from hydrophobic to 
hydrophilic. The equatorial domains do not undergo such profound conformational 
changes, but only minor tilting and twisting motions. Since substrate binding and 
rearrangement is slower (~5s-1) than ATP binding (~100s-1), ATP would bind the GroEL 
cis ring in either its Rs1 or Rs2 state followed by GroES binding (~1-2s-1)79. The substrate 
is given a chance to fold in isolation for about 7-10 seconds, the time required for 
hydrolysis of seven ATP molecules to ADP within cis cavity (at 25°C). Afterwards, seven 
new ATP molecules bind to the trans ring and cause the release of ADP, GroES and 
encapsulated substrate. If the protein reaches the native state after one round of assisted 
refolding, it is released to bulk solution. Otherwise it re-binds GroEL. Now the former 
trans ring has become cis ring and another round of assisted refolding can commence. 
Essentially, the cycles as described make GroEL a two-stroke engine, allowing only one of 
the cavities at the time in assisting protein folding50. Apart from the prevalent mode of 
encapsulation as a means of assisting refolding, there are GroEL substrates which have a 
mass larger than 60 kDa71. For such proteins refolding may occur via trans folding, which 
means that the substrate is bound to apical domains of a trans ring where it undergoes 
conformational stretching and is released into solution after GroES binding to the 
opposite cis ring81. 
 
Figure 19: Series of formation and breaking of salt bridges in GroEL cis ring during 
reaction cycle. 
GroEL crystal structure (PDB: 1OEL) shown in ribbon representation was flexibly fit into cryo-EM density 
(EMDB. 1997-2000) shown in white. For comparison, GroEL/ES crystal structure in ribbon 
representations is shown (PDB: 1SVT). Shown are two GroEL subunits interacting within a ring. Helices 
H, I and M are in red, orange and green, respectively. Charged residues involved in intra-ring interactions 
are shown in space-filling representation. Negatively charged residues are in red and positively charged 
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in blue. GroEL ring starts in tense (T) state where E255-K207 and R197-E386 salt bridges are formed. 
Upon ATP binding the GroEL ring proceeds to Rs1 state characterized by formation of E255-K245 and 
K80-E386 salt bridges. In next state, Rs2, the salt bridges are preserved, however, when the cis ring 
reaches Rs-open state both former salt bridges are broken. Upon ES binding, the GroEL cis ring is in its 
final state R-ES where K80-E386 salt bridge is re-established (reproduced from Clare et al.79). 
It has been reported that the folding of substrate in presence of GroE system experiences 
an increase in folding rate. There are several models proposed in the field to explain this 
phenomenon82. 
2.4.7 GroE mechanism of protein folding 
The passive (Anfinsen) cage model postulates that the increase in a protein's refolding 
rate by the GroEL/ES system is due to the prevention of reversible aggregation83. The 
system plays no direct role in modulating the folding landscape of the substrate but 
merely allows folding to occur at infinite dilution, thus preventing any unwanted 
aggregation. Folding in free solution, on the other hand, generates aggregates, which can 
gradually disaggregate and allow monomers to fold. This reversible 
aggregation/disaggregation step would result in a slower apparent spontaneous 
refolding rate. Experimental work supporting this view was performed by dynamic light 
scattering measurements on the refolding of DM-MBP in absence or presence of 
GroEL/ES84. It is clear from this experiment that aggregates, which are otherwise absent 
in presence of chaperonin, form during spontaneous refolding. However, the reversibility 
of aggregation was not demonstrated. 
The iterative annealing model states that the GroE system has an active role in refolding 
even in the absence of reversible aggregation85,86. The active contribution of GroEL would 
consist of successive rounds of substrate binding, stretching and release into either bulk 
solution or the chaperonin cavity. Therefore, the GroEL inner cavity plays no critical role 
in assisted protein folding. What is crucial in this model is stretching of the bound 
substrate, which exerts forces large enough to break non-native contacts and unfold 
kinetically trapped intermediates. Such a 'forced unfolding' event is followed by substrate 
release either into the cavity or into solution. The protein is then given another chance to 
partition between either productive or unproductive folding trajectories. The 
accumulated body of evidence shows that an average GroEL substrate folds in ~30-60 
seconds, which at ~7-10 seconds per cycle at 25°C comes to ~3-10 cycles per folding 
event71,87. This observation would support the need for iteration. Additionally, theoretical 
studies88 on polymers showed that iterative annealing can be a way to increase folding 
rate, however, studies with single ring variant of GroEL (SR1-EL), where absence of an 
allosteric signal from the second ring makes SR1-EL/ES complex long-lived89, have shown 
that a single round of encapsulation is sufficient for a substrate to refold90,91 at the same 
rate as during cycling. In that regard, additional, modified view of iterative annealing has 
been proposed based on MD simulations of a GroEL-encapsulated β-hairpin92. After the 
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first and only cycle, the substrate, after being encapsulated, would iteratively bind to and 
release from the inner cavity wall. The wall functions as a binding surface and participates 
in the formation of successive folding intermediates that lead to the native state. Such an 
interpretation, however, already departs from the classical forced unfolding model. 
The active cage model attributes an active role in refolding to the environment within the 
cavity90,91,93,94. Therefore it is of utmost importance that the substrate after the binding 
and stretching event is displaced into the cavity after GroES binding95,96. Encapsulation 
has a dual role, it prevents aggregation and it provides a folding environment markedly 
different from the one free in solution. The character of the cavity wall changes upon ATP 
and GroES binding from hydrophobic to hydrophilic and acquires a net negative charge of 
-42 clustered in two layers75. Charge clusters are conserved among GroEL homologs, 
suggesting a function in assisted protein folding97. 
Several experimental studies thus far have shown the importance of the cavity in 
accelerating the refolding of substrates90,91,93. Two obvious questions come to mind, how 
is this environment different from the one in bulk solution, and by what means is this 
realized?  
A recent GroEL mutation study has shown91, that in the GroEL mutant termed KKK2 
(Figure 20), where the second negative charge cluster is mutated to positive, resulting in 
net neutral charge, the ability of the chaperonin to accelerate folding was abolished. This 
directly points to the importance of negative charges lining the inner cavity wall. 
Additionally, in the same study and later confirmed90, the first experimental observation 
on the role of the confining effect of encapsulated, folding substrate was shown. According 
to polymer theory, confinement would reduce the entropy of the unfolded chain by 
sterically preventing extended conformations. This view was later challenged98 by taking 
into account the effect of confinement not only on polypeptide chain but on solvent 
molecules as well. Nevertheless, the confining effect is necessary but not sufficient for 
accelerated folding, as demonstrated by the GroEL KKK2 mutant91. Despite confinement, 
GroEL KKK2 cannot accelerate substrate folding. One might speculate that the cavity upon 
encapsulation has a dual role. It isolates the protein and provides a structural framework 
to position negative charges, which then point into the cavity and influence the chemical 
environment of the cavity90 or participate in interactions with engulfed substrate99. In the 
latter case, an intricate interplay between both substrate and inner-wall physicochemical 
properties would dictate the folding propensity. It was shown by MD simulation99, that 
only if the cavity has a repulsive character relative to the substrate would the refolding be 
accelerated. Later on, another role for negative charges was suggested by MD 
simulation100. It was proposed that the negative charges in the cavity influence water 
structure, and in turn the folding process. According to that study100 in wild type GroEL, 
solvent in the cavity displays a higher degree of structure. The degree of water structure 
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was defined as number of water molecules 1 nm from the cavity wall. Simulation showed 
a correlation between experimentally observed DM-MBP refolding rates with different 
GroEL charge mutants and number of water molecules as determined from the 
simulation. Interestingly, the authors showed a higher water density at the level of the 
second charge cluster. Higher water density would cause the unfolded substrate to pay a 
larger thermodynamic cost for not being able to bury its hydrophobic amino acid residues. 
Essentially, as compared to bulk solution, the hydrophobic effect would be stronger inside 
the cavity. This led to the conclusion that the negative charges on the inner cavity wall 
accumulate water, and due to a stronger hydrophobic effect the encapsulated protein 
folds faster. 
 
Figure 20: Inside of SR1-EL/ES complex. 
Cross-section of one ring of GroEL/ES complex shown in space-filling representation (PDB: 1AON).  
Inside view of four GroEL/ES subunits. Two conserved charged clusters are coloured red and blue, 
respectively (reproduced from Tang et al.91). 
So far only one experimental study101 has attempted to detect any increase in water 
density or decrease in water diffusion inside the GroEL cavity upon ATP binding and 
GroES complex formation. For this, the authors used a single ring variant of GroEL D398A 
(SR1-EL D398). GroEL D398A mutant can bind ATP but it hydrolyses it at 2% rate of wild 
type GroEL. The D398A mutation in the context of SR1-EL makes the complex with GroES 
even more stable. In order to measure water properties, the GroES Y71C mutant was used. 
It has a cysteine residue that points into the cavity upon complex formation and is suitable 
for spin labelling in an NMR experiment. The result of the study was negative: no changes 
in water properties upon complex formation were shown. A reason could be that only 
local changes in proximity of charged clusters play the role, or that the water structuring 
effect is significant only in the presence of a substrate. 
This clearly opposing results from simulation and experiment demand that more studies 
be performed on the question of how charges accelerate GroEL/ES assisted protein 
folding. 
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2.4.8 GroEL model substrate DM-MBP 
Maltose binding protein (MBP) is an E. coli periplasmic protein of ~41 kDa. Removal of 
the signal peptide results in a cytosolic protein that can fold robustly and rapidly. MBP 
has two domains, discontinuous in sequence (Figure 21). The maltose binding site is 
located in the cleft between the domains135. MBP is convenient for protein folding studies 
due to eight intrinsic tryptophans that are spaced throughout the sequence. Upon 
denaturation, the tryptophan signal is reduced five-fold. As confirmed by other 
experiments (CD, maltose binding), the change in tryptophan fluorescence reports on 
global folding or unfolding. 
 
Figure 21: Structure of MBP. 
Crystal structure of MBP (PDB: 1OMP) shown in ribbon representation. DM-MPB has two domains 
discontinuous in sequence with maltose binding pocket in the cleft between the N-domain (blue) and C-
domain (yellow). Residues V8 and Y283 are shown in ball and stick representation and are coloured in 
green. Tryptophan residues are shown in ball and stick representation and are coloured in red. N- and C-
termini are indicated (reproduced from Tang et al.91). 
There are several destabilizing mutants of MBP which have reduced folding kinetics136,137. 
A specific mutant of MBP (DM-MBP) with two point mutations (V8G, Y283D) in the N-
domain, was shown to strongly interact with GroEL. Furthermore, it was shown that 
GroEL accelerates the folding of DM-MBP up to 10-fold91. Recent studies have shown that 
DM-MBP, upon dilution from denaturant, forms a collapsed kinetically trapped 
intermediate on a millisecond time scale. This intermediate has almost no secondary 
structure and is structurally flexible90. GroEL binds this intermediate on a millisecond 
timescale138 and causes partial expansion. Upon ATP binding, the subsequent 
conformational changes cause further DM-MBP stretching. Following GroES binding DM-
MBP is displaced into the cavity, where it adopts compact conformation and has the 
opportunity to fold to the native state. 
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2.5 GroEL/ES substrates 
Under normal cellular conditions no more than 10% of cytosolic proteins utilize the 
GroEL/ES system for folding (Figure 22)71. The identification of GroEL/ES substrates 
from E. coli spheroplasts was achieved by affinity chromatography and subsequent mass 
spectrometry. This study led to the identification of ~250 proteins, among which were 
components of the transcription/translation machinery, metabolic enzymes, chaperones 
and structural proteins. The identified proteins were divided into three classes based on 
their GroEL dependency71. Class I substrates (38 proteins), were found inside GroEL/ES 
complex, but do not stringently need the chaperonin for folding. Class II substrates (126 
proteins) are defined as those that require GroEL/ES for productive folding, but can be 
folded by Hsp70 system as well. Class III substrates (84 proteins) are the most 
aggregation prone and can fold at 37 °C only in the presence of GroEL/ES. Interestingly, 
among class III substrates, almost 50% percent have a (αβ)8 TIM-barrel fold with a 
complex topology and many long-range interactions. This is significantly more than the 
6.8% occurrence of the TIM-barrel fold among all E. coli lysate proteins. A later study102 
recapitulated earlier findings and found a reduction in the number of these substrates 
upon GroEL depletion in E. coli cells. Based on depletion experiments a new class IV within 
the former class III was defined. Class IV substrates (49 proteins) are defined as those that 
aggregate or are degraded upon depletion of GroEL. 
 
Figure 22: GroEL interactors. 
There are ~250 proteins that interact with GroEL and can be divided into three classes. Class I substrates 
do not require GroEL for successful folding. Class II substrates can be folded by DnaK/J system and do 
not necessarily require GroEL. Class III substrates are stringent GroEL substrates and can fold at 37°C 
only in presence of GroEL. Interestingly, almost 50% of class III substrates have TIM barrel fold 
(reproduced from Kerner et al.71). 
The analysis of GroEL substrates showed that most of them have a mass lower than 60 
kDa71, which allows them to fit into the cavity (Figure 23). Most of the substrates have a 
net-negative charge which coincides with net-negative charge of the cavity wall. A 
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comparison with GroEL independent substrates showed that GroEL substrates are less 
hydrophobic. Moreover, E. coli homologs from an organism Ureaplasma urealyticum, 
which has no GroEL, have more hydrophobic amino acid residues. It might be that an 
increase in hydrophobicity causes a more efficient collapse due to increased hydrophobic 
effect. This would be analogous with the effect due to increased water structure in GroEL 
cavity. 
 
Figure 23: Substrate protein S-adenosylmethionine synthase (MetK) inside GroEL 
cavity. 
Cross-section of one ring GroEL/ES complex (PDB: 1PF9) shown in space-filling representation. Inside 
the GroEL/ES cavity crystal structure of MetK (42kDa) (PDB: 5H9U) shown in space-filling 
representation coloured red is modelled. In its molten globule state MetK would have ~30% expanded 
volume (reproduced from Hayer-Hartl et al.50). 
Besides using natural E. coli GroEL substrates, it is possible to study GroEL function using 
heterologous proteins which normally interact with mitochondrial or chloroplastic 
chaperonins, such as mitochondrial rhodanese (mRho) or Rhodospirillum rubrum 
Rubisco, respectively. Another type of substrate is a double mutant of maltose binding 
protein (DM-MBP) which in its natural setting never interacts with the chaperonin. 
Recently95,96, it has been proposed, for two heterologous substrates, rhodanese and DM-
MBP, that the substrate can 'escape' from the cavity during the refolding. Escape was 
described as an event where the aforementioned substrates approach and protrude 
through ‘windows’ (~10 Å in size) in the GroEL/ES complex cavity wall. Moreover, even 
more substrate escapes in the presence of a specific antibody against that substrate. Such 
an escape was termed 'forced escape'. Another study103 addressed the question of escape 
by comparing the rates of ATP, substrate and GroES binding, and conformational changes 
of apical domains of SR1-EL. According to that study, 'substrate escape' is displacement 
of the substrate upon GroES binding due to overlap in binding sites of substrate and 
GroES. Additionally, one has to consider differences between non-native states of 
homologous and heterologous substrates when binding GroEL. Most probably, in case of 
heterologous non-native substrates, fewer hydrophobic residues are exposed which 
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results in weaker binding. Moreover, addition of ATP and associated conformational 
changes of apical domains further increase the KD for substrate binding, which allows for 
easier displacement by GroES. For homologous or highly aggregation prone heterologous 
substrates, escape was never observed for either GroEL or its single ring variant. 
2.6 RuBisCo – a highly chaperone dependent protein 
Ribulose-1,5-bisphosphate-carboxylase/-oxygenase (Rubisco) is the key enzyme in the 
Calvin-Benson-Bassham cycle (CBB). It is responsible for carbon fixation in all 
photosynthetic organisms104. It catalyses the reaction of carboxylation of a sugar 
substrate ribulose-1,5-bisphosphate (RuBP), which from an unstable carboxyketone 
(Figure 24) splits into two molecules of 3-phosphoglycerate (3PG). The latter is then 
converted to glyceraldehyde-3-phosphate (G3P). G3P is used for the synthesis of sugar 
molecules, fatty acids and amino acids, as well as regeneration of RuBP. Due to the 
electrostatic similarity of CO2 and O2, and the atmospheric abundance of O2 (21%) over 
CO2 (0.04%), Rubisco cannot completely discriminate between them, which leads to 
oxygenation of RuBP in a process called photorespiration105. Oxygenation of RuBP results 
in one molecule of 3PG and one molecule of 2-phosphoglycolate (2P-glycolate). 2P-
glycolate is toxic and has to be recycled in an ATP-dependent manner via the 
mitochondrial-peroxisome pathway, resulting in a loss of CO2. Photorespiration has long 
been perceived as an energetically wasteful process. However, recent studies show that it 
plays an important role in other plant metabolic pathways106, such as nitrate 
assimilation107. 
 
Figure 24: Rubisco catalytic cycle. 
Rubisco substrate RuBP is carboxylated and transformed to unstable carboxyketone which then splits to 
two molecules 3-phosphoglycerate (3PG). 3PG is then converted via series of steps to glyceraldehyde-3-
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phosphate (G3P) which is then used for the biosynthesis of other macromolecules. In a competing 
reaction O2 reacts with RuBP which forms peroxyketone that splits to one molecule of 3PG and one 
molecule of 2-phosphoglycolate (2-PG). 2-PG is toxic to cell and is recycled to 3PG through 
photorespiration involving peroxisome and mitochondrion. In the process ATP is used and fixed CO2 is 
lost (reproduced from Whitney et al.108). 
2.6.1 Structure of Rubisco large and small subunits 
There are several structural forms of Rubisco found in nature109. Plants, algae, 
cyanobacteria and proteobacteria have form I Rubisco. Form I is a hexadecameric 
structure composed of eight large (RbcL, ~50 kDa) and eight small (RbcS, ~15 kDa) 
subunits. Eight RbcL subunits are arranged as a tetramer of anti-parallel dimers (RbcL8 
core complex). The core complex is capped on the top and bottom by four RbcS subunits. 
The holoenzyme (RbcL8RbcS8) with a total mass of ~520 kDa has a cylindrical shape with 
a diameter of ~110 Å and a height of ~100 Å (Figure 25). Form II Rubisco, which is found 
in certain bacteria and dinoflagellates, is simpler. It consists only of two RbcL subunits, 
which form a dimer without RbcS subunits. 
 
Figure 25: Rubisco form I structure. 
a.) Structure of Form I Rubisco (PDB: 1RBL) from Synechococcus elongatus PCC6301 shown in surface 
representation. Alternating large subunits are coloured cyan and grey. Small subunits are coloured green. 
One RbcL2 antiparallel dimer is shown in ribbon representation coloured grey and yellow. Inhibitor 
caraboxyarabinitol-1,5-bisphosphate (CABP) bound in the active site is shown in space-filling 
representation and is coloured violet. b.) Crystal structure of single Rubisco large subunit. It has two 
domains, N-terminal α+β domain and C-terminal TIM barrel domain. N- and C- termini are indicated 
(reproduced from Hauser et al.104). 
Form III Rubiscos found in archaea consist of three to five RbcL dimers arranged in ring-
like assemblies. Unlike Form I and Form II Rubiscos, Form III Rubisco is not involved in 
photosynthesis, but is involved in regeneration of RuBP in nucleotide biosynthesis109. 
Despite high sequence conservation110 (~80% amino acid identity) form I RbcL 
sequences can be phylogenetically classified into green-type enzymes (Figure 26) (forms 
IA and IB of plants, green algae, cyanobacteria) and red-type enzymes (form IC and ID of 
non-green algae and phototrophic bacteria). 
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Figure 26: Rubisco phylogenetic tree. 
Phylogenetic tree of selected Rubisco sequences. Form IA and IB belong to green-type Rubiscos whereas 
forms IC and ID to red-type Rubiscos. The RbcL C-terminal sequences and their cognate activases are 
indicated. X represents variable residues. For species in bold activases have been biochemically and/or 
structurally characterized (reproduced from Bhat et al.105). 
In contrast to RbcL, RbcS subunits have lower sequence conservation110 (~30-40% amino 
acid identity). The diversity of RbcS subunit sequences is responsible for functional 
differences between Rubisco enzymes. In eukaryotes, RbcL is always plastid encoded. 
RbcS however, is plastid encoded in non-green algae and nuclear encoded in green algae 
and plants111. Nuclear encoded RbcS have a cleavable N-terminal targeting sequence for 
chloroplast import. 
The RbcL subunit consists of an N-terminal α+β domain of ~150 amino acids and a ~325 
amino acids long C-terminal domain which consists of β8α8 triosephosphate isomerase 
(TIM) barrel domain (~320 amino acids) and an unstructured C-terminal tail (~15 amino 
acids in green type Rubisco and~25 amino acids in red type rubisco)109 (Figure 25). The 
antiparallel RbcL dimer has two active sites formed by residues of the opposing N-
terminal domain of one subunit and the C-terminal TIM-barrel domain of the adjacent 
subunit109. 
2.6.2 Rubisco catalytic cycle 
In order for Rubisco to successfully catalyse CO2 fixation, it first has to be activated. 
Activation of Rubisco enzyme (E) is achieved by a spontaneous carbamylation reaction 
where one non-substrate molecule of CO2 reacts with active site Lysine 201, followed by 
binding of an Mg2+ ion112. Rubisco is now in its activated form (ECM). Activation of Rubisco 
is necessary because chemical modification of the active site allows for correct positioning 
of the RuBP which is essential for a successful electrophilic attack by the second molecule 
of CO2 that will be fixed into RuBP110. Binding of RuBP to the active site of activated 
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Rubisco is followed by movement of the retracted mobile loop 6 of the TIM barrel over 
the active site. Loop 6 is pinned down in its new position by the unstructured C-terminal 
tail through a so called C-terminal latch113. These conformational changes result in closing 
of the active site and its dehydration, which is mandatory for a successful electrophilic 
reaction. 
2.6.3 Folding and assembly of Rubisco 
Due to its complex topology109 the RbcL subunit needs help from chaperonins to reach its 
unique three-dimensional structure114. Plastid encoded RbcL relies on Cpn60/Cpn10, 
which are chloroplast homologs of bacterial GroEL/GroES. In-vitro experiments have 
shown that Form II RbcL can assemble into active enzyme after GroEL/ES assisted 
refolding114. Form I RbcL subunit, however, fails to assemble and stays associated with 
GroEL, despite having reached its native state115. This observation suggested that there 
have to be additional factors which facilitate assembly of the RbcL8 core followed by 
formation of RbcL8S8 holoenzyme. The protein encoded by the rbcX gene located in the 
intergenic space of the rbcL and rbcS genes seemed as a possible candidate for the 
assembly chaperone. Indeed, co-expression of RbcX with RbcL and RbcS in E. coli 
increased the yield of enzymatically active Rubisco115. Further biochemical and structural 
studies showed that RbcX is a homodimer of ~15 kDa subunits which functions as a 
specific assembly chaperone. Cyanobacterial Form I Rubisco could recently be 
reconstituted in vitro in the presence of GroEL/ES and RbcX. After assisted refolding, RbcX 
binds the unstructured C-terminal of RbcL and mediates proper antiparallel alignment of 
two RbcL subunits, thus functioning as a molecular clamp. Each RbcL anti-parallel dimer 
has RbcX bound on top and on bottom. Such stabilization of the dimer then shifts the 
equilibrium towards the RbcL8:RbcX8 assembly intermediate. In the final step, RbcS 
displaces RbcX and enzymatically active RbcL8:RbcS8 is formed (Figure 27). 
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Figure 27: Green-type Rubisco folding and assembly. 
Upon GroEL/GroES assisted refolding and release of cyanobacterial RbcL, RbcX binds the unstructured 
C-terminal tail and mediates proper alignment of the RbcL dimer. RbcL2:RbcX2 complex is followed by 
assembly into RbcL8:RbcX8 complex. RbcS binding to pre-formed binding interface in RbcL8:RbcX8 leads 
to structuring of RbcL N-terminus and 60s loop which results in displacement of RbcX and formation of 
RbcL8:RbcS8 holoenzyme(reproduced from Hauser et al.104). 
2.6.4 Metabolic maintenance of Rubisco 
Despite its pivotal role, Rubisco is an inefficient enzyme. It fixes only ~3-10 molecules of 
CO2 per second in plants. The slow rate of Rubisco catalysed incorporation of CO2 is to a 
degree compensated by the significant amount of Rubisco, which can reach up to 50% of 
soluble leaf protein116. Another drawback of Rubisco is that RuBP can bind to the active 
site before the enzyme activation event takes place, leading to an inactive enzyme. 
Additionally, there are other inhibitory sugar-phosphates, some of which are mis-fire 
products of Rubisco's multistep catalytic reaction (XuBP, PDBP), while others (CA1P) 
function as a night-time inhibitors which are produced by plant under low-light 
conditions117. In all cases mentioned above, Rubisco is trapped in its closed, inhibited form 
(EI or ECMI) (Figure 28). 
 
Figure 28: Sugar phosphates involved in Rubisco inhibition. 
Rubisco activity is regulated or inhibited by various sugar phosphates. E, the non-carbamylated enzyme; 
ECM, carbamylated and Mg2+ ion bound enzyme; EI, the sugar phosphate inhibited E form; ECMI, the 
inhibited ECM form; Rca, Rubisco activase (reproduced from Bhat et al.105). 
Rubisco can be rescued from its inactive form by spontaneous opening of the active site, 
however to reactivate Rubisco on a biologically relevant time scale, evolution has 
equipped many photosynthetic organisms with an enzyme called Rubisco activase 
(Rca)118. 
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2.6.5 Rubisco activases 
Rca belongs to a superfamily of proteins termed AAA+ (ATPases associated with various 
cellular activities)118. These are macromolecular machines that are powered by ATP 
hydrolysis for unfolding, disassembly or remodelling of their substrates119. Rca 
metabolically repairs Rubisco by opening the active site and releasing the inhibitory 
sugar120. Rubisco can then be reactivated and acquire its catalytically competent state. Rca 
proteins have been found to reactivate both red- and green-type Rubisco in organisms 
ranging from chemoautotrophic bacteria to higher plants121,122,123. Despite considerable 
sequence variability among different activases124, they all share a common domain 
architecture characteristic of AAA+ proteins125, consisting of N-terminal α/β nucleotide 
binding subdomain and a C-terminal α-helical subdomain105. The functional form of the 
activase is a ring-shaped hexamer with a central pore, where pore loop residues 
indispensable for Rubisco remodelling are located126,127 . 
2.6.5.1 Red-type activases 
Red-type activases, which remodel form IC and form ID Rubisco (red-type) have an 
additional α-helical extension at the N-terminus126. The two subdomains of the AAA+ core 
module are separated by a flexible linker. Walker A and Walker B nucleotide binding 
motifs are located in the N-terminal α/β subdomain (Figure 29). 
 
Figure 29: Red type Rubisco activase. 
a.) Domain organization of red type RsRca. b.) Crystal structure of RsRca protomer (PDB: 3SYL) shown 
in ribbon representation. α-helical and α/β subdomains are indicated. Bound ADP; RuBP, pore loops and 
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N-terminal extension are indicated. c.) rsRca ring-like hexameric model fitted into EM reconstruction 
(EMDB: 1932) shown in top and side views: Bound ADP and RuBP are indicated in side view. d.) rsRca 
filament formed in absence of RuBP. Filamentous form would serve as a storage for rsRca in absence of 
photosynthesis. Start of photosynthesis causes the accumulation of RuBP to millimolar concentrations. 
Free RuBP binds to Rca leading to its hexamerization. e.) Model of rsRca interaction with Rubisco where 
rsRca docks onto Rubisco and transiently pulls by Rubisco C-terminal tail into the central pore. This 
opens the Rubisco active site and releases inhibitory sugar. Rca is shown as in c.) Rubisco structure (PDB: 
4F0K) is shown in surface representation. RbcL and RbcS are shown in different shades of pink. RbcL C-
terminal tails are depicted in red lines (reproduced from Bhat et al.105). 
Red-type activase from the proteobacterium Rhodobacter sphaeroides (RsRca) attains its 
functional homohexameric structure in the presence of RuBP and ATP126 (Figure 29). 
RuBP and Rubisco stimulate RsRca ATPase activity. In the absence of RuBP, RsRca forms 
high-molecular weight filaments which are ATPase inactive and are believed to represent 
a storage form for the activase in absence of photosynthesis (Figure 29). Reactivation of 
the red-type form IC Rubisco by the remodelling activity of RsRca depends on two 
elements: the extended C-terminal tail of RsRbcL126 and conserved pore loop residues 
(Tyr/Ile/Gly) of RsRca lining the central channel (diameter of ~25Å) of the active 
hexamer126. Pore loops were implicated in exerting the pulling force on the extended C-
terminal tail of the RbcL subunit. This puts forward a mechanism where RsRca docks onto 
Rubisco with its conserved top surface and pulls the C-terminal tail into the pore thereby 
opening the active site which results in the release of the inhibitory sugar105 (Figure 29).  
Eukaryotic Rca from red algae Cyanidioschyzon merolae (CmRca) is a hexamer consisting 
of two different protomers in a 1:1 ratio122, and exerts its remodelling activity on Form ID 
Rubisco. One of the protomers is nuclear encoded and the other is plastid encoded. Both 
of them have 60-70% identity with RsRca105. In the case of CmRca, RuBP is not required 
for hexamerization. However, RuBP has role as an allosteric regulator of CmRca ATPase 
activity and thus couples the state of CBB cycle and Rubisco activity. 
2.6.5.2 Green-type activases 
Recently123, prokaryotic Rubisco activases of green-type Rubisco form IA from the 
chemoautotrophic bacteria Acidithiobacillus ferrooxidans and Halothiobacillus 
neapolitanus have been described. These proteins are homohexamers (AfRcaI; HnRca) 
that need an additional adaptor protein CbbO to interact with Rubisco. AfRcaI and HnRca 
α/β subdomains can be classified as MoxR group of prokaryotic AAA+ proteins128, which 
interact with proteins that have a von Willebrand factor A (VWA) domain (Figure 30). 
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Figure 30: Prokaryotic green type Rubisco activase. 
a.) Domain organization of HnRca and its adaptor protein HnCbbO. b.) Crystal structure of HnRca 
protomer (PDB. 5C3C) in ribbon representation. α-helical and α/β subdomains are indicated. Bound ADP 
and pore loops are indicated. c.) Ring-like hexameric model of HnRca fitted into EM reconstruction 
(EMDB: 6477 shown in top and side views. Bound ADP is indicated in side view. d.) Model of HnRca 
interaction with Rubisco where HnRca docks onto Rubisco via VWA domain of CbbO recognizing exposed 
Asp82 (marine blue). It is still not clear whether HnRca central pore engages with Rubisco. Rca is shown 
as in c.) Rubisco (PDB:1SVD) is shown in surface representation. RbcL and RbcS are shown in different 
shades of blue. RbcL C-terminal tails are depicted with blue lines (reproduced from Bhat et al.105). 
Interestingly, CbbO has a VWA domain, and as is characteristic for this domain, a metal-
ion-dependent adhesion site (MIDAS) mediates protein-protein interaction via a cation 
(usually Mg2+)129 (Figure 30). The ATPase activity of AfRcaI and HnRca is stimulated by 
RuBP but inhibited by Rubisco and CbbO. The mode of remodelling action of AfRcaI and 
HnRca remains to be elucidated since recent experiments123 showed that its remodelling 
activity, in contrast to RsRca, does not depend on pore loop residues. However, 
interaction with the C-terminal tail of RbcL is still required for reactivation123. 
One of the first Rubisco activases to be discovered130, Rca in Arabidopsis thaliana, is a 
eukaryotic Rubisco activase of green-type Rubisco form IB. Eukaryotic activases of green-
type Rubisco form IB have, in addition to the AAA+ core module, an N-terminal domain 
important for binding to Rubisco (localized at the top surface of the hexamer127 for 
Nicotiana tabacum) and a C-terminal extension crucial for constitutive ATPase activity105 
(Figure 31). 
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Figure 31: Eukaryotic green-type Rubisco activase. 
a.) Domain organization of NtRca. b.) Crystal structure of NtRca protomer (PDB: 3T15) shown in ribbon 
representation. α-helical and α/β subdomains are indicated. Pore loops, specificity helix 9, N-terminal 
domain are indicated. c.) Ring-like hexameric model of NtRca fitted into EM reconstruction (EMDB: 1940) 
shown in top and side views. Additional density at the top is attributed to N-terminal domain. Specificity 
helix 9 is coloured in purple d.) Model of NtRca interaction with Rubisco where NtRca docks onto Rubisco 
via N-terminal domain and specificity helix 9 recognizes Arg89. How the ntRca interacts with Rubisco C-
terminal tail still remains to be to be investigated. Rca is shown as in c.) Rubisco is shown in surface 
representation (PDB: 1EJ7). RbcL and RbcS are shown in different shades of green. RbcL C-terminal tails 
are depicted as green lines(reproduced from Bhat et al.105). 
Regulation of activase hexamer formation and activity in higher plants (A. thaliana, rice, 
barley, maize and cotton) is far more intricate than for the other activases described 
above. One such regulatory mechanism is the formation of disulphide bonds in the C-
terminal extension under oxidizing conditions (night time, in the absence of 
photosynthesis) which inhibits ATP binding to the activase and thereby Rubisco 
activation131. Moreover, hexamer formation of plant activases is sensitive to the ATP:ADP 
ratio132, with a higher ratio favouring hexamer formation and thus the active form. 
Additionally, catalytic activity also depends on concentration of Mg2+ ions (higher Mg2+ 
concentration increases the activity in NtRca) as a response to changes in available 
light133. The mechanism of remodelling of plant Rubisco is still not established. From 
experiments thus far we know that NtRca engages with inhibited Rubisco via the N-
terminal domain and needs conserved loop segments that face the pore to reactivate 
Rubisco. What is not clear, is how the activase exerts force on plant Rubisco lacking an 
extended C-terminal tail105. Interestingly, no inhibited forms of cyanobacterial Rubiscos 
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have been reported thus far, although cyanobacteria contain genes encoding Rca-like 
proteins134. 
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3 Publications 
3.1 Article 1 - Active Cage Mechanism of Chaperonin-Assisted 
Protein Folding Demonstrated at Single-Molecule Level 
This study resolved the long-standing question whether the GroEL/ES system functions 
as a folding catalyst84,93. We also reassessed the role of the GroEL cavity in the process of 
assisted folding85. To address these questions, we used a combination of biochemical, 
ensemble and single molecule fluorescence, and other spectroscopic methods. 
Additionally, we developed a novel single molecule fluorescence approach for measuring 
the spontaneous and assisted folding rate of the model substrate DM-MBP. Single 
molecule FRET, fluorescence correlation spectroscopy (FCS) and fluorescence cross-
correlation spectroscopy (FCCS) measurements were conducted at very low protein 
concentration (100 pM), where any unwanted protein aggregation is prevented. With this 
study, it has become clear that the observed increase in DM-MBP folding rate is due to an 
active role of the GroEL/ES system and not solely due to aggregation prevention by the 
GroEL/ES system. Furthermore, we showed that a single round of folding is enough to 
achieve an increase in folding rate, thus excluding the need for several binding, unfolding 
and release events as stated by the iterative annealing model. Lastly, we showed 
unequivocally that the substrate, once encapsulated, cannot escape from the GroEL cavity. 
Successful encapsulation is of utmost importance for the substrate to experience the 
environment within the GroEL cavity which is markedly different from one in bulk 
solution. Thus, the GroEL cavity does not only allow the substrate to fold in isolation, but 
it actively modulates the folding landscape of an encapsulated protein, resulting in an 
increased folding rate. 
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Journal of Molecular Biology (2014)139 
Gutpa AJ, Haldar S, Miličić G, Hartl FU, Hayer-Hartl M. 
Contribution: This project was performed in collaboration with Amit Gupta and 
Shubhasis Haldar. I performed encapsulation experiments using analytical gel filtration 
chromatography, SDS gel electrophoresis, fluorogel imaging and western blotting in order 
to find appropriate conditions (buffer, salt concentration, pH) for successful 
encapsulation of the DM-MBP by SR1-EL. These experiments showed that there is no 
substrate escape after encapsulation. Moreover, the established conditions for successful 
encapsulation by SR1-EL allowed for subsequent ensemble and single molecule 
fluorescence experiments to be conducted. 
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e FRET. Folding intermediate bound to GroEL shows a
FRET efficiency distribution. Upon refolding, DM-MBP
verts to its compact native structure that exhibits a high
ET efficiency distribution.The cylindrical chaperonin GroEL and its lid-shaped
cofactor GroES of Escherichia coli have an essential
role in assisting protein folding by transiently
encapsulating non-native substrate in an ATP-regu-
lated mechanism. It remains controversial whether
the chaperonin system functions solely as an infinite
dilution chamber, preventing off-pathway aggrega-
tion, or actively enhances folding kinetics by
modulating the folding energy landscape. Here we
developed single-molecule approaches to distin-
guish between passive and active chaperonin
mechanisms. Using low protein concentrations
(100 pM) to exclude aggregation, we measured the
spontaneous and GroEL/ES-assisted folding of
double-mutant maltose binding protein (DM-MBP)
by single-pair fluorescence resonance energy trans-
fer and fluorescence correlation spectroscopy. We
find that GroEL/ES accelerates folding of DM-MBP
up to 8-fold over the spontaneous folding rate.
Accelerated folding is achieved by encapsulation of
folding intermediate in the GroEL/ES cage, indepen-
dent of repetitive cycles of protein binding and
release from GroEL. Moreover, photoinduced elec-
tron transfer experiments provided direct physical
evidence that the confining environment of the
chaperonin restricts polypeptide chain dynamics.
This effect is mediated by the net-negatively charged
wall of the GroEL/ES cavity, as shown using the
GroEL mutant EL(KKK2) in which the net-negative
charge is removed. EL(KKK2)/ES functions as apassive cage in which folding occurs at the slow
spontaneous rate. Taken together our findings
suggest that protein encapsulation can accelerate
folding by entropically destabilizing folding interme-
diates, in strong support of an active chaperoninn open access article under the CC BY-NC-ND license
J. Mol. Biol. (2014) 426, 2739–2754
2740 Mechanism of Chaperonin-Assisted Protein Foldingmechanism in the folding of some proteins. Accel-
erated folding is biologically significant as it adjusts
folding rates relative to the speed of protein
synthesis.
© 2014 The Authors. Published by Elsevier Ltd. This is an
open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by/3.0/).Introduction
Chaperonins are large ATP-driven macromolecu-
lar machines composed of two rings of ~60 kDa
subunits stacked back to back. They have an
essential role in assisting protein folding in bacteria,
archaea and eukarya [1–6]. Group I chaperonins
occur in bacteria (GroEL), mitochondria (Hsp60) and
chloroplasts (Cpn60). They consist of heptameric
rings and functionally cooperate with lid-like cofac-
tors (GroES in bacteria, Hsp10 in mitochondria and
Cpn10/Cpn20 in chloroplasts) that function to
transiently encapsulate non-native substrate protein
in a cage-like compartment. Group II chaperonins in
archaea and the cytosol of eukaryotic cells have
rings of 8–9 subunits and employ a mechanism of
opening and closing their central cavity that is in-built
into the structure of the chaperonin ring.
The group I chaperonins GroEL and GroES of
Escherichia coli have been investigated most widely
and numerous biochemical and structural studies
indicate that they function as a nano-compartment
for single protein molecules to fold in isolation [7–23].
However, whether protein encapsulation actively
p romo tes fo ld ing rema ins con t rove rs ia l
[12,17,19,22,24–27].
Each subunit of GroEL is divided into apical,
intermediate and equatorial domains [28] (Fig. 1a).
The apical domains form the ring opening and expose
hydrophobic amino acid residues for the binding of
molten globule-like folding intermediates [29–31].
ATP binding and hydrolysis in the equatorial domains
results in conformational changes that are transduced
to the apical domains via the hinge-like intermediate
domains, regulating substrate affinity and GroES
binding through an allosteric reaction cycle [4,32]. In
the current model, non-native protein substrate binds
to the open ring (trans-ring) of an asymmetricalGroEL/
ES complex (Fig. 1b) (The corresponding video file
for the animated Abstract can be found online at
doi:10.1016/j.jmb.2014.04.018). Subsequent ATP
binding causes apical domain movements that may
result in stretching the bound polypeptide [18,33–36],
and at the same time, ADPandGroESdissociate from
the opposite ring (Fig. 1b). ATP binding is closely
followed by GroES binding, resulting in the displace-
ment of the bound substrate and its encapsulation in
the newly formed GroEL/ES cage (cis-ring). Encap-sulated protein (up to ~60 kDa in size) is now free to
fold unimpaired by aggregation in a cage with a
hydrophilic, net-negatively charged wall (in cage-
folding). The time allowed for folding is dependent
on the rate of hydrolysis of the seven ATP in the
cis-ring (~5–10 s at 25 °C). After completion of ATP
hydrolysis, ATP binding to the GroEL trans-ring
causes dissociation of ADP and GroES (Fig. 1b).
Folded protein is released, while not-yet folded
protein will be rapidly recaptured for possible
stretching, encapsulation and folding. Symmetrical
GroEL/ES complexes with GroES bound to both
GroEL rings have also been observed, but their
function in the reaction cycle is still under investi-
gation [27,37,38].
Three models have been proposed to explain how
this basic chaperonin cycle promotes protein folding.
The “passive cage” (also known as “Anfinsen cage”)
model suggests that GroEL/ES essentially provides
an infinite dilution chamber [25,39,40]. The rate of
spontaneous folding, when measured in the ab-
sence of reversible aggregation, is identical with the
rate of folding inside the cage. The model implies
that GroEL/ES-dependent proteins fold at a biolog-
ically relevant timescale as long as aggregation is
prevented. In contrast, the “active cage” model
states that, besides preventing aggregation, the
physical environment of the cage also modulates
the folding energy landscape, resulting in accelerat-
ed folding of certain proteins. This is attributed to an
effect of steric confinement that limits the conforma-
tional space to be explored during folding
[12,17,19,22,41–43]. The active cage model implies
that cells contain a set of proteins with kinetically
frustrated folding pathways that require folding
catalysis to reach their native states at a biologically
relevant speed. Finally, the “iterative annealing”
model posits that the function of GroEL/ES is to
unfold misfolded proteins through cycles of binding
and release, with folding occurring either inside or
outside the cage [27,44] (out of cage-folding;
Fig. 1b). In this model, accelerated folding may
result from the active unfolding of kinetically trapped
species that can then partition between productive
and unproductive folding trajectories. The transient
encapsulation of substrate is thought to be a mere
by-product of the unfolding reaction [27].
In an effort to distinguish between thesemodels, we
developed novel approaches to investigate protein
folding by GroEL/ES at single-molecule level. Using
single-pair fluorescence resonance energy transfer
(spFRET), dual-color fluorescence cross-correlation
spectroscopy (dcFCCS) and photoinduced electron
transfer (PET), we could exclude reversible aggrega-
tion as the cause of slow spontaneous folding and
unequivocally distinguish between active and passive
chaperonin mechanisms. We find that GroEL/ES
accelerates the folding of a double-mutant maltose
binding protein (DM-MBP) up to ~8-fold relative to its
ab
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Fig. 1. Structure and function of the GroEL/ES chaperonin. (a) Left: Structure of the GroEL subunit in the apo-state in
ribbon representation (PDB ID 1SS8). Apical domain, yellow; intermediate domain, blue; equatorial domain, red. Middle:
Structure of the apo-GroEL 14-mer (PDB ID 1SS8). One subunit of GroEL is shown in color. Right: Structure of the GroEL/
GroES complex in the ADP state (PDB ID 1PF9). The two rings of GroEL are shown in gray and beige, and GroES is
shown in green. (b) Model of the GroEL/GroES reaction cycle. See Introduction and Discussion for details.
2741Mechanism of Chaperonin-Assisted Protein Foldingspontaneous rate. Accelerated folding occurs upon a
single round of encapsulation, as demonstrated using
SREL, a single-ring variant of GroEL that results in
stable protein encapsulation without GroES dissocia-
tion. Thus, multiple rounds of substrate binding and
release as proposed by the iterative annealing model
are not required for folding catalysis. Instead, accel-
erated folding is due to the physical confinement of
non-native protein in the net-negatively charged
GroEL/ES cage. Consistent with this mechanism,
we demonstrate that, during the GroEL/ES reaction
cycle, the substrate protein spends ~82% of its time
inside the chaperonin cage and only ~18% in the
GroEL-bound state, with negligible amounts of non--
native protein being free in solution.
Results
Transient aggregation is not the cause of slow
spontaneous folding
We used DM-MBP (~41 kDa), a double mutant of
MBP, which has previously been used as a model
substrate to compare the rates of spontaneous and
GroEL/ES-assisted folding [17,22,45]. DM-MBPcarries mutations V8G and Y283D that delay the
rate-limiting folding step of the N-domain [46]
(Fig. 2a). As a result, the spontaneous refolding of
DM-MBP is slow (t1/2 ~ 35 min at 25 °C and
physiological salt concentration) but nevertheless
fully efficient [17,24], with only largely unstructured
intermediate and the native state being populated
during folding [22]. The GroEL/ES-assisted folding of
DM-MBP has a 6- to 10-fold faster rate. However,
there is disagreement whether the observed rate
acceleration is due to GroEL/ES actively modulating
the folding energy landscape [17] or to GroEL/ES
passively preventing reversible aggregation that
would slow spontaneous folding [24,26].
To establish conditions of spontaneous refolding
in which transient aggregation is excluded, we
resorted to single-molecule fluorescence measure-
ments. A single cysteine mutant of DM-MBP,
DM-MBP(312C), was labeled with the fluorophore
Atto532 or Atto647N and used in dual-color fluores-
cence cross-correlation (dcFCCS) experiments. The
native, labeled proteins were mixed 1:1 at a final
concentration of 50 pM each. The probability, at
100 pM, for two monomeric DM-MBP molecules to
be simultaneously present in the observation volume
(1 fL) is ≤1%. As expected, no cross-correlation
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Fig. 2. Absence of DM-MBP aggregation during spontaneous refolding. (a) Ribbon structure of maltose binding protein
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A 1:1 mixture of DM-MBP(312C) labeled with either Atto532 or Atto647N was denatured in 6 MGuHCl and 10 mMDTT for
1 h at 20 °C. Refolding was initiated by 200-fold dilution into buffer A to a final concentration of 50 pM each. dcFCCS was
recorded with pulsed interleaved excitation [60] within the first 10 min of refolding (red). As a positive control, 5 pM native,
double-labeled protein, DM-MBP(DL), was added to the mixture of single-labeled, denatured proteins during refolding to
simulate the presence of an oligomeric (dimeric) species (blue). A 1:1 mixture of the native, single-labeled proteins (50 pM
each) was analyzed as a negative control (black). Shown are representative results of least three independent
experiments. (c) Average number of fluorescent-labeled particles inside the confocal observation volume during the
course of spontaneous refolding of 100 pM DM-MBP(312C) labeled with Atto647N in buffer A. FCS was recorded over the
course of 3 h. FCS analysis was performed for continuous time windows of 10 min and the average number of particles
was extracted from the amplitude of the fit. Averages ± SD from three independent experiments are shown. Dotted line is
the simulated increase in number of particles assuming that reversible aggregation limits spontaneous refolding.
2742 Mechanism of Chaperonin-Assisted Protein Foldingsignal was observed (Fig. 2b). To investigate
DM-MBP under refolding conditions, we denatured
the differently labeled DM-MBP molecules in GuHCl
as a 1:1 mixture and allowed them to refold upon
dilution fromdenaturant at 100 pM final concentration.
No cross-correlation signal was observed during
refolding (Fig. 2b). The sensitivity of the method was
demonstrated using the double cysteine mutant
DM-MBP(30C/312C) labeled with Atto532 and
Atto647N [DM-MBP(DL)]. A strong cross-correlation
signal was observed when 5 pM of the double-labeled
protein,mimicking thepresenceof dimeric aggregates,
was added to the 100 pMmixture of the single-labeled
refolding proteins (Fig. 1b). These measurementsshow clearly that, at 100 pM, the labeled DM-
MBP(312C) proteins are monomeric during refold-
ing and do not form oligomers.
Analysis by fluorescence correlation spectros-
copy (FCS) further confirmed the absence of
reversible aggregates by demonstrating that the
number of Atto647N-labeled DM-MBP(312C) par-
ticles in the observation volume remained constant
over the refolding time (Fig. 2c). In contrast, if
reversible aggregation was to limit the rate of
spontaneous folding, the number of diffusing
particles would be expected to increase as native
monomeric protein is produced (Fig. 2c, simulated
broken curve).
2743Mechanism of Chaperonin-Assisted Protein FoldingSpontaneous and GroEL/ES-assisted folding
measured at single-molecule level
Having established conditions of spontaneous
refolding in the absence of aggregation, we next
developed a spFRET approach to measure the
rates of spontaneous and GroEL/ES-assisted
refolding at single-molecule level. Specifically, we
tested the prediction of the passive cage model that,
under conditions equivalent to infinite dilution, no
rate acceleration by chaperonin would be observed
[24]. As shown previously, DM-MBP(DL) in its
native state and the unfolded protein when bound
to GroEL have different FRET efficiency (fE)
distributions in single-molecule spFRET measure-
ments [18]. The native protein shows a distribution
of compact conformations with a peak at a high fE of
0.72 (Fig. 3a). In contrast, GroEL-bound
DM-MBP(DL) has ~40% molecules at a low fE of
0.06, consistent with a highly expanded conformation,
with the remainder of molecules populating a broad
distribution of less expanded states around an
intermediate fE of 0.38 (Fig. 3b). To obtain the kinetics
of spontaneous folding, we took advantage of the
ability of GroEL to bind folding intermediates, but not
the native protein, thereby stopping refolding and
reverting not-yet folded DM-MBP(DL) molecules to
the low fE distribution (stretching; Fig. 1b). Assisted
folding in the presence of GroEL/ES and ATP was
stopped by the addition of apyrase, resulting in rapid
hydrolysis of ATP and ADP to AMP. Quantification of
the low and high fE peak areas (fE of 0.06 and 0.72,
respectively) at different times enabled us to extract
protein folding rates at a concentration of 100 pM
DM-MBP(DL) (Fig. 3c and d). The rate of spontaneous
refolding was ~5.6-fold slower than the assisted rate
(Fig. 3e). To validate our findings, we measured the
refolding rate of DM-MBP(DL) at a protein concentra-
tion of 100 nM. In these ensemble experiments we
took advantage of the finding that, following initial
collapse (with decrease in donor fluorescence due to
FRET), the donor fluorescence of DM-MBP(DL)
increases during folding, apparently due to changes
in the chemical environment of the fluorophore. The
observed rates were in good agreement with the
single-molecule data and showed a ~7.7-fold accel-
eration of folding by chaperonin (Fig. 3f). Moreover,
similar folding rates were previously measured for the
unlabeled DM-MBP(30C/312C) by tryptophan fluo-
rescence [18].
As an alternative single-molecule approach to
measure folding rates, we utilized the difference in
diffusion coefficients (D) of GroEL bound
(~49 μm2 s−1) and free DM-MBP (~160 μm2 s−1)
by FCS (Fig. 4a). We recorded the time-dependent
change in the average diffusion rate during refolding
of 100 pM DM-MBP(DL) using the Atto647N fluo-
rescence signal (Fig. S1). Again, spontaneous
folding was stopped by addition of excess GroELand the assisted folding with apyrase. The folding
rates obtained in these measurements (Fig. 4b)
were in agreement with those obtained by spFRET
(Fig. 3e).
The previously reported effect of chloride salt to
slow the spontaneous refolding of DM-MBP [22,26]
was preserved under single-molecule conditions
where aggregation is excluded (Fig. S2). Conse-
quently, chloride salt does not decelerate sponta-
neous refolding by increasing aggregation [26] but
by modulating the intrinsic folding properties of
DM-MBP [22]. The electrostatic environment of the
GroEL/ES cage apparently renders DM-MBP
refolding salt insensitive [22].
PET-FCS as a measure of chain motion during
folding
The active cage model of chaperonin action posits
that encapsulation of non-native protein can reduce
chain entropy, thereby accelerating folding kinetics
[12,17,22]. Here we used fluorescence quenching via
PET to test this hypothesis. In PET, the fluorescence
of an oxazine dye (Atto655) is quenched via van der
Waals contact with a Trp residue by direct transfer of
an electron. Atto655 has the advantage of showing
virtually no triplet blinking or other photophysical
fluctuations [47,48] and thus is well suited to assess
conformationally induced fluctuations at fast time-
scales. MBP contains 8 Trp residues spaced
throughout the sequence (Fig. 2a) (note that
GroEL and GroES do not contain Trp). The combina-
tion of PET with FCS serves as a powerful method to
measure structural fluctuations in proteins at the
single-molecule level on timescales from nanosec-
onds to milliseconds [48]. PET-FCS has been used to
study denatured state dynamics and early events in
protein folding [47].
The auto-correlation signal of Atto655-labeled
DM-MBP(312C) [DM-MBP(Atto655)] was measured
30 s after dilution from denaturant, when essentially
all DM-MBP populates a dynamic folding intermedi-
ate that converts only slowly to the native state [22].
The auto-correlation curve could not be fitted with a
single component diffusion model due to the
presence of a fast fluctuating component (Fig. 5a).
It was fitted by a one-exponential one-diffusion
equation (Fig. 5b), with the exponential term
describing the PET amplitude F, which is propor-
tional to the abundance of conformationally dynamic
molecules, and the relaxation time (τR) providing a
measure of chain motion (Fig. S3a). Based on these
measurements, the slow folding intermediate of
DM-MBP(Atto655) shows fast fluctuations of the
fluorescence signal at a τR of 40 ± 3 μs, indicating
high chain entropy. As a control, Atto655-labeled
wild-type MBP(312C) showed no fast fluorescence
fluctuation during folding (Fig. 5c), as this rapidly
folding protein (t1/2 ~ 23 s) [17] does not significantly
2744 Mechanism of Chaperonin-Assisted Protein Foldingpopulate the dynamic intermediate in which the dye
can approach Trp residues. Similarly, when
DM-MBP(Atto655) was allowed to refold to comple-
tion, the fluorescence fluctuations at the short corre-
lation times were no longer detected (Fig. 5d). This is
consistent with the fact that no Trp residue is in contact
distance to residue 312 in the native state. Thus, fastGroEL/ES-assisted
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Fig. 4. Spontaneous and GroEL/ES-assisted refolding
of DM-MBP measured by FCS. (a) Normalized fluores-
cence auto-correlation amplitudes G (τ) of Atto647N
fluorescence for 100 pM GroEL bound and spontaneously
refolded DM-MBP(DL) in buffer A. Diffusion coefficients
(D) are indicated. ±SD from at least 3 independent
measurements. (b) Refolding kinetics based on the
difference in mean diffusion time through the confocal
volume between GroEL-bound and free, native protein.
Refolding was performed as in Fig. 3 and stopped either by
adding GroEL (spontaneous refolding) or apyrase
(assisted refolding), shifting not-yet folded DM-MBP to
the slow diffusion time of the GroEL complex. Refolding is
plotted as fraction of GroEL-bound protein and fitted to
single exponential rates. ±SD from at least 3 independent
measurements.
Fig. 3. Spontaneous and GroEL/ES-assisted refolding of D
(fE) histograms from spFRET measurements of native (a) and
(GroEL, 2 μM). (c) fE histograms upon spontaneous refolding o
A and stopped at the times indicated by addition of 2 μM GroE
Gaussian fit to the fE distributions are indicated. Representative
are shown. (d) fE histograms upon GroEL/ES-assisted refoldin
diluted from 6 MGuHCl into buffer A containing 2 μMGroEL. R
and stopped by addition of apyrase at the times indicated. Rep
5, 15 and 45 min are shown. Histograms shown in (a–d) are r
Kinetics for spontaneous and assisted refolding were obtained f
time-dependent increase of the area of the high fE peak, corr
single exponential rate. Data represent averages ± SD from a
of 100 nM DM-MBP(DL) measured by conventional fluoresc
curves in buffer A were monitored over time at donor excita
respectively, and are plotted as donor fluorescence relative
measurements are shown.(Fig. S3b). This would be expected if refolding is
limited by a kinetic energy barrier with a large entropic
component. The rate of decrease in amplitude F was
accelerated ~4-fold during GroEL/ES-assisted refold-
ing (Fig. 5e), consistent with the chaperonin system
reducing the entropic component of the energy
barrier. In contrast, a constant high PET-FCS signal
was observed when the labeled protein was diluted
into buffer containing 0.5 M GuHCl, which stabilizes
DM-MBP in its dynamic intermediate state [22]
(Fig. 5e). The rate of spontaneous refolding of
DM-MBP(Atto655) measured by PET-FCS was con-
centration independent over a concentration range of
4 orders of magnitude (100 pM to 1 μM) (Fig. S3c),
further excluding aggregation as the cause of slow
spontaneous refolding.
Evidence for conformational confinement in the
GroEL/ES cage
While the amplitude of the PET-FCS signal is
proportional to the concentration of dynamic parti-
cles, the τR of the PET signal is indicative of the
kinetics of chain motion. During the first minute of
spontaneous refolding, the τR of DM-MBP(Atto655)
was 40 ± 3 μs, similar to the τR measured for the
kinetically trapped intermediate in 0.5 M GuHCl
(34 ± 10 μs) (Fig. 5f). Note that no τR could be
measured for the native protein (Fig. 5d). The τR of
the GroEL-bound protein was 59 ± 10 μs, indicating
that the interaction of the unfolded DM-MBP with the
apical GroEL domains reduces chain dynamics
(Fig. 5f). Interestingly, the τR during the first minute
of GroEL/ES-assisted refolding (≤20% molecules
folded) was increased to 96 ± 5 μs (Fig. 5f), sug-
gesting that the encapsulated protein is significantly
restricted in chain motion, even when compared to
the GroEL-bound state. To test this further, we
measured chain mobility upon stable encapsulation
of unfolded DM-MBP in the non-cycling SREL/ES
complex (Fig. 5f). SREL is a single-ring variant ofM-MBP measured by spFRET. (a and b) FRET efficiency
GroEL-bound (b) DM-MBP(DL) at 100 pM concentration
f 100 pM DM-MBP(DL). Refolding was performed in buffer
L, followed by spFRET analysis for 1 h. Peak values of a
histograms for the refolding times of 0, 45, 80 and 160 min
g of 100 pM DM-MBP(DL). Unfolded protein was 200-fold
efolding was initiated by addition of 4 μMGroES/5 mMATP
resentative histograms for the assisted refolding times of 0,
epresentative of least three independent experiments. (e)
rom spFRETmeasurements as in (c) and (d) by plotting the
esponding to native DM-MBP(DL). Data were fitted with a
t least 3 independent measurements. (f) Refolding kinetics
ence spectroscopy in an ensemble approach. Refolding
tion and emission wavelengths of 532 nm and 550 nm,
to native. Averages ± SD from at least 3 independent
2746 Mechanism of Chaperonin-Assisted Protein FoldingGroEL that binds unfolded protein, ATP and GroES
but ceases to hydrolyze ATP after a single round due
to the absence of the allosteric signal from the GroEL
trans-ring (see Fig. 1b) [8]. The SREL/ES complex is
salt sensitive [9,49], and thus, the experiments with
SREL were performed in low salt buffer using
urea-denatured DM-MBP(Atto655). Stable substrate
encapsulation was confirmed by size-exclusion
chromatography (Fig. S4). Approximately 90–95%
of DM-MBP co-fractionated with SREL/ES duringa
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0.5 M GuHCl KTIfolding, with the remainder eluting at a low molecular
weight corresponding to free DM-MBP (Fig. S4a and
b). Refolded DM-MBP was retained in the SREL/ES
complex formore than 30 min (Fig. S4b, top panel) but
was rapidly released when the SREL/ES complex
was dissociated by addition of Mg chelator and high
salt (Fig. S4b, bottom panel). The τR during the first
minute of encapsulation in SREL/ES-assisted refold-
ing was 99 ± 1 μs, identical with the value measured
with the cyclingGroEL/ES systemunder the same low
2747Mechanism of Chaperonin-Assisted Protein Foldingsalt buffer condition (Fig. 5f). Thus, the environment of
the chaperonin cage causes a considerable reduction
of chain entropy, presumably promoting the conver-
sion of dynamic folding intermediate to the native
state.
Substrate protein spends most of its time in the
encapsulated state during folding
The finding that, during GroEL/ES cycling, the
substrate protein is conformationally restricted to the
same extent as upon stable encapsulation in SREL/
ES suggested that the vast majority of folding protein
is in the encapsulated state. This would be consis-
tent with recapture of non-native DM-MBP by GroEL
occurring in less than 0.3 s at 25 °C [22]. Indeed the
diffusion time of DM-MBP(DL) measured during the
first minute of folding with GroEL/ES/ATP was
virtually identical with that of the GroEL-bound
protein and well discriminated from the fast diffusion
time of spontaneously refolding DM-MBP(DL) (Fig.
S5a). To quantify the relative amounts of GroEL--
bound and encapsulated DM-MBP during the
GroEL/ES reaction, we used single-molecule
spFRET. DM-MBP(DL) showed similar FRET effi-
ciency distributions when bound to GroEL or SREL
with ~34–40% of molecules being in an expanded
state (fE of 0.06 and 0.1, respectively) and the
remainder populating a broad distribution around an
intermediate fE of ~0.4 (Fig. 6a and b, left panels).
During the first minute of encapsulation in SREL/ES,
essentially all DM-MBP(DL) molecules populated a
broad range of collapsed states around an fE of 0.66
(Fig. 6b, right panel). In contrast, during the firstminute
of the GroEL/ES reaction, a bimodal fE distributionFig. 5. Analysis of DM-MBP refolding and conformationa
auto-correlation amplitudes G (τ) for DM-MBP(Atto655) (a and
spontaneous refolding at final concentration of 1 nM in buffer
minute after 200-fold dilution of denatured protein into refolding
model (a and c) or with a one-diffusion one-exponential model (
amplitude F in addition to a diffusion component (τD and ρ) (F
curves shown are representative of least three independent ex
completion of spontaneous refolding (open circles) and immed
(folding intermediate) (filled circles). Auto-correlation curves
experiments. (e) Rates of spontaneous and GroEL/ES-ass
time-dependent decrease in PET-FCS amplitude (F) (Fig. S3a
refolding and was continued for 2 h. F was also analyzed up
containing 0.5 M GuHCl to stabilize the kinetically trapped inte
and 10 min for late time points (GroEL/ES-assisted) or time win
refolding and kinetically trapped intermediate) were correlated
exponential fits to plots of the amplitude of the exponential co
least 3 independent measurements are shown. (f) Conform
chaperonin cage. Relaxation time (τR) of the PET signal of DM
refolding buffer A (200 mM KCl) (spontaneous refolding; spont.
buffer A containing GroEL (2 μM) (GroEL-bound) or during the
was also analyzed during the first minute of GroEL/ES- and SR
buffer B (20 mM KCl). FCS auto-correlation curves were fitte
were extracted, which are inversely proportional to protein ch
independent measurements.was observed, with the low fE peak representing
GroEL-bound molecules and the high fE population
representing encapsulated and folded molecules
(Fig. 6a, middle panel). The fraction of folded
molecules was ~12%, as determined by addition of
apyrase after 1 min to stop folding and revert the
not-yet foldedmolecules to the bound state with low fE
value (Fig. 6a, right panel). Taking into consideration
that the ~12% of folded DM-MBP(DL) were no longer
GroEL associated, we calculated that ~18% of
GroEL-associated molecules were bound and ~82%
were encapsulated. Thus, during the cycling GroEL/
ES reaction, the vast majority of substrate protein is in
the encapsulated state during folding, in agreement
with the PET-FCS measurements.
Next, we measured the duration of the GroEL/ES
ATPase cycle as a function of substrate concentra-
tion. GroEL hydrolyzed ATP at a rate of ~53 ATP
min−1 at 20 °C and GroES reduced the rate to ~21
ATP min−1 [50] (Fig. S5b). The presence of
non-native substrate protein has been reported to
stimulate the ATPase [29] by triggering ADP and
GroES release from the GroEL trans-ring [38,51,52].
A single round of substrate binding and encapsula-
tion occurs in the time it takes GroEL to hydrolyze 7
ATP (the hemi-cycle) in the presence of GroES and
non-native substrate. Because spontaneous folding
of DM-MBP is slow, we could measure the GroEL
ATPase under conditions of substrate excess. At a
concentration of 0.2 μM GroEL and 0.4 μM GroES,
the initial ATPase rate reached a maximum of ~59
ATP per GroEL 14-mer min−1 at ~0.8 μM denatured
DM-MBP and remained constant at higher DM-MBP
concentrations (Fig. 6c and Fig. S4b). Thus, the
duration of the GroEL/ES hemi-cycle at substratel dynamics by PET-FCS. (a–c) Normalized fluorescence
b) and for Atto655-labeled wild-type MBP(312C) (c) during
A at 20 °C. Auto-correlation data collected during the first
buffer A (final MBP, 1 nM) were fitted with a one-diffusion
b), which contains an exponential time constant (τR) with an
ig. S3a). Residuals of the fits are shown. Auto-correlation
periments. (d) PET-FCS curves for DM-MBP(Atto655) after
iately upon dilution from denaturant into refolding buffer A
shown are representative of least three independent
isted refolding of DM-MBP(Atto655) measured as the
). FCS recording was started immediately upon initiation of
on dilution of denatured DM-MBP(Atto655) into buffer A
rmediate (KTI). Time windows of 2 min for early time points
dows of 10 min for early and late time points (spontaneous
and fitted as in (b). Refolding rates were extracted by single
mponent F versus refolding time. Averages ± SD from at
ational dynamics of DM-MBP is decreased inside the
-MBP(Atto655) upon 200-fold dilution from 6 M GuHCl into
) or into buffer A containing 0.5 M GuHCl to form KTI or into
first minute of GroEL/ES-assisted refolding in buffer A. τR
EL/ES-assisted refolding of 10 M urea-denatured protein in
d to a one-diffusion one-exponential model and τR values
ain motion. Data represent averages ± SD from at least 3
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Fig. 6. Analysis of GroEL-bound and encapsulated DM-MBP during assisted refolding. (a) FRET efficiency (fE)
histograms from spFRET measurements of GroEL-bound DM-MBP(DL), as well as during the first minute of DM-MBP(DL)
refolding and after stopping refolding at 1 min with apyrase (Apy). Measurements were performed as in Fig. 3a and d.
Histograms representative of at least three independent experiments are shown. (b) fE histograms as in (a) performed for
SREL-bound DM-MBP(DL) and during the first minute of DM-MBP(DL) refolding while encapsulated in SREL/ES (buffer B
at 20 °C). Peak values of a Gaussian fit to the fE distributions are indicated. Histograms representative of at least three
independent experiments are shown. (c) Measuring the GroEL ATPase (open circles) and the duration of the GroEL
hemi-cycle (filled circles) in the presence of GroES and increasing concentrations of non-native DM-MBP. Denatured
DM-MBP was diluted 200-fold to final concentrations from 0 to 1.5 μM into buffer A containing 0.2 μM GroEL and 0.4 μM
GroES. ATPase activities were measured photometrically using a NADH coupled enzymatic assay at 20 °C (see Materials
and Methods). ±SD from at least 3 independent measurements. (d) Duration of GroEL ATPase hemi-cycle as measured in
(c) in the presence of 1 μM non-native DM-MBP at 20 °C and 37 °C. Data represent averages ± SD from at least 3
independent measurements.saturation is ~7 s at 20 °C (Fig. 6c and d). As
measured by stopped-flow mixing, binding of dena-
tured DM-MBP to GroEL is complete after ~0.3 s
and encapsulation upon addition of ATP and GroES
is complete after ~0.5 s [18]. This would mean thatthe substrate spends ~1 s in the GroEL-bound state
and ~6 s in the GroEL/ES cage, corresponding to
~14% and ~86% of hemi-cycle duration, respec-
tively, in good agreement with the fraction of bound
(~ 18%) and encapsulated substrate (~ 82%)
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EL(KKK2)/ES-assis ted refo ld ing of unlabeled
DM-MBP(312C) in buffer A (200 mM KCl) were measured
by monitoring the increase in Trp fluorescence at 20 °C as
described in Fig. S3. Relaxation times (τR) of the PET
signal of DM-MBP(Atto655) were measured during the first
minute of spontaneous and assisted refolding. ±SD from
at least 3 independent measurements. (b) Spontaneous
and assisted refolding with GroEL/ES, SREL/ES and
SR(KKK2)/ES were measured in buffer B (20 mM KCl)
and τR values were also analyzed during the first minute of
refolding as in (a). Data represent averages ± SD from at
least 3 independent measurements.determined by spFRET mentioned above. The
hemi-cycle duration in the presence of excess
substrate at 37 °C was ~2.2 s (Fig. 6d). Thus, the
reaction has a Q10 temperature coefficient of ~2,
consistent with classical Arrhenius behavior and
suggesting that all steps of the GroEL/ES mecha-
nism undergo similar temperature-dependent rate
acceleration.
Role of the net-negative charged GroEL
cis-cavity wall
The wall of the GroEL cis-cavity has a net charge
of minus 42 resulting from a cluster of exposed
negatively charged residues (Glu252, Asp253,
Glu255, Asp359, Asp361 and Glu363) [17]. Most
of these are highly conserved among GroEL
homologs but have no apparent function in binding
of substrate or GroES. We have previously report-
ed that mutating three of these residues (Asp359,
Asp361 and Glu363) in SREL to lysines [SR(KKK2)],
converting the cavity net charge to 0, impairs the
ability of SR(KKK2)/ES to fold DM-MBP and bacterial
ribulose bisphosphate carboxylase/oxygenase
(RuBisCO), but not mitochondrial rhodanese [17].
Both DM-MBP and RuBisCO experience a signif-
icant rate acceleration of folding with wild-type
SREL/ES [12,17], while rhodanese does not,
suggesting that the negative charges have a role
in enhancing folding kinetics. Here we analyzed
this possibility using the SR(KKK2) and EL(KKK2)
mutants.
Under standard conditions of physiological salt
concentration, GroEL/ES accelerated the spontane-
ous folding of DM-MBP(312C) by ~4.5-fold. In
contrast, no rate acceleration was observed with
EL(KKK2)/ES (Fig. 7a). Remarkably, EL(KKK2)/ES
d id no t res t r i c t the cha in dynamics o f
DM-MBP(Atto655) during folding as measured by
PET-FCS, in striking contrast to GroEL/ES (Fig. 7a).
Notably, DM-MBP(DL) when bound to EL(KKK2)
displayed the same conformational properties as
when bound to GroEL, as demonstrated by spFRET
measurements (Fig. S5c). Moreover, during the first
minute of folding with EL(KKK2)/ES/ATP, the diffu-
sion time of DM-MBP(DL) was identical with that of
the EL(KKK2)-bound protein (Fig. S5a), indicating
that essentially all substrate was chaperonin asso-
ciated. The fraction of bound and encapsulated
substrate analyzed from spFRET histograms was
~16% and ~84%, respectively, close to the values
obtained with GroEL/ES (Fig. S4c and Fig. 6a). The
ATPase activity of EL(KKK2) was similar to that of
GroEL and was inhibited by GroES. However, unlike
GroEL, excess non-native DM-MBP had only a
minor effect in stimulating the ATPase of EL(KKK2)/
ES (Fig. S5b). These results suggested that the
charge properties of the cis-cavity wall may have a
dual role in entropically confining encapsulatedsubstrate protein and in coupling the presence of
substrate with the ATPase activity of GroEL.
To uncouple these two effects, we next used
SR(KKK2) to analyze the chain dynamics of
DM-MBP during folding when stably encapsulated.
GroES-mediated substrate encapsulation by
SR(KKK2) at low salt (Fig. S5d and e) was as
efficient as with SREL (Fig. S4). When bound to
SR(KKK2), DM-MBP(DL) displayed similar confor-
mational properties as when bound to GroEL or
SREL (Fig. S5c and f). During the first minute of
encapsulation, DM-MBP(DL) populated compact
conformations, as observed with SREL/ES (Fig.
S5f). GroEL/ES and SREL/ES mediated the refold-
ing of DM-MBP(312C) at essentially the same rate
(measured at low salt) (Fig. 7b), and folding by
2750 Mechanism of Chaperonin-Assisted Protein FoldingSR(KKK2)/ES was not accelerated beyond the
spontaneous rate (Fig. 7b). Interestingly, while the
folding rates with GroEL/ES and SREL/ES are salt
independent, the KKK2 mutant displays a similar salt
dependence of folding rate as spontaneous renatur-
ation (Fig. 7a and b and Fig. S2) [22]. Compared to
high salt, the low salt condition resulted in reduced
chain dynamics (slower τR) and ~2-fold faster folding
for the spontaneous renaturation (Fig. 7a and b).
Accordingly, in low salt, folding in SR(KKK2)/ES is
~2-fold faster than in EL(KKK2)/ES at high salt
(Fig. 7a and b). Importantly, DM-MBP(Atto655) when
inside SR(KKK2)/ES nevertheless displayed signifi-
cantly higher chain dynamics (τR of 66 ± 4 μs)
compared to SREL/ES (τR of 99 ± 1 μs) (Fig. 7b).
Together these findings indicate that the net-negative
charge of the cis-cavity plays a critical role in
entropically confining dynamic folding intermediates
of encapsulated substrate, thereby accelerating their
conversion to the native state.
Discussion
Active versus passive GroEL/ES function
It has been argued that accelerated folding of
DM-MBP by GroEL/ES [17,19,22] is due to the ability
of chaperonin to prevent reversible aggregation that
would otherwise reduce the rate, but not the yield, of
spontaneous folding [24,26]. The basic assumption
of this passive cage model is that GroEL/ES
functions solely as an anti-aggregation device and
that folding inside the GroEL/ES cage occurs at the
same rate as it would during spontaneous folding at
infinite dilution [25]. Here we have tested this idea by
monitoring folding by single-molecule experiments at
100 pM DM-MBP. Since the probability of more than
one molecule of DM-MBP residing in the confocal
observation volume is ≤1% at this concentration, we
were able to compare the rates of GroEL/ES-as-
sisted folding and spontaneous folding at de facto
infinite dilution. The absence of aggregation during
spontaneous folding was confirmed by FCS and
dcFCCS measurements. Using GroEL to sort
non-native from native molecules, we showed by
spFRET and FCS that GroEL/ES accelerates
fluorescent-labeled DM-MBP refolding 4- to 8-fold,
demonstrating the active chaperonin mechanism.
Active cage model versus iterative annealing
According to the iterative annealing model, sub-
strate binding and release during ATP-dependent
GroEL/ES cycling serve to unfold kinetically trapped
folding intermediates, affording them a chance at
productive folding either inside or outside the GroEL/
ES cage [27,44]. Using SREL/ES, we demonstrated
that a single round of encapsulation inside thechaperonin cage is sufficient to achieve accelerated
DM-MBP folding at full yield. This argues for
encapsulation being the active principle. However,
an active cage may function synergistically with
iterative annealing for certain substrates, for exam-
ple, when a fraction of molecules were to form
long-lived, misfolded states during assisted folding.
We also note that the SREL experiments do not rule
out the possible contribution of a single round of
unfolding to subsequent accelerated folding inside
the cage. A conformational expansion of substrate
protein upon binding to GroEL and additional
stretching upon ATP-mediated apical domain move-
ment has been observed [18,34,35] (as well as this
study) (Fig. 1b). Furthermore, duringGroES-mediated
encapsulation, the protein is released in a step-wise
fashion, with the less hydrophobic and thus less tightly
bound, sequence elements dissociating before the
more hydrophobic ones [18]. This mode of release
would modulate the mechanism of hydrophobic
collapse and may contribute to avoiding the formation
of kinetically trapped folding intermediates.
The iterative annealing model assigns no specific
function to the chaperonin cage in aggregation
prevention or accelerating folding and accordingly
suggests that folding may equally occur inside the
GroEL/ES cage or outside [27] (Fig. 1b). Out of
cage-folding would require that not-yet folded protein
spends significant time in free solution during GroEL/
ES cycling. This is inconsistent with our PET-FCS
and spFRET measurements, which demonstrate
that, in the cycling reaction, non-native DM-MBP
spends ~80% of the duration of the GroEL/ES
hemi-cycle (7 ATP hydrolyzed; ~7 s at 20 °C) in the
encapsulated state and the remainder bound to the
apical GroEL domains. Considering that GroEL
recaptures non-native DM-MBP from solution within
0.3 s or less (at 25 °C) [18], the fraction of out of
cage folding would be insignificant (b5%). Moreover,
even vastly increasing the concentration of GroEL/
ES relative to substrate, as in our single-molecule
experiments (100 pM DM-MBP, 2 μM GroEL/4 μM
GroES), did not slow folding kinetics or yield, which
can only be explained by in cage folding. It has also
been argued that, at 37 °C, the dwell time of
substrate inside the GroEL/ES cage becomes too
short for efficient folding [27]. We measured the
duration of the GroEL/ES hemi-cycle under sub-
strate saturation at 37 °C to be 2.2 s. Making the
reasonable assumption that all the steps of the
GroEL/ES reaction undergo temperature-dependent
acceleration, the vast majority of folding would
nevertheless occur in cage. Indeed, authentic
GroEL-dependent proteins are typically highly ag-
gregation prone in a temperature-dependent manner
[16,53,54]. Under so-called non-permissive condi-
tions, where irreversible aggregation prohibits sponta-
neous folding, the GroEL/ES-assisted folding of these
proteins stops immediately when rapid recapture of
2751Mechanism of Chaperonin-Assisted Protein Foldingfolding intermediate by GroEL is prevented [12],
indicating that folding must occur in cage.
Function of the GroEL/ES cage
Protein encapsulation by chaperonin has been
proposed to serve a dual purpose: it prevents
aggregation and accelerates folding for certain
proteins, adjusting folding speed relative to the rate
of protein synthesis and thereby preventing the
accumulation of unfolded or misfolded protein
molecules [12]. Rate enhancement of folding was
attributed to an effect of steric confinement, entropi-
cally destabilizing dynamic folding intermediates and
thereby facilitating their conversion to the native
state [17,19,22]. Two physical properties of the
GroEL/ES cage may be critical in this regard: the
volume of the cage relative to the size of the folding
pro te in ( i .e . , s te r ic con f inement proper
[17,19,41,42,55]) and the negative net charge of
the cavity wall [17,19] that has been suggested to
increase the hydrophobic effect by ordering water
structure [56]. In the present study, we used
PET-FCS to directly measure the effect of encapsu-
lation on polypeptide chain dynamics. While binding
of unfolded protein to GroEL restricts chain dynam-
ics only moderately, we find that encapsulation
results in a marked restriction of flexibility, as
reflected in an increase of the τR of the DM-MBP
folding intermediate from 40 ± 3 μs during sponta-
neous refolding to 99 ± 1 μs when encapsulated.
Notably, τR of the folding intermediate was very
similar when measured during active GroEL/ES
cycling or upon stable encapsulation in SREL/ES.
This provides direct evidence that, during folding, the
protein spends the vast majority of the time in the
encapsulated state. Contrary to a recent report [57],
our experiments with SREL/ES did not reveal a
functionally significant “escape” of DM-MBP from the
non-cycling SREL/ES cage.
Using EL(KKK2) or SR(KKK2), a mutant in which
the negative net charge of the cavity wall of 42 is
reduced to 0, we analyzed the effect of cavity charge
on substrate chain dynamics by PET-FCS. Striking-
ly, these measurements showed that the KKK2 cage
is unable to restrict the conformational motion of
encapsulated protein relative to the folding interme-
diate in free solution. This correlates with a loss of
function of the KKK2 mutant in accelerating
DM-MBP folding. Thus, in essence, removal of the
negative net charge converts the active GroEL/ES
cage to a passive cage. Moreover, we found that the
negatively charged residues exposed in the cis-cav-
ity are required for the stimulation of the GroEL
ATPase by substrate protein. It thus appears that the
cage senses the encapsulated protein. In summary,
we suggest that steric confinement and the nega-
tively charged cavity wall function cooperatively in
promoting folding.Materials and Methods
Strains, plasmids and proteins
TheE. colistrainsDH5αandBL21 (DE3)Gold (Stratagene)
were used for cloning and protein expression, respectively.
DM-MBP (MBP V8G, Y283D) and its cysteine variants,
DM-MBP(312C) and DM-MBP(30C/312C), were constructed
in pCH vectors (T7 promoter) by site-directed mutagenesis
usingQuikChange (Stratagene) andwere expressed, purified
and labeled with fluorophore [17,18] (see Supplementary
Methods for details).
GroEL, GroES, SREL, EL(KKK2) and SR(KKK2) were
expressed and purified as previously described [17,19].
GroEL preparations were subjected to rigorous quality control
by the following assays: ATPase activity in presence and
absence of GroES [19], rhodanese aggregation prevention
[58] and DM-MBP refolding [17]. GroES preparations were
controlled for efficient inhibition of GroEL ATPase activity and
ability to accelerate DM-MBP refolding.DM-MBP refolding
DM-MBP was unfolded in 6 M GuHCl/10 mM DTT or in
10 M urea/10 mM DTT for 1 h at 50 °C, as indicated in the
figure legends. Spontaneous refolding was initiated upon
200-fold dilution into refolding buffer A [20 mM Tris–HCl
(pH 7.5), 200 mM KCl and 5 mM Mg(C2H3O2)2] or refold-
ing buffer B [50 mM Hepes–NaOH (pH 7.5), 20 mM KCl
and 10 mM MgCl2] as indicated in the figure legends. For
assisted refolding, denatured DM-MBP was diluted
200-fold into refolding buffer containing either 2 μM
GroEL or 1 μM SREL and refolding was initiated upon
addition of 4 μM GroES and 5 mM ATP.
In ensemble experiments (100 nM DM-MBP), folding
was recorded by the time-dependent increase in the
intrinsic Trp fluorescence (excitation: 295 nm; emission:
345 nm) of DM-MBP and its variants on a Fluorolog F3-22
spectrofluorometer (Horiba), equipped with Peletier ther-
mostat set to 20 °C (GroEL and GroES do not contain Trp)
[17]. Photobleaching was carefully avoided by limiting the
excitation slit width to 2 nm, with the emission slit width
being set to 8 nm. Fluorescence signal was excited and
emission was collected every 30 s for a 100-ms window
using an automated shutter. Note that, at low concentra-
tions of DM-MBP, bleaching of Trp fluorescence may result
in measuring seemingly faster folding rates than at higher
concentrations.
For DM-MBP(DL), refolding could not be measured by
Trp fluorescence due to quenching. However, fluores-
cence of the donor dye in the folding intermediate was
significantly lower than in the native state of DM-MBP(DL).
The time-dependent increase in donor fluorescence was
used as a measure of DM-MBP(DL) folding in ensemble
measurements at 100 nM (excitation wavelength, 532 nm;
emission wavelength, 550 nm).Analysis of protein encapsulation
Encapsulation experiments were performed in buffer B.
DM-MBP(Atto655) was unfolded in 10 M urea/10 mM DTT
2752 Mechanism of Chaperonin-Assisted Protein Foldingfor 1 h at 50 °C. The denatured protein was diluted 200-fold
(30 nM final) into refolding buffer containing 1 μM SREL or
SR(KKK2). The reaction was incubated for 5 min at room
temperature. Refolding was started by addition of 3 μM
GroES and 1 mMATP at 20 °C. The reaction was separated
onaSuperdex 200PC3.2/30 gel-filtration column (Amersham
Biosciences), equilibrated in buffer B/50 mMurea/1 mMATP,
either immediately or after 30–60 minof incubationat 20 °Cor
after 30–60 min of incubation at 20 °C and dissociation of the
SREL/ES complex by the addition of 50 mM CDTA/70 mM
GuHCl/200 mM KCl. Fractions were collected and analyzed
by 15% SDS-PAGE, Coomassie staining and fluorescence
imaging (FujiFilm FLA3000) and were quantified by
densitometry.
ATPase assay
The ATPase activity of 0.2 μM GroEL or EL(KKK2) was
measured in buffer A at 20 °C in the absence or in the
presence of 0.4 μM GroES or 0.4 μM GroES with
increasing concentration of denatured DM-MBP (diluted
200-fold from 6 M GuHCl). Control reactions received
equivalent amounts of GuHCl (30 mM final). The hydroly-
sis of ATP to ADP was followed photometrically using an
NADH coupled enzymatic assay (2 mM phosphoenolpyr-
uvate, 30/20 U ml−1 pyruvate kinase/lactate dehydroge-
nase, 0.5 mM NADH and 1 mM ATP) at 20 °C in a
spectrophotometer (Jasco) essentially as previously de-
scribed [59].Single-molecule spectroscopy
Single-molecule spectroscopy was performed on a
Microtime 200 inverse time-resolved fluorescence mi-
croscope (PicoQuant) using pulsed interleaved excita-
tion [60] (see Supplementary Methods for details). The
instrument was maintained at a constant temperature of
20 °C. dcFCCS and FCS were used to investigate the
oligomeric state of DM-MBP during refolding [18,22],
while spFRET and FCS were used to assess folding
rates of DM-MBP at 100 pM. The significant size difference
of folded DM-MBP monomer (~41 kDa) and non-native
DM-MBP in complex with GroEL (~830 kDa) results in
different diffusion rates (106 ± 6 μm2 s−1 and 49 ±
1 μm2 s−1, respectively) that can be monitored using
FCS. The auto-correlation data were fitted with the
following one triplet one-diffusion equation using the
Symphotime software (PicoQuant):
G τð Þ ¼ 1−T þ T  e −
τ
τT
 " #
 ρ 1þ τ
τD
 −1
 1þ τ
τD  κ2
 −1=2" #
:
The mean diffusion time τD of particles through the focal
spot is described by the structural parameter κ = z0/ω0
where z0 and ω0 denote the axial and radial dimensions of
the confocal volume, respectively. The amplitude of the
correlation function is denoted by ρ. The first term is used
to compensate for fast dynamics arising from dye
photophysics such as triplet blinking with the amplitude Ton the timescale τT [61]. Diffusion coefficients were
calculated using the following equation
D ¼ V eff  π
−3=2  κ−1 2=3
4 τD
by calibrating the confocal volume Veff with Atto655 dye,
for which accurate diffusion parameters have been
published [62]. To analyze refolding kinetics, we plotted
the mean diffusion time, reflecting a shift of DM-MBP
molecules from GroEL bound to free against the refolding
time and fitted it with a single exponential rate.
PET-FCS was used as an approach to assess
conformational dynamics of refolding DM-MBPmolecules
[47,48]. DM-MBP(Atto655) (or Atto655-labeled wild-type
MBP) was unfolded in 6 M GuHCl/10 mM DTT for 1 h at
20 °C or 10 M urea/10 mM DTT for 1 h at 50 °C.
Refolding was started by 200-fold dilution of the protein
(final 100 pM to 1 μM) into refolding buffer A or buffer B as
indicated in the figure legends. FCS measurements were
performed immediately. In order to resolve fast dynamics
in the microsecond timescale, we recorded fluorescence
on two detectors simultaneously. Cross-correlation of the
signals allowed removal of detector after pulsing. The
correlated data were fitted with either a single component
diffusion model
G τð Þ ¼ ρ 1þ τ
τD
 −1
 1þ τ
τD  κ2
 −1=2
or the following one-exponential one-diffusion equation,
with the exponential term describing amplitude F and
relaxation time τR of PET
G τð Þ ¼ 1−F þ F  e −
τ
τR
 " #
 ρ 1þ τ
τD
 −1
 1þ τ
τD  κ2
 −1=2" #
in Symphotime (PicoQuant). For relaxation time extrac-
tion, only the first or the last 30 s of a 2-h refolding
experiment was considered. For folding rate extraction,
the measurement was subdivided into 2 min time
windows and extracted values for F were plotted against
refolding time. These data were fitted with a single
exponential function in Origin (OriginLabs) to give
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Supplementary Methods 
Fluorescent labeling 
For single molecule experiments, genetically engineered cysteine mutants of MBP and DM-MBP 
were constructed, taking advantage of the lack of Cys residues in the MBP sequence. The 
introduced, surface-exposed cystein residues were modified with fluorescent probes (AttoTec) 
using maleimide chemistry. The purified protein in buffer A/10 mM DTT was first buffer 
exchanged on a NAP5 column (Amersham Biosciences) equilibrated in buffer A and 
immediately mixed with a 1.2-molar excess of dye molecules (for single labeling) and incubated 
for 30 min at 20°C. In case of double-labeling of DM-MBP(30C/312C), the protein was 
incubated with a 3-fold molar excess of a 1:1 mixture of donor and acceptor dye (Atto532 and 
Atto647N, respectively). The labeling reaction was quenched by addition of 10 mM DTT. Free 
dye was removed and native conformation ensured by binding the labeled protein to an Amylose 
column (NEB) followed by extensive washing with buffer A/10 mM DTT. The labeled protein 
was then eluted using buffer A/10 mM DTT/5 mM maltose. Subsequently the buffer was 
exchanged on a NAP5 column (Amersham Biosciences) to buffer A/10 mM DTT. The protein 
was concentrated using Vivaspin concentrators (MWCO 3 kDa, GE Healthcare). The degree of 
labeling (DOL) was controlled by absorption spectroscopy using the following extinction 
coefficients (MBP, ε280 = 64860 M-1 cm-1; Atto532, εmax = 115000 M-1 cm-1 cf280 = 0.11; 
Atto647N, εmax = 150000 M-1 cm-1 cf280 = 0.05; Atto655, εmax = 125000 M-1 cm-1 cf280 = 0.08) 
and the equation, 
DOL =
Adye×εdye
(−(Adye×cf280) + A280)×εprotein
 
DOL was >90 %. The absence of free dye in the sample was confirmed by FCS. 
  
3 
 
Fluorescence correlation spectroscopy (FCS) 
FCS measurements using pulsed interleaved excitation (PIE) [60] were performed on a 
Microtime 200 inverse time-resolved fluorescence microscope (PicoQuant), which was 
maintained at a constant temperature of 20°C. For excitation of Atto647N, Atto655 and Atto532, 
ps pulsed diode lasers at 640 nm (LDH-PC-640B) and at 530 nm (LDH-P-FA-530) were used. 
Each laser had a laser power of 60 µW measured before the major dichroic. The lasers were 
pulsed with a rate of 27 mHz. The excitation light was guided through a water immersion 
objective (60 × 1.2 NA, Olympus) into the sample cuvette (Ibidi). The emitted fluorescence was 
separated from excitation light by a dichroic mirror (Z532/635RPC), guided through a pinhole 
(75 µm) and in case of cross-correlation split according to wavelength by a beamsplitter 
(600 DCXR) onto photon avalanche diodes (SPADs) (PDM series, MPD). The emission light 
was cleaned up by emission bandpass filters (HQ 690/70 and HQ 580/70, Chromas) in front of 
the respective detector. Detection was performed using time correlated single photon counting, 
making it possible to correlate any given photon with the excitation source. In case of auto-
correlation measurements, after-pulsing artifacts were removed using fluorescence lifetime filters 
(Symphotime, PicoQuant) [63]. 
 
Dual color fluorescence cross-correlation spectroscopy (dcFCCS) 
dcFCCS was employed to demonstrate the absence of inter-molecular association during 
spontaneous refolding of DM-MBP at 100 pM. DM-MBP(312C) was either labeled with Atto532 
or Atto647N as described above. The labeled proteins were denatured at 10 nM in 6 M 
GuHCl/10 mM DTT for 1 h at 20°C. Refolding was induced by 200-fold dilution into buffer A to 
a final concentration of 50 pM each. FCCS was recorded with PIE [60] during refolding at 20oC. 
As a positive control, 5 pM of DM-MBP(30C/312C), double labeled with Atto532 and Atto647N 
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was mixed with 50 pM of each of the single labeled DM-MBP(312C) proteins, to mimic the 
presence of a dimeric species (the smallest aggregate) and to demonstrate the high sensitivity of 
this approach. A mixture of 50 pM native Atto532-labeled DM-MBP(312C) and 50 pM native 
Atto647N-labeled DM-MBP(312C) was used as a negative control. 
 
Analysis of refolding by spFRET 
DM-MBP(30C/312C) was double-labeled with Atto532 and Atto647N (DM-MBP(DL)), a 
commonly used FRET pair with a Förster radius of 52 Å [18,22]. DM-MBP(DL) was unfolded at 
a concentration of 20 nM in 6 M GuHCl/10 mM DTT for 1 h at 20°C. 
Spontaneous refolding was induced upon 200-fold dilution into buffer A. Refolding at 
100 pM was allowed to proceed at 20°C and was stopped at different time points by addition of 
2 µM GroEL. Non-native conformers of DM-MBP are recognized by GroEL and by binding to 
the GroEL apical domains, are converted to a low fE population. In contrast, natively folded 
protein molecules have high fE and are not recognized by GroEL. For assisted refolding reactions, 
unfolded DM-MBP(DL) was diluted into buffer A containing 2 µM GroEL. Refolding was 
started by addition of 4 µM GroES and 5 mM ATP. Refolding was stopped by addition of 5 U 
apyrase (Sigma). Stopping was instant as no refolding was measured when apyrase was added 
immediately after initiating refolding with ATP (0 time point of refolding). Upon depletion of 
ATP, GroEL reverts to the apo-state that binds non-native DM-MBP(DL). After stopping 
refolding, reactions were transferred to the confocal microscope for spFRET analysis. 
Measurements were performed on a Microtime 200 instrument in two color mode with 
PIE [18,60] as described under fluorescence correlation spectroscopy. Data was analyzed using a 
burst intensity approach [64,65] in Symphotime (PicoQuant). A single molecule diffusing 
through the confocal observation volume results in a burst in fluorescence intensity. A burst was 
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considered as a significant event when it contained more than 25 photons in a 1 ms time window. 
In addition a threshold of 15 photons following red excitation was used to confirm the presence 
of a functional acceptor fluorophore. FRET efficiencies were calculated from fluorescence 
intensities of Donor ID and Acceptor IA fluorophore by the equation: 
E =
IA
IA + γID
 
Where γ = (ΦAηA/ΦDηD) denotes a correction factor for differences in quantum yields (Φ) and 
detection efficiencies (η) [18,66] and has been found to be 0.9 for the FRET pair used. Average 
intensity values of spectral crosstalk and direct excitation of acceptor fluorophores by the green 
laser were subtracted. 
The resulting FRET efficiency histograms were analyzed using Origin (OriginLabs). To 
quantify the fraction of native molecules, the area of the histogram corresponding to native 
molecules was divided by the total area of the histogram. This fraction was plotted against 
refolding time and then fitted with a single exponential function, yielding the rate of refolding. 
Importantly, very similar results were obtained when the disappearance of the peak area 
corresponding to GroEL-bound molecules was analyzed. For each time point during refolding a 
minimum of 1000 particles was analyzed. All experiments were done at least in triplicate to 
ensure reproducibility. 
 In addition to steady state measurements, spFRET measurements were performed during 
the first minute of assisted refolding. DM-MBP(DL) was denatured in 6 M GuHCl/10 mM DTT 
at 20°C for GroEL/ES- and EL(KKK2)/ES-assisted refolding and in 10 M urea/10 mM DTT at 
50°C for SREL/ES and SR(KKK2)/ES experiments. Unfolded protein was diluted 200-fold to a 
final concentration of 100 pM into buffer A or buffer B containing either 2 µM GroEL or 1 µM 
SREL, respectively. Refolding was initiated by addition of 4 µM GroES and 5 mM ATP and data 
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collected immediately for 1 min. The experiment was repeated to obtain statistically significant 
FRET efficiency values from at least 1000 particles. From the resulting FRET efficiency 
histograms the relative peak areas for low FRET (chaperonin-bound molecules, fE ~0.1) and high 
FRET (folded and encapsulated molecules, fE ~0.65) were calculated. The amount of folded 
molecules within the first minute of the reaction was estimated by stopping the reaction with 
apyrase after 1 min. From the resulting FRET efficiency histogram, the bound state histogram 
was subtracted to give the amount of folded molecules. This amount of folded molecules was 
subtracted from the high FRET efficiency distribution to obtain the relative fraction of 
chaperonin-bound and encapsulated molecules. 
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Supplementary Figures 
 
 
Fig. S1.  Spontaneous and GroEL/ES-assisted refolding of DM-MBP measured by FCS. 
(a) Auto-correlation curves of Atto647N fluorescence of DM-MBP(DL) at different times of 
spontaneous refolding as in Fig. 4b. The sample was subsequently analyzed by FCS. Correlation 
curves of GroEL-bound (red) and free native DM-MBP(DL) (blue), as well as all the time points 
taken during refolding (black) are shown.  
(b) Auto-correlation curves as in (a) for assisted refolding. 
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Fig. S2.  Kinetics for spontaneous refolding of DM-MBP(DL) (denatured in 10 M urea/10 mM 
DTT) in buffer A containing 20 mM KCl were obtained from spFRET measurements as in Fig. 
3e and compared to spontaneous refolding in bufferA/200 mM KCl (data of Fig 3e). Data were 
fitted with a single exponential rate. Data represent averages ± s.d. from at least 3 independent 
measurements. 
9 
 
 
 
Fig. S3.  Analysis of DM-MBP refolding by PET-FCS. 
(a) Simulation of a characteristic FCS measurement with one diffusion and one exponential 
component. Fit parameters are indicated. D and  indicate diffusion time and amplitude of the 
diffusion component, respectively, and F andR indicate amplitude of the exponential term 
arising from PET and relaxation time, respectively. 
(b) Spontaneous and assisted refolding of DM-MBP(312C) analyzed by Trp fluorescence at a 
final concentration of 100 nM in buffer A at 20oC. Averages ± s.d. from at least 3 independent 
measurements are shown. 
(c) Rates of spontaneous refolding of DM-MBP(Atto655) either alone at 100 pM or 1 nM, or at 1 
nM in the presence of 10, 100 or 1000 nM of unlabeled, refolding DM-MBP(312C). Refolding 
was monitored by recording the time-dependent decrease in the amplitude of the exponential 
component F in PET-FCS as in Fig. 5e. Rates were extracted by single exponential fit. Data 
represent averages ± s.d. from at least 3 independent measurements. 
 
10 
 
 
 
 
Fig. S4.  Encapsulation of DM-MBP(Atto655) by SREL/ES analyzed by size-exclusion 
chromatography. 
(a) DM-MBP(Atto655) was unfolded in 10 M urea/10 mM DTT for 1 h at 50°C and diluted 200-
fold into refolding buffer B at 20oC containing 1 µM SREL. After 5 min encapsulation was 
initiated by addition of 4 µM GroES and 1 mM ATP, and the reaction was applied to a Superdex 
200 gel filtration column equilibrated in buffer B/50 mM urea/1 mM ATP. Fractions (50 l) were 
collected over a period of 30 min. Top-panel: Coomassie stained 15 % SDS-PAGE shows 
coelution of SREL and GroES. Visualization of the SDS-PAGE with a fluorescence imager 
showed that DM-MBP(Atto655) coelutes with SREL. Quantification of the DM-MBP(Atto655) 
bands by densitometry is indicated. 
(b) In a control experiment the SREL/ES-assisted refolding reaction as in (a) was incubated for 
30 min at 20oC, followed by size-exclusion chromatography without further additions or after 
addition of 50 mM CDTA/200 mM KCl /70 mM GuHCl to induce the dissociation of the 
SREL/ES complex and allowing the release of folded, encapsulated protein. The fractions were 
analyzed as in (a). 
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Fig. S5.  Effect of net-negative charges in the chaperonin cis-cavity on DM-MBP folding and 
conformational dynamics. 
(a) Diffusion times (D) of DM-MBP(DL) measured by FCS (see Fig. S3a) during the first 
minute of spontaneous refolding or bound to GroEL or EL(KKK2) or during the first minute of 
refolding with GroEL/ES/ATP or EL(KKK2)/ES/ATP in buffer A at 20oC. Data represent 
averages ± s.d. from at least 3 independent measurements. 
(b) ATPase activity of GroEL (0.2 µM) was measured in buffer A at 20°C in absence or presence 
of GroES (0.4 µM) or 0.4µM GroES (0.4 µM)/non-native DM-MPB (1 µM). Measurements were 
performed as in Fig. 6c-d. Data represent averages ± s.d. from at least 3 independent 
measurements. 
(c) FRET efficiency (fE) histograms from spFRET measurements of GroEL- and EL(KKK2)-
bound DM-MBP(DL), as well as during the first minute of DM-MBP(DL) refolding with 
EL(KKK2)/ES . Measurements were performed and analyzed as in Fig. 6a. Histograms shown 
are representative of at least three independent experiments. 
(d) Encapsulation of DM-MBP(Atto655) by SR(KKK2)/ES analyzed by size-exclusion 
chromatography as in Fig. S4a. 
(e) In a control experiment the SR(KKK2)/ES-assisted refolding reaction as in (c) was incubated 
for 60 min at 20oC, followed by size-exclusion chromatography without further additions or after 
dissociation of the SR(KKK2)/ES complex as in Fig. S4b. The fractions were analyzed as in Fig. 
S4a. 
(f) fE histograms from spFRET measurements of SREL- and SR(KKK2)-bound DM-MBP(DL), 
as well as during the first minute of DM-MBP(DL) refolding with SR(KKK2)/ES. Measurements 
were performed and analyzed as in Fig. 6b. Histograms shown are representative of least three 
independent experiments. 
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3.2 Article 2 - Chaperonin-assisted protein folding: Relative 
population of asymmetric and symmetric GroEL:GroES 
complexes 
In the GroEL field there is an ongoing debate whether the functional form of the GroEL/ES 
system in the folding cycle is an asymmetrical, bullet shaped GroEL/ES complex with 
GroES bound to one side of GroEL or a symmetrical, American football shaped GroEL/ES 
complex with GroES bound to both sides of GroEL86,140,141,142. The following study 
addressed this question by measuring cross-correlation between two populations of 
differently labelled GroES molecules on a single molecule level, under variety of 
conditions. We also employed a range of other biochemical and biophysical methods. We 
showed that symmetrical complexes (GroEL:GroES2) are populated when the GroEL/ES 
system interacts with model non-foldable substrates, such as α-lactalbumin (α-LA) and α-
casein, which functionally uncouple the two GroEL rings. Uncoupling of the rings leads to 
a diminished negative allostery between the two rings and allows GroES to bind on both 
sides of GroEL. In the absence of any substrate, or in the presence of foldable substrates, 
for example mitochondrial rhodanese (mRho), mitochondrial malate dehydrogenase 
(mMDH), DM-MBP or Rhodospirillum rubrum Rubisco, the canonical asymmetric form of 
the GroEL/ES complex is the prevailing species. Additionally, we showed that 
physiological ratios of ATP:ADP favour the formation of bullet shaped GroEL/ES 
complexes. These observations led us to conclude that the physiologically relevant form 
of the GroEL/ES complex is asymmetrically shaped and that GroEL/ES system works as a 
two-stroke machine. 
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Haldar S, Gutpa AJ, Yan X, Miličić G, Hartl FU, Hayer-Hartl M. 
Contribution: This project was performed in collaboration with Shubhasis Haldar, Amit 
Gupta and Xiao Yan. I conducted negative stain electron microscopy experiments of 
GroEL:GroES complexes under variety of conditions. In addition, I helped in performing 
spectroscopic measurements of the GroEL ATPase activity, which led to understanding 
the substrate effect on decoupling of both rings. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ArticleShubhasis Hal0022-2836/© 2015 ElseviChaperonin-Assisted Protein Folding:
Relative Population of Asymmetric and
Symmetric GroEL:GroES Complexesdar1, Amit J. Gupta1, Xiao Yan, Goran Miličić,
F. Ulrich Hartl and Manajit Hayer-Hartl
Department of Cellular Biochemistry, Max Planck Institute of Biochemistry, Am Klopferspitz 18, 82152 Martinsried, GermanyCorrespondence to F. Ulrich Hartl and Manajit Hayer-Hartl: uhartl@biochem.mpg.de; mhartl@biochem.mpg.de
http://dx.doi.org/10.1016/j.jmb.2015.04.009
Edited by S. RadfordAbstract
The chaperonin GroEL, a cylindrical complex consisting of two stacked heptameric rings, and its lid-like
cofactor GroES form a nano-cage in which a single polypeptide chain is transiently enclosed and allowed to
fold unimpaired by aggregation. GroEL and GroES undergo an ATP-regulated interaction cycle that serves to
close and open the folding cage. Recent reports suggest that the presence of non-native substrate protein
alters the GroEL/ES reaction by shifting it from asymmetric to symmetric complexes. In the asymmetric
reaction mode, only one ring of GroEL is GroES bound and the two rings function sequentially, coupled by
negative allostery. In the symmetric mode, both GroEL rings are GroES bound and are folding active
simultaneously. Here, we find that the results of assays based on fluorescence resonance energy transfer
recently used to quantify symmetric complexes depend strongly on the fluorophore pair used. We therefore
developed a novel assay based on fluorescence cross-correlation spectroscopy to accurately measure
GroEL:GroES stoichiometry. This assay avoids fluorophore labeling of GroEL and the use of GroEL cysteine
mutants. Our results show that symmetric GroEL:GroES2 complexes are substantially populated only in the
presence of non-foldable model proteins, such as α-lactalbumin and α-casein, which “over-stimulate” the
GroEL ATPase and uncouple the negative GroEL inter-ring allostery. In contrast, asymmetric complexes are
dominant both in the absence of substrate and in the presence of foldable substrate proteins. Moreover,
uncoupling of the GroEL rings and formation of symmetric GroEL:GroES2 complexes is suppressed at
physiological ATP:ADP concentration. We conclude that the asymmetric GroEL:GroES complex represents
the main folding active form of the chaperonin.
© 2015 Elsevier Ltd. All rights reserved.Introduction
The chaperonin GroEL and its cofactor GroES
have an essential function in folding a subset of
proteins in the bacterial cytosol [1]. GroEL is an
ATP-driven macromolecular machine of ~800 kDa
consisting of two rings with seven ~57-kDa subunits
stacked back to back. GroES is a single heptameric
ring of ~10-kDa subunits that attaches coaxially to
the ends of the GroEL cylinder [2,3] (Fig. 1). Protein
substrate binds as a molten globule-like folding
intermediate in the ring center of GroEL to hydro-
phobic amino acid residues exposed by the apical
GroEL domains. Upon binding of ATP to GroEL,
GroES caps the GroEL ring that holds the substrate
(cis-ring), resulting in its displacement into aner Ltd. All rights reserved.enclosed chamber large enough for proteins up to
~60 kDa. This step is accompanied by conforma-
tional changes that render the GroEL cavity hydro-
philic. The encapsulated protein is free to fold during
the time required for the hydrolysis of the seven ATP
molecules in the cis-ring. According to current
understanding, binding of ATP to the opposite
GroEL ring (trans-ring), followed closely by GroES
binding, then causes the dissociation of GroES from
the cis-ring and substrate release into solution. Prior
to ATP binding, the trans-ring may capture a new
substrate molecule.
The GroEL/ES system is allosterically regulated
with positive cooperativity of ATP binding and
hydrolysis within rings and negative cooperativity
between rings [3,4]. In the chaperonin reaction cycleJ Mol Biol (2015) 427, 2244–2255
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Fig. 1. Structures of asymmetric and symmetric GroEL/ES complexes. (a) Space-filling representation of the crystal
structure of the asymmetric GroEL/ES:ADP complex (PDB ID 1AON) [40] with the cis- and trans-rings of GroEL colored
beige and gray, respectively. For one subunit of GroEL in each of the rings, the apical (A), intermediate (I) and equatorial
(E) domains are colored gold, blue and red, respectively. The cofactor GroES is colored green. The fluorophore labeling
positions on GroEL(E315C) and GroES(98C) are indicated. (b) The crystal structure of the symmetric EL(D52A/D398A)/
ES-ATP complex (PDB ID 3WVL) [41], colored as in (a).
2245Chaperonin-Assisted Protein Foldingas described above, the two GroEL rings function in
an alternating fashion with the GroES-bound cis-ring
forming an enclosed folding environment while the
trans-ring is open to receive a new substrate protein.
Such asymmetric GroEL:GroES complexes [5,6] are
often referred to as “bullet” shaped [7] (Fig. 1a).
In addition, symmetric GroEL:GroES2 complexes,
with both GroEL rings being capped by GroES, have
also been observed (referred to as “football” shaped)
[7–9] (Fig. 1b). The functional significance of these
symmetric complexes has been subject of debate
[10–15], but there was agreement that they may
occur as a transient intermediate in the reaction
cycle, when a GroES binds to the trans-ring before
release of GroES from the cis-ring is complete.
However, recent reports marked a notable deviation
from this basic concept [16–19]. These studies,
employing calibrated fluorescence resonance ener-
gy transfer (FRET) to monitor the GroEL:GroES
interaction, suggest that symmetric complexes are
highly populated during the functional cycle and thus
are proposed to be the main, if not the only, folding
active form of the chaperonin. Specifically, it was
reported that nearly 100% symmetric complexes areinduced by the binding of substrate protein to GroEL,
with the two rings functioning independently and
GroES binding and release occurring in a stochastic
fashion [17–19]. Thus, fundamentally different
mechanisms would underlie the GroEL/ES reaction
cycle in the absence and presence of substrate
protein.
Here, we use dual-color fluorescence cross-
correlation spectroscopy (dcFCCS) to accurately
measure the occurrence of the different GroEL:-
GroES complexes under a variety of conditions. By
using two populations of differently labeled GroES,
the dcFCCS method allowed us to analyze
the interaction of GroES with wild-type GroEL in
solution, thereby avoiding possible artifacts associ-
ated with the use of fluorophore-labeled mutant
GroEL. Our results show that symmetric complexes
are substantially populated only in the presence of
proteins that cannot be folded by the chaperonin, a
condition under which the GroEL rings become
uncoupled. In contrast, symmetric complexes are a
minor species either in the absence of substrate or in
the presence of foldable substrate proteins or at a
physiological concentration ratio of ATP and ADP.
2246 Chaperonin-Assisted Protein FoldingWe conclude that the asymmetric GroEL:GroES
complex represents the main folding active form of
the chaperonin and that fundamentally similar
mechanisms govern the GroEL/ES interaction
cycle in the absence and presence of substrate
protein.Results
Analysis of GroEL:GroES complexes by FRET
It is well established that GroEL and GroES form
asymmetric complexes in the presence of ADP
[5,15,20], whereas symmetric complexes form in the
presence of ATP/BeFX (a beryllium fluoride com-
plex) [18,21]. Under the former condition, only the
cis-ring has ADP bound. In contrast, in the presence
of ATP/BeFX, all 14 nucleotide sites are trapped in
the hydrolysis transition state with ADP/BeFX bound
and the functional asymmetry between the two rings
is lost [21] (Fig. 1). However, there is disagreement
as to the relative occurrence of asymmetric and
symmetric complexes during the functional chaper-
onin cycle in the presence of ATP and substrate
protein.
Much of the uncertainty regarding the functional
significance of the different GroEL:GroES complexes
is associatedwith themethods used for their detection
and quantification. Recently, two groups have used
calibrated FRET between fluorophore-labeled
GroEL and GroES to measure complex formation
and determine complex stoichiometry [17–19].
While the labeling positions are the same in the
two studies (E315C in the apical substrate binding
domain of GroEL; 98C in GroES), the fluorophore
pairs are different {Cy3 and Cy5 [17]; IAEDANS
(5-[2-[(2-iodo-1-oxoethyl)amino]ethylamino]-1-
naphthalenesulfonic acid) and F5M (fluorescein-5-
maleimide) [18,19]}. Notably, the results obtained with
the different fluorophore pairs are not consistent,
varying dramatically in the proportions of symmetric
complexes during the GroEL/ES functional cycle. We
therefore reassessed the FRET-based quantification.
As in the previous studies, we introduced the E315C
mutation for site-specific labeling of GroEL and added
a C-terminal cysteine residue (position 98) in GroES.
Labeling efficiencies and stoichiometries with the
respective fluorophore pairs were essentially as
previously reported [16–18]. To calibrate the amount
of FRET between IAEDANS/F5M and Cy3/Cy5 upon
formation of asymmetric or symmetric complexes, we
measured fluorescence spectra upon donor excitation
(IAEDANS, 336 nm; Cy3, 550 nm) either in the
absence of nucleotide or in the presence of ADP/
BeFX or ATP/BeFX at 25 °C (Fig. 2a and b). GroES
does not bind GroEL in the absence of nucleotide,
ADP/BeFX results in the formation of only asymmetriccomplexes and symmetric complexes are populated
in the presence of ATP/BeFX [18,21]. As expected, for
both fluorophore pairs, we observed FRET upon
GroES binding to GroEL, reflected in a decrease in
donor fluorescence and a concomitant increase in
acceptor fluorescence (Fig. 2a and b). In the presence
of ADP/BeFX (asymmetric complexes), donor fluores-
cence decreased by ~27% for Cy3/Cy5 and ~31% for
IAEDANS/F5M relative to the control in the absence of
nucleotide (Fig. 2a and b). In the presence of ATP/
BeFX (symmetric complexes), donor fluorescence
decreased by ~55% for Cy3/Cy5 and ~56% for
IAEDANS/F5M (Fig. 2a and b). Note that the increase
in acceptor fluorescence resulting from FRET is
relatively small due to the 5-fold excess of GroES
over GroEL used in the assay [18], but the relative
change in donor fluorescence associated with the
formation of symmetric complexes is similar for the
two fluorophore pairs. However, during functional
cycling of GroEL/ES in the presence of ATP and
ATP regenerating system, donor fluorescence for
Cy3/Cy5 decreased substantially (by ~21%) below
the value obtained with ADP/BeFX, whereas only a
marginal decrease (by ~8%) was measured with
IAEDANS/F5M (Fig. 2a and b). Based on the
relative increase in FRET efficiency (fE) compared
to the 100% symmetric complex control (ATP/
BeFX), these values correspond to ~59% and
~16% symmetric GroEL:GroES2 complexes, re-
spectively, being populated during cycling with
ATP (Fig. 2c). Similar results were obtained when
the measurements were performed at 37 °C (Fig.
S1). This striking difference in the proportions of
symmetric complexes observed here and reported
previously [17,18] indicates that the calibrated
FRET assay is highly dependent on the fluorophore
pair used.
The calibrated FRET studies also presented data
that substrate protein induces the formation of
symmetric complexes [17–19]. We therefore tested
the effect of substrate using the different FRET pairs.
The model substrate α-lactalbumin (αLA), a disulfide-
bonded secretory protein, is unable to fold in the
presence of DTT and in the absence of calcium ions.
Under these conditions, αLA populates an ensem-
ble of molten globule-like folding intermediates with
affinity for GroEL [22]. Addition of this non-foldable
protein to the IAEDANS/F5M chaperonin reaction
(at a 30-fold excess over GroEL [19]) resulted in an
increase in symmetric complexes from ~16% during
cycling in the absence of substrate to ~64% in the
presence of αLA at 25 °C (Fig. 2c) and to ~76% at
37 °C (Fig. S1c), which is less than the reported
value of 100% [19]. In contrast, with the Cy3/Cy5
fluorophore pair, similar proportions of symmetric
complexes (~50–60%) were measured in the
absence and presence of αLA at both temperatures
(Fig. 2c and Fig. S1c). To analyze the effect of
a foldable substrate, we used a double mutant of
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Fig. 2. Analysis of GroEL/ES symmetric complexes by calibrated FRET. The fluorophore pairs Cy3/Cy5 (a) and
IAEDANS/F5M (b) were used as FRET reporters [17,18]. We analyzed 140 nM GroEL(E315C) labeled with IAEDANS or
Cy3 and 700 nM GroES(98C) labeled with F5M or Cy5 in buffer C at 25 °C in the absence of nucleotide (Control) or in the
presence of either ADP/BeFX or ATP/BeFX or ATP with ATP regenerating system. Fluorescence spectra were recorded
immediately after nucleotide addition with donor excitation at 550 nm (a) or 336 nm (b). The inset in (b) shows a zoom-in
on the donor fluorescence emission. (c) The proportion of symmetric GroEL:GroES2 complexes was estimated based on
the donor fluorescence relative to the donor fluorescence in the presence of ADP/BeFX (0% symmetric complexes) and in
the presence of ATP/BeFX (100% symmetric complexes) (seeMaterials andMethods). Donor fluorescence wasmeasured
at 565 nm (Cy3) and 465 nm (IAEDANS). The proportion of symmetric complexes was also measured in the presence of a
30-fold excess of non-foldable substrate protein αLA or a 6-fold excess of foldable DM-MBP. Averages ± SD from three
independent experiments are shown.
2247Chaperonin-Assisted Protein Foldingmaltose binding protein (DM-MBP). This protein has
a high affinity for GroEL in the non-native state and
its spontaneous folding is accelerated 5- to 10-fold
byGroEL/ES [23,24]. Since the spontaneous folding
is slow (t1/2 ~ 30 min at 25 °C) but highly efficient,
DM-MBP can be added to the chaperonin reaction in
excess over GroEL [25]. In the case of GroEL and
GroES labeled with IAEDANS and F5M, respective-
ly, DM-MBP also induced the formation of symmetric
complexes, although to a lesser extent than αLA
(Fig. 2c). In contrast, with the Cy3/Cy5-labeled
proteins, DM-MBP substantially reduced the pro-
portion of symmetric complexes compared to the
reaction with ATP in the absence of substrate
(Fig. 2c). Similar results were obtained at 37 °C
(Fig. S1c). Thus, dependent on the FRET pair used,
protein substrates seem to either induce or reduce
the occurrence of symmetric complexes, indicating
that the calibrated FRET assay is not a reliable
method tomeasureGroEL:GroES stoichiometries in
the functional chaperonin reaction.Quantitative analysis of GroEL:GroES
complexes by dcFCCS
Given the uncertainties associated with the FRET
measurements, we developed a novel approach to
quantify the relative proportion of asymmetric and
symmetric GroEL:GroES complexes using dcFCCS.
In this assay, the co-diffusion of two differently labeled
GroES molecules through the confocal observation
volume results in a quantifiable cross-correlation
signal, the amplitude of which is proportional to the
relative amount of complexes that contain both
labeled species. Here, we labeled GroES(98C) with
either a singlemolecule ofAtto532 (ES532) orAtto655
(ES655) per heptamer and GroEL remained unla-
beled. The labeled GroES bound efficiently to GroEL
in a nucleotide-dependent manner, as demonstrated
by measuring cross-correlation of labeled GroEL
and GroES (Fig. S2). An important advantage of
the dcFCCS assay is that cross-correlation is only
observed for GroEL:GroES2 complexes. Moreover,
2248 Chaperonin-Assisted Protein Foldingany form of mutant GroEL can be readily analyzed, as
labeling of GroEL is not required. Note that the
diffusion time of GroEL complexes through the
confocal volume was measured to be ~1 ms at
20 °C [25,26], at least 3 orders of magnitude faster
than the half-life of GroEL:GroES complexes that is
determined by ATPase activity (see Ref. [25] and
Fig. 5 below).
As expected, only background cross-correlation
was measured with 100 nM GroEL and 200 nM
each of ES532 and ES655 in the presence of ADP or
ADP/BeFX (Fig. 3a and b), where 100% asymmetric
complexes are populated. A clear cross-correlation
signalwas observedwith theATP-hydrolysis-deficient
GroEL mutant, EL-D398A (Fig. 3a), which binds
ATP but hydrolyzes it very slowly [15] and gener-
ates 100% symmetric complexes with GroES
[16,27]. Cross-correlation in the presence of ATP/
BeFX with wild-type GroEL was similar to that
measured with EL-D398A and ATP (Fig. 3b).
Interestingly, only ~10% symmetric complexes(a)
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Fig. 3. Quantification of GroEL/ES complexes by dcFCC
formation of symmetric GroEL/ES complexes. A 1:1 mixture of
was added to buffer A containing 100 nM of either EL-D398A o
1 mM ATP (with ATP regenerating system) or ADP and the cros
20 °C. (b) Cross-correlation amplitudes of GroES obtained as a
conditions indicated. Background cross-correlation was meas
from three independent experiments are shown. (c) Cros
concentrations of EL-D398A. The amplitude of the cross-correl
Averages ± SD from three independent experiments are showwere detected with GroEL/ES in the presence of
ATP (with ATP regenerating system), indicating that
mainly asymmetric complexes are populated during
functional cycling in the absence of substrate
protein (Fig. 3a and b). The cross-correlation signal
with EL-D398A/ES ATP was linearly dependent on
the concentration of EL-D398A, demonstrating the
quantitative nature and high sensitivity of the assay
(Fig. 3c).
Differential effect of foldable and non-foldable
substrate protein
Next we analyzed the effect of substrate protein on
the relative proportion of asymmetric and symmetric
GroEL:GroES complexes. To exclude photophysical
artifacts, wemeasured the auto-correlation for the two
labeled GroES species individually in the presence of
GroEL/ATP and increasing amounts of non-native
αLA or DM-MBP. We found the auto-correlation
amplitudes to be independent of the presence of(b)
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2249Chaperonin-Assisted Protein Foldingsubstrate (Fig. S3), excluding fluorescence quenching
in the presence of substrate protein. Cross-correlation
experiments with various substrate proteins were
performed in the presence of an ATP regenerating
system. The non-foldable αLA resulted in a cross-
correlation signal that saturated at an ~25-fold excess(a)
Correlation time  (ms)
G
CC
 
()
0.000
0.001
0.002
0.003
0.004
0.006
0.1 100 10000.01 101
0.005
(b)
0.10.01 1
(d)
0.1 100 10000.01 101
0.000
0.001
0.002
0.003
0.004
0.006
0.005
(e)
0.10.01 1
EL-D398A/ES ATP
GroEL/ES ATP + LA
GroEL/ES ADP
EL-D398A/ES ATP
GroEL/ES ATP
GroEL/ES ADP
+ mRho
(g)
Am
pl
itu
de
 (%
 of
 
EL
-D
39
8A
/E
S 
AT
P)
0
10
20
30
40
60
50
SP
-
LA
DM
-M
BP
-
ca
se
in
m
Rh
o
m
MD
H
Rr
Ru
bis
co
non-
foldable SP
foldable SP
τ
G
CC
 
() τ
τ
CorrelatiCorrelation time  (ms)τ
Correlati
−
+α
+α +
+ +
+
α
Fig. 4. Effect of non-foldable and foldable substrate protei
Symmetric complexes were quantified by dcFCCS as in Fig.
Effect of non-foldable substrate proteins αLA and α-casein (a
mMDH and RrRubisco (c–f) on the cross-correlation signal. Cro
non-foldable substrates and 1 min for foldable substrate prote
ADP are shown as controls. (g) Quantification of symmetri
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2250 Chaperonin-Assisted Protein Folding[28], also induced symmetric complexes, albeit to a
lesser extent of ~23% (Fig. 4b and g). In contrast, four
different foldable substrate proteins, DM-MBP, mRho
(mitochondrial rhodanese), mMDH (mitochondrial ma-
late dehydrogenase) and RrRubisco (Rhodospirillum
rubrum ribulose bisphosphate carboxylase oxygen-
ase), when added from denaturant, did not induce
measurable GroEL:GroES2 complexes (Fig. 4c–f and
g). Thus, we were unable to reproduce recent reports
using calibrated FRET that foldable substrate proteins
induce symmetrical complexes to 80–90% [18,19].
Note that our measurements were performed with
saturating amounts of substrate protein and during the
first minute of refolding to ensure substrate occupation
of GroEL (see Materials and Methods). Moreover, in
the case of DM-MBP, which does not aggregate
significantly during spontaneous refolding [23,24],
substrate saturation of GroEL was ensured by using
a 6-fold molar excess over GroEL [25]. The residual
concentration of denaturant (~6 mM GuHCl) in the
measurements did not destabilize symmetric com-
plexes, as demonstrated by addition of GuHCl to
reactions in the presence of αLA (Fig. S4). These
results suggest that only non-foldable but not foldable
substrate proteins induce the formation of symmetric
GroEL:GroES2 complexes.
Link between GroEL ATPase activity and
formation of symmetric complexes
It has been suggested that substrate protein shifts
GroEL to a state in which both rings hydrolyze ATP
independently and bind and release GroES stochas-
tically [16,18,19]. To test this possibility, we mea-
sured the steady-state ATPase activity of GroEL in
the presence of GroES and the various substrate
proteins. While the ability of non-native substrate to
stimulate the GroEL ATPase is well established
[6,25,28–30], we were surprised to find that both
non-foldable substrates, αLA and α-casein, caused
an ~2-fold higher ATPase activity than the foldable
substrates (Fig. 5). This “over-stimulation” of the
ATPase correlated with the formation of symmetric
complexes (Fig. 4g), presumably as a result of
weakening of the negative allosteric coupling of the
two GroEL rings [29]. This would allow both rings to
bind and hydrolyze ATP simultaneously. These
findings also imply that if foldable substrates were
to induce symmetric complexes, they would have a
longer half-life than those induced by non-foldable
substrates and should have been detected by
dcFCCS.
Physiological ADP concentration suppresses
formation of symmetric complexes
The negative cooperativity between GroEL rings
with respect to ATP binding is known to increase in
the presence of ADP, ensuring that the two rings ofGroEL are not in phase [31,32]. We hypothesized that
physiological concentrations of ADP should therefore
reduce the formation of GroEL:GroES2 complexes.
The molar ratio of ATP:ADP in Escherichia coli in
mid-log-phase has been measured at ~10:1, with the
ATP concentration being ~3 mM [33]. Using this ratio
of ATP:ADP at 1 mM, ATP reduced the proportion of
symmetric complexes in the presence of αLA from
~54% to ~27% (Fig. 6a). At an ATP:ADP ratio of 5:1,
only a background level of cross-correlation was
observed (Fig. 6a). Refolding experiments with a
4-fold excess of DM-MBP over GroEL demonstrat-
ed that the chaperonin system in the presence of
ATP:ADP was functional in accelerating the spon-
taneous folding reaction (Fig. 6b). Note that when
DM-MBP is in excess over GroEL, the measured
folding rate is a combination of accelerated folding
in theGroEL/ES cage and slow spontaneous folding
in bulk solution. The presence of ADP slightly
reduced the flux of DM-MBP through GroEL, reflected
in a decrease in overall folding rate, presumably by
slowing GroES cycling. These results demonstrate
that, at a physiological ATP:ADP ratio, the propensity
of GroEL/ES to populate symmetric complexes is
strongly diminished and the asymmetric GroEL:-
GroES complex functions as the folding active form
of the chaperonin.Discussion
Here, we have reinvestigated the functional
significance of asymmetric and symmetric GroEL/
ES complexes during chaperonin-assisted protein
folding. We show that recent FRET-based assays
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2251Chaperonin-Assisted Protein Foldingused to detect these complexes provide inconsistent
results for the proportion of GroEL:GroES2 com-
plexes in the absence of substrate and overestimate
their population in the presence of substrate protein.
We attribute these problems to the limited sensitivity
of the calibrated FRET assay that measures the
signal indicative of symmetric complexes over a
large background FRET signal (minimally 50%) from
asymmetric complexes. Possible adverse effects
from fluorophore labeling the apical domains of
GroEL, which house the substrate and GroES
binding regions, may also be an issue. We therefore
developed a novel and robust in-solution dcFCCS
assay for GroEL:GroES complex quantification in
which labeling of GroEL is avoided and only the
symmetric GroEL:GroES2 complex generates the
signal, providing superior sensitivity.
Our da ta demons t ra te tha t symmet r i c
GroEL:GroES2 complexes are not significantly popu-
lated in the absence of substrate or presence of
foldable substrate proteins, in contrast to recent reports
[17–19]. However, non-foldable substrate proteins
such as αLA and α-casein can induce the formation
of symmetric complexes. This effect of non-foldable
substrates correlated with an ~2-fold over-stimulation
of the GroEL ATPase rate (in presence of GroES)
above that measured with foldable substrates. Thus,
the interaction with non-foldable substrates appears to
weaken the negative allosteric coupling between the
two GroEL rings to an extent that allows them to bind
and hydrolyze ATP simultaneously, and accordingly,
each ring can bind GroES. The reason for the different
behavior of the chaperonin system in the presence of
non-foldable and foldable substrate proteins remains
to be investigated. The inability of non-foldable
proteins to rapidly compact and bury hydrophobicresidues upon encapsulation in the GroEL/ES
folding cage may play a role in this context [34,35].
Furthermore, experiments performed at physiolog-
ical ATP:ADP concentration ratios demonstrated
that the presence of ADP partially or completely
suppressed the ability of non-foldable substrate
proteins to induce symmetric GroEL:GroES2 com-
plexes. This is consistent with findings that ADP is a
potent allosteric effector of the chaperonin ATPase
cycle [31,32]. Specifically, ADP enhances the
negative allosteric coupling between GroEL rings,
such that they bind and hydrolyze ATP sequentially
rather than simultaneously. As a consequence,
asymmetric complexes dominate.
Taken together, our results do not support the view
that the symmetric GroEL:GroES2 complex is the
main or only folding active unit of the chaperonin
reaction. Instead, we find that asymmetric com-
plexes dominate both in the absence and in the
presence of substrate protein, supporting a model in
which the GroEL rings function sequentially in
chaperonin-assisted folding.Materials and Methods
Strains, plasmids and proteins
The E. coli strains DH5α and BL21 (DE3) Gold
(Stratagene) were used for cloning and protein expression,
respectively. GroEL, GroES and chaperonin cysteine
mutants were expressed and purified as previously
described [23,36]. Purification of substrate proteins
DM-MBP and RrRubisco followed published proce-
dures [23,37]. mMDH, mRho, αLA and α-casein were
purchased from Sigma.
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mRho, mMDH and RrRubisco were denatured in 6 M
GuHCl/5 mM DTT for 1 h at 25 °C. GroEL substrate
complexes were prepared by diluting the denatured
substrate protein 300-fold into buffer A [20 mM Mops/
NaOH (pH 7.4), 200 mM KCl and 10 mM MgCl2]/5 mM
DTT containing GroEL (1 μM), with gentle shaking.
Aggregated protein was removed by centrifugation at
20,000g for 10 min at 15 °C. Denatured substrate protein
addition and centrifugation was repeated three times to
ensure GroEL saturation with substrate. For ATPase
assays and dcFCCS experiments, the GroEL substrate
complexes were diluted 10-fold to a final GroEL concen-
tration of 100 nM. The final GuHCl concentration was
~6 mM. In experiments with the non-aggregating sub-
strate protein DM-MBP, the protein in 6 M GuHCl was
diluted 200-fold into buffer A/5 mM DTT to give a 4- to
6-fold excess over GroEL [25]. The non-foldable substrate
αLA was unfolded in presence of 5 mM DTT and added in
up to 30-fold excess over GroEL, while the non-foldable
substrate α-casein, which exposes hydrophobic residues
in its native state, was added directly to buffer A/5 mMDTT
containing GroEL [28]. All concentrations of GroEL and
GroES indicated refer to the oligomeric complexes.
Protein labeling
Purified GroEL(E315C), GroEL(D490C) or GroES(98C)
in storage buffer [20 mM Mops/NaOH (pH 7.5), 100 mM
NaCl and 10 mM DTT] was buffer exchanged on a NAP5
column (Amersham Biosciences) equilibrated in buffer B
[20 mM Tris/HCl (pH 7.5) and 100 mM KCl] and immedi-
ately mixed with an equimolar concentration of dye
molecules per oligomer to label a single subunit or with
the respective excess of dye for labeling multiple subunits
and incubated for 30 min at 20 °C in case of GroES(98C)
and 15 min in case of GroEL cysteine proteins (which
contain three endogenous cysteine residues). Note the
endogenous GroEL cysteine residues are not accessible to
dye molecules during the labeling time used. The labeling
reaction was quenched by addition of 10 mMDTT. Free dye
was removed by gel filtration on commercial G25 columns
(GE) equilibrated in buffer B/10 mM DTT. The protein was
concentrated usingVivaspin concentrators (molecularmass
cutoff, 10 kDa; GE Healthcare). The degree of labeling
(DOL) was controlled by absorption spectroscopy using the
following extinction coefficients (GroEL 14-mer, ε280 =
146,020 M−1 cm−1; Cy3, εmax = 136,000 M
−1 cm−1 and
cf280 = 0.08; Cy5, εmax = 250,000 M
−1 cm−1 and cf280 =
0.05; F5M, εmax = 83,000 M
−1 cm−1 and cf280 = 0.3; IAE-
DANS, εmax = 5700 M
−1 cm−1 and cf280 = 0.27; Atto532,
εmax = 115,000 M
−1 cm−1 and cf280 = 0.11; Atto655
εmax = 125,000 M
−1 cm−1 and cf280 = 0.08) and the
equation,
DOL ¼ Adye  εdye
− Adye  c f 280
 þ A280  εprotein
In case of GroES labeling due to the low GroES
concentration after labeling (low micromolar range)
and the low extinction coefficient (GroES 7-mer, ε280 =
10,430 M−1 cm−1), the protein concentration (cprotein) was
determined by Bradford assay (Bio-Rad). An unlabeledGroES sample of known concentration (determined photo-
metrically at a high concentration of 100 μM) was used as a
standard. The dye concentration was determined by
absorption spectroscopy and the DOL determined using
the equation:
DOL ¼ Adye  εdye
cprotein
DOL for a given dye molecule was in all cases N90%.
The absence of free dye in the sample was confirmed by
fluorescence correlation spectroscopy (measured diffu-
sion curves did not show additional components corre-
sponding to the diffusion time expected for free dye). For
calibrated FRET measurements (Fig. 2), GroEL(E315C)
contained ~6 dye molecules (IAEDANS) or ~1 dye
molecule (Cy3) per oligomer and GroES(98C) contained
~3 dye molecules (F5M or Cy5) per oligomer [16,18]. In
the case of cross-correlation measurements, GroES(98C)
contained ~1 dye molecule per oligomer. GroEL(D490C)
also contained ~1 dye molecule per oligomer (Fig. S2).
Ensemble FRET
Fluorescence measurements were performed on a
Fluorolog F3-22 spectrofluorometer (Horiba), equipped
with a Peltier element set to 25 °C or 37 °C. Scans were
taken in increments of 1 nm with an integration time of
0.1 s. GroEL(E315C) (140 nM) labeled with IAEDANS or
Cy3 was mixed with GroES(98C) (700 nM) labeled with
F5M or Cy5, respectively, in buffer C [50 mM Tris/HCl
(pH 7.5), 200 mM KCl, 10 mMMgCl2 and 1 mMDTT]. The
mixture was supplemented either with ADP/BeFX (10 mM
KF/1 mM BeSO4/1 mM ADP) to populate asymmetric
complexes or with ATP/BeFX (10 mM KF/1 mM BeSO4/
1 mM ATP) to populate symmetric complexes or with
1 mM ATP/ATP regenerating system [4.5 mM phospho-
enolpyruvate (PEP)/0.2 U pyruvate kinase (Pyk)] to
analyze functional chaperonin cycling. Fluorescence
spectra were recorded immediately after nucleotide
addition with donor excitation at 336 nm (IAEDANS) or
550 nm (Cy3). To analyze the effect of substrate proteins,
we prepared GroEL:substrate complexes as described
above. FRET efficiency (fE) was calculated with the
following equation:
f E ¼ 1− IW=IWOð Þ
where IW is the donor fluorescence in the presence of
nucleotide and IWO is the donor fluorescence in the
absence of nucleotide. To calculate the fraction of
symmetric complexes, we used the following equation:
FractionSYM ¼ f E− f E ASYMð Þ= f E SYM− f E ASYMð Þ
where fE ASYM is the fE in the presence of ADP/BeFX (100%
asymmetric complexes) and fE SYM is the fE in the presence
of ATP/BeFX (100% symmetric complexes).
Dual-color fluorescence cross-correlation
spectroscopy
Correlation spectroscopy was performed on a Micro-
Time 200 inverse time-resolved fluorescence microscope
(PicoQuant) using pulsed interleaved excitation [25,38].
2253Chaperonin-Assisted Protein FoldingFor excitation, picosecond pulsed diode lasers at 640 nm
(LDH-PC-640B) and at 530 nm (LDH-P-FA-530) were
used at a pulse rate of 27 mHz. As cross-correlation
experiments were performed at high concentrations of
the fluorophore (400 nM), the laser power was decreased
to 5 μW measured before the major dichroic. Reactions
in buffer A with additions as indicated in figure legends
were measured in a microscopy cuvette (ibidi) that was
blocked with 6 mg/ml bovine serum albumin for 1 min and
rigorously washed with water to remove unbound bovine
serum albumin. The microscope was maintained at a
temperature of 20 °C. Measurements were performed for
10 min in case of non-foldable substrate proteins and
1 min in case of foldable substrate proteins. Recorded
fluorescence traces were either auto-correlated or cross-
correlated. The general function to express auto-correlation
or dual-color cross-correlation of fluorescence fluctuation is
GGR τð Þ ¼ δFG tð Þ  δFR t þ τð Þh iFG tð Þh i  FR tð Þh i
where δFG and δFR denote the fluctuation of the signal of
green and red fluorescence at time points t and t + τ. In case
of auto-correlation of a single color, G = R. The resulting
correlated data are approximated by a single diffusion
component fit in case of cross-correlation or a diffusion and
triplet model in case of auto-correlation (note that, in
dcFCCS, blinking and triplet formation is not correlated
and does not need to be accounted for):
G τð Þ ¼ ρ  1þ τ
τD
 −1
 1þ τ
τD  κ2
 −12
G τð Þ ¼ 1−T þ T  e −
τ
τT
 " #
ρ  1þ ττD
 −1
 1þ ττDκ2
 −12 	
In both functions, τdenotes the correlation time, τDdenotes
the diffusion time, ρ is the amplitude of the correlation
function and κ is the structural parameter that describes the
quotient of the axial and radial dimensions of the confocal
volume. In case of the latter triplet model, used for fitting of
auto-correlation data, T denotes the triplet state fraction on
the timescale τT. In most cases, only the parameter ρ is of
interest as the amplitude of the correlated data in
auto-correlation is inversely proportional to the concentra-
tion of particles and in case of cross-correlation is directly
proportional to the concentration of double-labeled particles:
CRGh i ¼ Gcc 0ð ÞGR 0ð Þ GG 0ð Þ  V eff
The average concentration of double-labeled particles is
directly proportional to the amplitude of the cross-correlation
function Gcc(0) and inversely proportional to the amplitudes
of the auto-correlation functions for particles labeled red
GR(0) and greenGG(0). Veff denotes the volume of the focal
spot. For constant values of GR(0) and GG(0), Gcc(0) can
be used as a direct measure for changes in complex
concentrations.
ATPase assay
The ATPase activity of GroEL (100 nM) was measured
in buffer A at 25 °C in presence of GroES (400 nM) with orwithout substrate proteins as described above. Control
reactions were performed in presence of equivalent
amounts of denaturant (GuHCl or DTT). ATP hydrolysis
was followed using a NADH-coupled enzymatic assay
(2 mM PEP, 20 U/ml Pyk, 20 U/ml lactate dehydrogenase,
0.5 mM NADH and 1 mM ATP) at 25 °C in a temperature-
controlled spectrophotometer (Jasco) [39].
DM-MBP refolding
Refoldingwasmeasuredbymonitoring the time-dependent
increase in the intrinsic tryptophan fluorescence of
DM-MBP (excitation: 295 nm; emission: 345 nm) [25].
DM-MBP was unfolded in 6 M GuHCl for 1 h at 25 °C.
Denatured DM-MBP was diluted 200-fold into buffer A at
25 °C for spontaneous refolding or into buffer A containing
GroEL (100 nM)/GroES (400 nM) for assisted refolding
with refolding initiated by addition of either 1 mM ATP,
1 mM ATP/0.1 mM ADP, 1 mM ATP/0.2 mM ADP or
1 mM ATP/4.5 mM PEP/0.2 U Pyk.Acknowledgements
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Supplementary Figures 
 
 
Fig. S1.  Analysis of GroEL-GroES complexes by calibrated FRET. The fluorophore pairs 
Cy3/Cy5 (a) and IAEDANS/F5M (b) were used as FRET reporters [16,17]. 140 nM 
GroEL(E315C) labeled with IAEDANS or Cy3 and 700 nM GroES(98C) labeled with F5M or 
Cy5 in buffer C at 37oC was analyzed in the absence of nucleotide (Control) or in the presence of 
either ADP/BeFX or ATP/BeFX or ATP with ATP regenerating system. Fluorescence spectra 
were recorded immediately after nucleotide addition with donor excitation at 550 nm (a) or 
336 nm (b). (c) The proportion of symmetric GroEL:GroES2 complexes was estimated based on 
the donor fluorescence relative to the donor fluorescence in the presence of ADP/BeFX (0% 
symmetric complexes) and in the presence of ATP/BeFX (100% symmetric complexes) (see 
Materials and Methods). Donor fluorescence was measured at 565 nm (Cy3) and 465 nm 
(IAEDANS). The proportion of symmetric complexes was also measured in the presence of a 
30-fold excess of non-foldable substrate protein α-LA or a 6-fold excess of foldable DM-MBP. 
Averages ± SD from three independent experiments are shown. 
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Fig. S2.  Fluorophore labeled GroES is competent for GroEL interaction. (a) Cross 
correlation signal of 100 nM GroEL(D490C) labeled with Atto655 and 400 nM GroES(98C) 
labeled with Atto532 in absence or presence of 1 mM ATP. (b) Cross correlation signal of 
100 nM GroEL(D490C) labeled with Atto532 and 400 nM GroES(98C) labeled with Atto655 in 
absence or presence of 1 mM ATP. Both experiments were carried out in buffer A and in the 
presence of ATP regenerating system. 
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Fig. S3.  Presence of substrate protein does not affect dye fluorescence and correlation 
results. Auto correlation signals of separately labeled GroES (ES532 or ES655, 200 nM each) in 
the presence 100 nM GroEL and 1 mM ATP and increasing concentrations of substrate proteins 
αLA and DM-MBP relative to GroEL. αLA and DM-MBP were unfolded in presence of 5 mM 
DTT and 6 M GuHCl, respectively. Unfolded substrate protein was added in varying amounts to 
100 nM GroEL and 400 nM labeled GroES in buffer A including ATP regenerating system. 
GroEL/ES cycling was initiated by addition of 1 mM ATP. Cross correlation was measured 
immediately after nucleotide addition for a time window of 1 min. The auto correlation 
amplitudes of ES532 (a and c) and ES655 (b and d) were approximated by fit and plotted against 
either αLA (a and b) or DM-MBP (c and d) concentration. 
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Fig. S4.  Residual GuHCl does not destabilize symmetric GroEL:GroES2 complexes. Cross 
correlation amplitudes of GroES in reactions containing GroEL, ATP and ATP regenerating 
system were measured as in Fig. 4a in the presence of a 30-fold excess of LA over GroEL. 
GuHCl was added at the concentrations indicated. 
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3.3 Article 3 - Structure and mechanism of the Rubisco-
assembly chaperone Raf1 
Rubisco is an enzyme that catalyses the incorporation of atmospheric CO2 into organic 
carbon during photosynthesis. Rubisco consist of eight large subunits (RbcL) arranged in 
a tetramer of antiparallel dimers capped on the top and bottom by four small subunits 
(RbcS)104. In this project, we carried out a biochemical and structural characterization of 
Rubisco accumulation factor 1 (Raf1). We also investigated the role of Raf1 as an assembly 
chaperone acting downstream of chaperonin-assisted RbcL folding. Our X-ray structure 
of Raf1 showed that it is a ~40 kDa protein consisting of a β-sheet dimerization domain 
and a flexibly linked α-helical domain. It functions as a dimer in the RbcL8 assembly 
process. Chemical crosslinking coupled to mass spectrometry and a negative stain 
electron microscopy reconstruction showed that the dimerization domain of the Raf1 
dimer interacts along the equator of each antiparallel RbcL dimer and that the α-helical 
domains embrace the top and bottom edges of RbcL2. In such an intermediate, the 
rebinding of a structurally labile RbcL to GroEL is prevented. We also concluded that Raf1 
would bring RbcL subunits into proximity promoting RbcL2 formation. This would lead to 
an assembly of the larger RbcL8:Raf14 complex. In the final step, RbcS binding displaces 
Raf1 and completes the assembly of the holoenzyme. 
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Life on earth depends on the ability of photosynthetic organisms 
to convert atmospheric CO2 into organic carbon. The key enzyme 
responsible for this process is ribulose-1,5-bisphosphate carboxylase- 
oxygenase (Rubisco). Rubisco catalyzes the rate-limiting step of 
carbon fixation by carboxylating the five-carbon sugar substrate 
ribulose-1,5-bisphosphate (RuBP). In plants, algae, cyanobacteria 
and some proteobacteria, Rubisco (form I) is an oligomeric com-
plex of eight large (RbcL, ~50 kDa) and eight small (RbcS, ~15 kDa) 
subunits1. The RbcL subunits are arranged as a tetramer of antipar-
allel dimers (RbcL8 core) capped by four RbcS subunits at the top 
and four at the bottom (RbcL8S8 holoenzyme). Remarkably, Rubisco 
is a rather inefficient enzyme, fixing only around three to ten car-
bon atoms per second2,3. Moreover, certain Rubiscos confuse CO2 
with molecular oxygen as often as once in four catalytic cycles4, 
thus resulting in wasteful photorespiration5–7. Hence, engineering a 
more efficient Rubisco enzyme is central to efforts to increase global 
food production8–11.
Although the structure and mechanism of Rubisco are well under-
stood12,13, knowledge of the chaperone machinery required for 
Rubisco biogenesis remains limited. As recently demonstrated by 
in vitro reconstitution14, folding of cyanobacterial RbcL requires the 
chaperonin GroEL and its cofactor GroES (Cpn60, Cpn10 and Cpn20 
in chloroplasts15). The spontaneous assembly of folded RbcL is inef-
ficient and has been shown to be facilitated by a specific assembly 
chaperone, RbcX14,16. In several cyanobacteria, RbcX is encoded in 
an operon between the rbcL and rbcS genes, and coexpression with 
RbcX has been shown to enhance the production of active form I 
Rubisco in Escherichia coli16–21. RbcX, a homodimer of ~15-kDa 
subunits, functions as a molecular clamp in stabilizing the antiparal-
lel RbcL dimer and promotes formation of an RbcL8–RbcX8 assembly 
intermediate14,22 from which RbcX is displaced by RbcS14. However, 
RbcX is not essential in S. elongatus PCC7942 (Syn7942)23, thus sug-
gesting functional redundancy with other factors. Indeed, a recent 
screen of photosynthetic mutants in maize identified a nuclear-
encoded chloroplast protein, Raf1 (Rubisco accumulation factor 1), 
that is required for efficient Rubisco biogenesis24. Raf1 is conserved 
in all photosynthetic organisms containing RbcX and functions in 
Rubisco assembly in vitro and in vivo25,26.
Here we set out to functionally and structurally characterize the 
plant and cyanobacterial Raf1 proteins. We solved the crystal struc-
tures of the A. thaliana Raf1 domains and analyzed the interaction of 
Raf1 with RbcL by multiple biochemical and biophysical approaches. 
Our results show that Raf1 brackets the antiparallel RbcL dimer and 
stabilizes it in a state competent for assembly of higher oligomers up 
to RbcL8. Displacement of Raf1 by RbcS leads to formation of the 
functional holoenzyme. Thus, Raf1 fulfills a role similar to that of 
RbcX but uses a different structural scaffold and mechanism.
RESULTS
Reconstitution	of	Raf1	function	in	Rubisco	assembly
A. thaliana (At) contains two Raf1 homologs encoded by the AT3G04550 
(Atraf1.2) and AT5G28500 (Atraf1.1) genes, whereas cyanobacteria 
have only one raf1 gene. The respective Raf1 proteins share ~38% 
sequence similarity, and their cyanobacterial homologs are ~55%  
similar (Supplementary Fig. 1). We recombinantly expressed AtRaf1.1 
(42.6 kDa) and AtRaf1.2 (43.5 kDa) without their predicted transit 
peptides, as well as Raf1 from S. elongatus PCC7942 (Syn7942-Raf1; 
40.2 kDa) and Synechococcus sp. PCC7002 (Syn7002-Raf1; 39.9 kDa). 
The purified Raf1 proteins (Supplementary Fig. 2a) formed 
homodimers, as determined by size-exclusion chromatography 
1Department of Cellular Biochemistry, Max Planck Institute of Biochemistry, Martinsried, Germany. 2Gene Center Munich, Ludwig-Maximilians-Universität München, 
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Structure and mechanism of the Rubisco-assembly 
chaperone Raf1
Thomas Hauser1, Javaid Y Bhat1, Goran Milicˇ ić1, Petra Wendler2, F Ulrich Hartl1, Andreas Bracher1  
& Manajit Hayer-Hartl1
Biogenesis	of	the	photosynthetic	enzyme	Rubisco,	a	complex	of	eight	large	(RbcL)	and	eight	small	(RbcS)	subunits,	requires	
assembly	chaperones.	Here	we	analyzed	the	role	of	Rubisco	accumulation	factor1	(Raf1),	a	dimer	of	~40-kDa	subunits.	We	find	
that	Raf1	from	Synechococcus elongatus	acts	downstream	of	chaperonin-assisted	RbcL	folding	by	stabilizing	RbcL	antiparallel	
dimers	for	assembly	into	RbcL8	complexes	with	four	Raf1	dimers	bound.	Raf1	displacement	by	RbcS	results	in	holoenzyme	
formation.	Crystal	structures	show	that	Raf1	from	Arabidopsis thaliana	consists	of	a	b-sheet	dimerization	domain	and	a	flexibly	
linked	a-helical	domain.	Chemical	cross-linking	and	EM	reconstruction	indicate	that	the	b-domains	bind	along	the	equator	of	
each	RbcL2	unit,	and	the	a-helical	domains	embrace	the	top	and	bottom	edges	of	RbcL2.	Raf1	fulfills	a	role	similar	to	that	of	the	
assembly	chaperone	RbcX,	thus	suggesting	that	functionally	redundant	factors	ensure	efficient	Rubisco	biogenesis.
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combined with static light scattering (SEC-MALS) (Fig. 1a). 
Henceforth, concentrations of Raf1 refer to the dimer.
To analyze the function of Raf1, we performed reconstitution 
experiments with RbcL, RbcS and Raf1 from S. elongatus PCC7942 
(Syn7942). Upon folding of denatured RbcL with GroEL–GroES 
(GroEL–ES) in the presence of ATP, most RbcL remained associated 
with GroEL, as analyzed by native PAGE (Fig. 1b, lanes 1 and 2). 
Only a small amount of RbcL was released from GroEL, and it 
migrated as a diffuse band (Fig. 1b, lane 2). This species failed to 
assemble into holoenzyme with RbcS (Fig. 1b, lane 4). Addition 
of Raf1 at equimolar concentration to RbcL resulted in efficient 
release of RbcL from GroEL–ES and in formation of a well-defined 
RbcL species (denoted RbcL*) (Fig. 1b, lane 5). In addition, we 
detected small amounts of high-molecular-weight (HMW) com-
plexes migrating above the holoenzyme standard (RbcL8S8) (Fig. 1b, 
lane 5). Both RbcL* and the HMW forms represented complexes 
of RbcL with Raf1, as detected by immunoblotting with anti-Raf1 
(in which antibody reactivity with Raf1 was reduced in the HMW 
complexes) (Fig. 1c, lane 5). The RbcL–Raf1 complexes formed 
only in the presence of GroEL and GroES (Fig. 1b, lanes 3 and 5), 
thus indicating that Raf1 acts on folded RbcL. Efficient formation 
of enzymatically active RbcL8S8 occurred in the presence of Raf1 
and RbcS (Fig. 1b, lane 6, and Fig. 1d, lane 5). We also observed 
holoenzyme assembly when RbcS was added after treatment with 
apyrase, which hydrolyzes ATP to AMP and stops RbcL folding by 
GroEL–ES (Fig. 1b, lane 7, and Fig. 1d, lane 6). Thus, Raf1 main-
tained folded RbcL in an assembly-competent state. RbcL folding 
occurred with an apparent half-time of ~3 min (Fig. 1e), a result 
consistent with previous measurements14.
Assembly-competent RbcL* also formed during reconstitution with 
the heterologous Syn7002-Raf1 or AtRaf1.2 but not with AtRaf1.1 
(Supplementary Fig. 2b). Reconstitution was ~70% efficient with 
Syn7002-Raf1 and only ~10% efficient with AtRaf1.2. We obtained 
no active enzyme with AtRaf1.1 or a heterodimer of AtRaf1.1 and 
AtRaf1.2 (Supplementary Fig. 2c). Thus, Raf1 proteins appear to be 
adapted to their cognate RbcL proteins, results consistent with those 
in a recent report26.
RbcL–Raf1	assembly	intermediates
The results described above showed that Raf1 assists in the formation of 
RbcL assembly intermediates that are competent to form holoenzyme 
with RbcS. Next we tested whether Raf1 could also bind to preformed 
RbcL8. Recombinantly produced RbcL8 migrated as a stable complex 
in native PAGE16 (Fig. 2a, lane 1). Addition of Raf1 resulted in an 
upshift of RbcL8 indicative of the formation of RbcL8–Raf1 complexes 
(Fig. 2a, lane 3), which are similar to the HMW complexes obtained 
during reconstitution (Fig. 2a, lane 2). RbcS displaced Raf1, thus 
resulting in holoenzyme formation (Supplementary Fig. 2d). Binding 
of Raf1 to RbcL8 also produced a small amount of RbcL–Raf1 com-
plex that migrated indistinguishably from RbcL* (Fig. 2a,b, lanes 3). 
Raf1 did not interact with RbcL8S8 (Fig. 2a,b, lanes 6), and RbcL8 
remained stable in the presence of GroEL (Fig. 2a,b, lanes 7).
To determine the relative stoichiometry of RbcL and Raf1 in the 
RbcL* complex, we excised RbcL* from native PAGE gels and reana-
lyzed it by SDS-PAGE, which was followed by Coomassie staining and 
densitometry. Taking into account that RbcL stains approximately 
two-fold more intensely than Raf1, this analysis suggests that RbcL* is 
a complex of one Raf1 dimer and two RbcL subunits (Supplementary 
Fig. 2e), consistently with the antiparallel RbcL dimer being the 
building block of RbcL8.
Next we characterized the HMW complex consisting of RbcL and 
Raf1 by SEC-MALS and native mass spectrometry (native MS). The 
molar mass of RbcL8 was ~390 kDa by SEC-MALS and ~420 kDa 
by native MS, values close to the theoretical mass of 420.4 kDa 
(Fig. 2c,d). Addition of Raf1 to RbcL8 resulted in a complex of ~764 kDa 
by SEC-MALS and ~741 kDa by native MS (Fig. 2c,d), consist-
ently with four Raf1 dimers being bound to RbcL8 (theoretical mass 
740.9 kDa). SEC-MALS also detected a species of ~159 kDa, 
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Figure 1 Raf1-mediated assembly of S. elongatus Rubisco. (a) SEC-MALS analysis of purified Raf1 proteins  
from Syn7942, Syn7002 and A. thaliana. Horizontal lines across the peaks indicate molar mass and homogeneity  
of the sample. Calculated molar masses and hydrodynamic radii are indicated. (b,c) Analysis of Rubisco  
reconstitution reactions with homologous components, by native PAGE and immunoblotting with anti-RbcL (b)  
and anti-Raf1 (c). Samples are reactions in which denatured RbcL was diluted into buffer B containing GroEL;  
GroES, Raf1 and RbcS were then added in the combinations indicated; and folding was initiated by addition of  
ATP and incubation for 60 min at 25 °C. Apy (lane 7) indicates addition of apyrase to stop folding mediated by  
GroEL–ES before addition of RbcS. White dashed rectangles mark the positions of the RbcL–Raf1 complex RbcL*  
and of HMW RbcL–Raf1 complexes. Arrowheads in b point to a minor contaminant present in some Raf1 preparations  
that cross-reacts with anti-RbcL and migrates similarly to RbcL* in native PAGE. In c, the position of GroES (70 kDa) is shown, and the filled diamond 
indicates higher oligomers of Raf1, which are apparently not bound to RbcL. (d) Rubisco activity in reactions from b after addition of RbcS, which had 
been absent during reconstitution. Activities are expressed as a percentage of purified RbcL8 standard supplemented with RbcS (control). (e) Time 
course of RbcL-subunit folding. Samples are folding reactions performed in the presence of GroEL–ES and Raf1 as in b and stopped with apyrase. 
Rubisco activities were measured after addition of RbcS. Error bars in d and e are s.d. (n = 3 independent experiments).
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among Raf1 homologs; it forms a rather flat surface with hydro-
phobic and positively charged regions (Fig. 3c and Supplementary 
Fig. 5c). Particularly conspicuous is the hydrophobic face of helix 
4 (Asn130, Ile133, Val134 and Ser141) and the conserved charged 
residues (Arg167, Arg174, Arg196, Lys199, Arg228 and Glu232) of 
the adjacent helices 8 and 9.
We obtained two crystal forms for AtRaf1.2β of space groups C2 (2.8-
Å resolution) and P212121 (2.6-Å resolution) (Table 1). In both crystal 
forms, Raf1β exhibited mostly β-structured dimers with pseudo-two-
fold symmetry (Fig. 3d). The three independent copies were closely 
similar (r.m.s. deviation 0.469–1.139 Å), except for the domain swap-
ping of a loop in the P212121 crystal form (Supplementary Fig. 5d,e). 
The overall appearance of the dimer was again rod shaped, with dimen-
sions of 30 × 35 × 80 Å, and with the monomer core forming a curved, 
mixed β-sheet composed of strands A–J–G–F–B (Fig. 3d, side view). 
Satellite β-sheets (strands I–H–J and B and E) branch off the elongated 
β-strands B and J and curl back onto the central sheet on both sides. 
Three short α-helices are interspersed between the strands. The two-
fold symmetry is broken where the connectors between the first and sec-
ond β-strand meet, close to the dyad axis (Fig. 3d and Supplementary 
Fig. 5f). The dimer interface is formed by the β-hairpin protrusions 
(strands C and D) from one subunit and β-strands B and E from the 
other. The interface is highly hydrophobic, and it buries 1,400 Å2  
in each subunit (Supplementary Fig. 5g). Only the face of the dimer 
from which the linkers to the α-domains extend is conserved among 
Raf1 homologs (Fig. 3e). This surface is rather flat, and it contains 
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Figure 2 Interaction of Raf1 with preformed RbcL8 complexes.  
(a,b) Complex formation of RbcL8 with Raf1, analyzed by native PAGE 
and immunoblotting with anti-RbcL (a) and anti-Raf1 (b). Samples are 
purified RbcL8 or RbcL8S8, incubated with Raf1 or GroEL as indicated for 
15 min at 25 °C. Reconstitution reactions (as in Fig. 1b) in the presence 
of Raf1 or Raf1 and RbcS were analyzed in parallel. (c) SEC-MALS 
analysis of RbcL8–Raf1 complex in solution. Samples are purified RbcL8 
incubated with Raf1 for 15 min at 25 °C; RbcL8 alone; and Raf1 alone. 
Horizontal lines across the peaks indicate molar mass and homogeneity. 
Calculated molar masses are indicated. (d) Nano-ESI native MS spectra 
of Raf1, RbcL8 and RbcL8–Raf14 complex generated by incubation of 
RbcL8 with Raf1 for 15 min at 25 °C. Symbols indicate charge-state 
distributions; charge states are shown for some peaks. The calculated 
mass around the m/z values of the respective protein complexes and  
the accuracy of mass values calculated from the different m/z peaks  
are indicated. 
which is close to the theoretical mass of one Raf1 dimer bound to 
RbcL2 (RbcL*; theoretical mass 185.6 kDa) (Fig. 2c). We detected an 
~200-kDa complex by native MS, but it could not be assigned with 
confidence (Fig. 2d).
These results support a model in which the RbcL2–Raf1 complex is 
the first assembly intermediate, and the RbcL8–Raf14 complex is the 
end state of Raf1-mediated assembly. However, the latter was only a 
minor species during reconstitution in the absence of RbcS, and the 
equilibrium was shifted to the RbcL2–Raf1 complex (Fig. 2a,b, lane 2). 
Notably, the yield of active Rubisco decreased when Raf1 was present 
in excess over RbcL (Supplementary Fig. 2f).
Crystal	structures	of	Raf1	domains
Secondary-structure prediction suggested that Raf1 proteins consist 
of an α-helical N-terminal domain of ~185 residues and a C-terminal 
β-sheet domain of ~150 residues, connected by a linker of ~10–27 resi-
dues (Fig. 3a). Although Syn7942-Raf1 failed to crystallize, we obtained 
crystals of AtRaf1.2 containing either residues 62–275 (Raf1α) or 
281–449 (Raf1β), as determined by MS analysis, thus indicating pro-
tease sensitivity of the interdomain linker. We cloned and recom-
binantly expressed the respective α- and β-domains of the different 
Raf1 homologs for further analysis (Supplementary Fig. 2a). The Raf1α 
domains were monomeric, and the Raf1β domains behaved as dimers 
(Supplementary Fig. 3a). The domains on their own were essentially 
inactive in the Rubisco reconstitution assay (Supplementary Fig. 4).
We solved the crystal structures of AtRaf1.2α and AtRaf1.2β by 
single isomorphous replacement with anomalous scattering (SIRAS) 
at resolutions of 1.95 Å and 2.6–2.8 Å, respectively (Table 1 and 
Supplementary Fig. 5a,b). Raf1α is a slightly curved rod with dimen-
sions of 30 × 30 × 70 Å, composed of 11 stacked α-helices, the last 
three of which form a regular three-helix bundle (Fig. 3b). Only one 
face of the domain exhibits substantial surface-residue conservation 
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conserved hydrophobic (Pro348 and Trp350) 
and charged (Arg292, Glu297 and Arg432) 
residues in adjacent β-strands A and J. The 
C-terminal 12 residues were disordered in all 
crystal lattices.
Small-angle X-ray scattering (SAXS) 
measurements indicated maximum dimen-
sions (Dmax) of the isolated domains similar 
to those derived from the crystal structures 
(Supplementary Fig. 3b–d). The Dmax of 
the full-length AtRaf1.2 dimer was ~208 Å, 
and the radius of gyration (Rg) was 52 Å; 
we obtained similar values for Syn7942-
Raf1. This suggested that the highly charged, 
flexible linker allows dynamic move-
ments of the Raf1α domains relative to the 
β-domain dimer, as supported by an ensemble model of the AtRaf1.2 
structure (Supplementary Fig. 3e).
Mutational	analysis	of	Raf1
Next we performed a mutational analysis to determine the 
relevance of specific Raf1 residues for interaction with RbcL. Relative 
to wild-type Raf1, all mutants of the α-domain, except E159A, 
displayed enhanced formation of HMW RbcL8–Raf1 complexes 
at the expense of the RbcL2–Raf1 intermediate (Fig. 4a). In contrast, 
the β-domain mutants almost exclusively populated the RbcL2–Raf1 
complex, similarly to wild-type (Fig. 4a). Although most of the 
Raf1 mutants supported holoenzyme assembly upon addition 
of RbcS, two mutants with conserved positive charges in the 
α-domain (R104Q and K126A K129A, equivalent to Arg174, Arg196 and 
Lys199 in AtRaf1.2), resulted in a 45–70% reduced yield of activ-
ity (Fig. 4b,c). Mutant R104Q showed lower amounts of HMW 
RbcL–Raf1 complex and an increase in diffusely migrating, low- 
molecular-weight RbcL, presumably representing unassembled 
protein (Fig. 4b). This suggested that decreased binding affinity 
of Raf1 R104Q for RbcL generated unstable assembly intermedi-
ates. We also noted that several of the β-domain mutants resulted in 
incomplete conversion of RbcL2–Raf1 to RbcL8S8 (Fig. 4b), which 
correlated with a milder reduction in the yield of active enzyme by 
10–20% (Fig. 4c).
When taken together, our results suggest that mutations in the 
α-domain have a more pronounced effect on the binding properties 
of Raf1 than mutations in the β-domain, consistently with the larger 
conserved surface of the α-domains. The strength of the RbcL-Raf1 
interaction appears to be carefully tuned to allow efficient holoen-
zyme formation.
Analysis	of	RbcL-Raf1	interaction	by	chemical	cross-linking
To identify the contact regions between Raf1 and RbcL, we next 
performed cross-linking coupled to mass spectrometry (CXMS). 
We added Raf1 to S. elongatus RbcL8 to form the RbcL8–Raf14 com-
plex and then incubated the complex with a 1:1 H12 and D12 isotopic 
mixture of the lysine-specific cross-linker disuccinimidylsuberate 
(DSS) (Supplementary Fig. 6). We performed these experiments 
either with the homologous Syn7942-Raf1 or with the function-
ally active heterologous Syn7002-Raf1 (Supplementary Fig. 2b,c), 
which differ considerably in the number and distribution of lysine 
residues (Supplementary Fig. 1). We separated cross-linked products 
by SDS-PAGE and analyzed bands >170 kDa, which were likely to 
contain both Raf1 and RbcL (Supplementary Fig. 6d). The median 
Cα-Cα distance spanned by DSS is ~16.4 Å, with an upper boundary 
of ~36 Å for the structurally most dynamic regions27.
In total, we identified 39 cross-linked peptide pairs in the pres-
ence of Syn7942-Raf1 and 45 in the presence of Syn7002-Raf1 
a A. thaliana Raf1.2 ss Raf1α Raf1β1 61 75 264 288 434
Syn7942 Raf1 Raf1α Raf1β
1 12 192 202 342
Syn7002 Raf1 Raf1α Raf1β
1 15 195 205 345
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Figure 3 Crystal structures of Raf1 domains. 
(a) Schematic representation of the domain 
structures of Raf1 from A. thaliana (isoform 2; 
AtRaf1.2), S. elongatus PCC7942 (Syn7942) 
and Synechococcus sp. PCC7002 (Syn7002). 
The predicted chloroplast signal sequence (SS) 
of AtRaf1.2 is shown in gray. The α-helical 
and β-sheet domains are shown purple and 
orange, respectively. Variable linker regions 
are indicated in white. The domain boundaries 
for the cyanobacterial Raf1 proteins are based 
on the sequence alignment in Supplementary 
Figure 1. (b) Crystal structure of AtRaf1.2α. 
Views related by 90° rotation are shown. Helices 
are represented as cylinders. (c) Surface 
conservation in AtRaf1.2α. AtRaf1.2α is 
oriented as in b. (d) Structure of the AtRaf1.2β 
dimer. The two subunits are shown in orange 
and yellow. Secondary-structure elements are 
indicated by numbers for α-helices and by 
letters for β-strands. The position of the pseudo-
two-fold axis is shown. (e) Surface conservation 
in the AtRaf1.2β dimer, analyzed as in c.
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(Supplementary Data Set 1a–d and Supplementary Note). We were 
able to assign plausible intra- or intermolecular distances of 7 to 20 Å 
for 12 out of the 29 RbcL-RbcL cross-links, on the basis of the 
RbcL8S8 crystal structure28. The remaining 17 RbcL-RbcL cross-links 
could not be assigned distances because one or both of the cross-linked 
residues are located at the flexible N or C terminus. We identified 
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Figure 4 Structure-based mutational analysis of Raf1. (a,b) Native  
PAGE and anti-RbcL immunoblot analysis of S. elongatus Rubisco 
reconstitution reactions without (a) or with (b) addition of RbcS. Single 
and multiple point mutations in the α-domain (purple) or β-domain 
(orange) of Syn7942-Raf1 were analyzed as in Figure 1b for their 
ability to generate the RbcL2–Raf1 intermediate and HMW RbcL8–Raf1 
complexes (a) and RbcL8S8 upon addition of RbcS (b). (c) Rubisco 
activity in reconstitution reactions. Error bars, s.d. (n = 3 independent 
experiments). The equivalent residue numbering for Syn7942-Raf1 and 
AtRaf1.2 is shown.
Table 1 Data collection and refinement statistics
AtRaf1.2α native AtRaf1.2α K2[PtCl4] AtRaf1.2β native I AtRaf1.2β HMBA-I AtRaf1.2β native II
Data collection
Space group P41212 P41212 C2 C2 P212121
Cell dimensions
 a, b, c (Å) 29.77, 29.77, 457.09 29.36, 29.36, 454.86 157.54, 34.36, 106.89 155.72, 34.70, 115.86 39.68, 60.79, 143.27
 α, β, γ (°) 90, 90, 90 90, 90, 90 90, 93.67, 90 90, 97.84, 90 90, 90, 90
Peak Peak
Wavelength 1.072 1.009
Resolution (Å)a 45.71–1.95 (2.06–1.95)a 45.49–2.9 (3.05–2.9) 45.51–2.8 (2.96–2.8) 49.38–3.4 (3.58–3.4) 47.76–2.57 (2.71–2.57)
Rmerge 0.068 (1.067) 0.158 (0.706) 0.044 (0.697) 0.102 (0.941) 0.097 (0.909)
I / σ I 20.2 (2.1) 10.9 (2.9) 20.0 (1.9) 19.4 (2.6) 11.9 (2.1)
Completeness (%) 100 (99.8) 99.7 (98.2) 99.2 (96.5) 99.7 (98.3) 96.7 (81.8)
Redundancy 13.3 (12.6) 14.4 (12.9) 3.6 (3.5) 11.0 (11.2) 4.3 (4.2)
Refinement
Resolution (Å) 30–1.95 – 30–2.8 – 30–2.57
No. reflections 16,514 – 13,676 – 10,713
Rwork / Rfree 0.211 / 0.246 – 0.240 / 0.289 – 0.210 / 0.279
No. atoms
 Protein 1,630 – 4,443 – 2,282
 Phosphatesb – – 15 – –
 Water 60 – – – 9
B factors
 Protein 64.52 – 94.61 – 60.44
 Phosphates – – 138.06 – –
 Water 51.42 – – – 45.77
r.m.s. deviations
 Bond lengths (Å) 0.011 – 0.004 – 0.008
 Bond angles (°) 1.210 – 1.063 – 1.272
aValues in parentheses are for highest-resolution shell. bFrom precipitant.
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31 cross-links between RbcL and Raf1, 19 involving the α-domain, 
6 involving the β-domain, 4 involving the flexible N terminus and 2 
involving the interdomain linker of Raf1 (Supplementary Data Set 
1b,d and Supplementary Note).
According to homology models for the Syn7942-Raf1 and Syn7002-
Raf1 domains, most of the α-domain cross-links originated from the 
periphery of the conserved surface, and we found them multiple 
times (Fig. 3c, Supplementary Data Set 1b,d and Supplementary 
Note). They connected to the N domain of RbcL, including the flex-
ible N terminus and residues Lys11, Lys15, Lys29, Lys78 and Lys143, 
as well as to the TIM-barrel domain (Lys161, Lys172, Lys174, Lys224, 
Lys331 and Lys336) and the C-terminal domain (Lys447 and Lys471) 
(Fig. 5a–c, Supplementary Data Set 1b,d and Supplementary Note). 
The cross-links from the β-domain also involved lysines near its con-
served top surface (Figs. 3e and 5d,e). The Syn7942-Raf1β domain 
has only one lysine (Lys340), which cross-linked repeatedly to Lys336 
on RbcL (Fig. 5d,f, Supplementary Data Set 1b and Supplementary 
Note). The β-domain of Syn7002-Raf1 has six lysines, and of these 
Lys343 cross-linked exclusively to Lys336 on RbcL, whereas Lys344 
cross-linked to either Lys331 or Lys336 on RbcL (Fig. 5e,f and 
Supplementary Data Set 1d and Supplementary Note). Both the 
α- and β-domains cross-linked to residues Lys331 and Lys336 of 
RbcL (Supplementary Data Set 1b,d and Supplementary Note), thus 
suggesting that the Raf1 domains are in proximity, in accordance with 
the limited linker length of ten residues.
Structural	model	of	the	RbcL-Raf1	interaction
We obtained plausible distances for the cross-links between the 
β-domain and RbcL (19–21 Å) by positioning the β-domain dimer 
coaxially at the equatorial front face of each RbcL antiparallel dimer 
(Fig. 5g,h, Supplementary Data Set 1b,d and Supplementary Note). 
In contrast, positioning the β-domain dimer on the two-fold axis 
between RbcL dimers resulted in substantially increased cross-link 
distances (43–67 Å; data not shown), and thus such a topology seems 
less plausible. Indeed, we found similar cross-links during folding and 
assembly (Supplementary Data Set 1e,f and Supplementary Note), 
where mostly the RbcL2–Raf1 intermediate was populated (Fig. 2a,b). 
From the equatorial positioning of the β-domains, and taking the length 
of the α-β domain linker into account, we obtained optimal distances 
for the cross-links between the α-domain and RbcL (Supplementary 
Data Set 1b,d and Supplementary Note) by placing the α-domains 
so that they embraced the top and bottom edges of each RbcL2 unit. 
The shallow groove in the conserved surface of the α-domain (Fig. 3c) 
would cradle the back of the C-terminal domain of RbcL, consistently 
with mutations in this region weakening the interaction with RbcL 
(Fig. 5g and Fig. 4). In addition, the α-domains are also within cross-
linking distance to the adjacent RbcL2 unit in the RbcL8–Raf14 complex 
(Fig. 5h). The resulting tentative model for the RbcL8–Raf14 complex 
(Fig. 5g,h) is consistent with a role of Raf1 in stabilizing RbcL2 and 
allowing its assembly into the RbcL8 core complex. In the structure of 
RbcL8 determined by cryo-EM, the ~60 C-terminal residues of RbcL 
Figure 5 Probing the RbcL–Raf1 complex by chemical cross-linking. (a,b) Cross-linking sites in the Raf1 α-domains of Syn7942-Raf1 and Syn7002-Raf1. Cross-
linked lysine residues and the N-terminal amino group are shown in space-filling representation. The backbone is shown in ribbon representation underneath a 
translucent molecular surface. Disordered residues are indicated by dots. The orientation corresponds to Figure 3b, left. (c) Cross-linking sites from Raf1α on 
the surface of the RbcL dimer. The model is based on the crystal structure of Rubisco28. The RbcL subunits are shown in white and gray. Residues Lys172 and 
Lys174 of RbcL cross-linked to Raf1α are not indicated because they are partially buried in the RbcL dimer interface, and Lys161 is pointing inwards.  
(d,e) Cross-linking sites in the Raf1β domains of Syn7942-Raf1 and Syn7002-Raf1, displayed in the same style as in a and b. Top views are shown. (f) Cross- 
linking sites from Raf1β on the surface of the RbcL dimer. (g) Tentative model of the RbcL2–Raf1 protomer of the RbcL8–Raf14 complex, based on the cross-
linking data. The RbcL dimer is depicted as above; Raf1 is in ribbon representation. Functionally critical Raf1 residues are shown in space-filling representation. 
(h) Cross-links mapped onto the RbcL8–Raf14 complex. Dotted red lines indicate plausible cross-links between lysine residues of RbcL subunits and Raf1.
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are disordered but are ordered in the complex with the assembly chap-
erone RbcX14,22. Thus, it seems plausible that the C-terminal residues 
of RbcL are also ordered in the complex with Raf1.
To obtain additional structural information, we next per-
formed negative-stain EM and single-particle image analysis of the 
S. elongatus RbcL8–Raf14 complex. Our reference-free analysis of 
two-dimensional class averages (7,602 particles) revealed four-
fold symmetry in top views (Fig. 6a–c) and eigenimages from end 
views of the complex (Fig. 6d). Further analysis of a final data set of 
~6,200 particles resulted in a 25-Å density map when dihedral four-
fold symmetry was imposed (Fig. 6e and Supplementary Fig. 7a). 
When rendered at a threshold of 740-kDa mass, the particle dimen-
sions were 110 × 180 Å. Compared to RbcL8 in the holoenzyme 
crystal structure28, the RbcL8–Raf14 complex was ~10 Å taller 
and ~70 Å wider. However, it was ~35 Å taller than the cryo-EM 
structure of RbcL8 alone, in which the C-terminal ~60 residues of 
RbcL are disordered14.
To determine the position of Raf1 in the complex, we first fitted 
the RbcL8 core from the holoenzyme structure into the density with 
Chimera29 (Fig. 6e). The Raf1β dimer was docked into the protruding 
densities at the equatorial rim, and the α-domains were placed into 
additional densities at the top and bottom edges of RbcL2 units (Fig. 6f). 
The cross-links mapped on this model with plausible distances 
(Supplementary Data Set 1b and Supplementary Note). Overall 
the EM– and CXMS-derived structural models are in reasonable 
agreement (Supplementary Fig. 7b) with the differences in domain 
orientations, thus possibly reflecting the dynamic nature of the inter-
action. We note that we were able to obtain a somewhat improved 
fit into the density when assuming that the ~60 C-terminal residues 
in RbcL are disordered (Supplementary Fig. 7c, Supplementary 
Data Set 1b and Supplementary Note). However, in this model 
the conserved surface of Raf1α faced the solvent, and the distance 
between the Raf1 α- and β-domains would be beyond the contour 
length of the linker residues.
To potentially stabilize the RbcL8–Raf14 complex, we per-
formed the EM analysis after DSS cross-linking (Supplementary 
Fig. 7a,d). The three-dimensional (3D) reconstruction obtained 
from 5,183 particles resembled the non-cross-linked complex, with 
a cross-correlation coefficient of 0.9834 (Fig. 6g). Although the cross-
linked complex was slightly smaller (95 × 170 Å), and the Raf1β dimer 
was stabilized (Fig. 6h), cross-linking did not reduce heterogene-
ity in the EM data set (Supplementary Fig. 7d), thus suggesting 
that structural dynamics is an intrinsic functional property of the 
RbcL8-Raf1 interaction.
To further validate the EM structural model, we analyzed 
the RbcL–Raf1 complex of the thermophilic cyanobacterium 
Thermosynechococcus elongatus (Supplementary Fig. 7a,e). The 
purified complex, obtained upon coexpression of T. elongatus 
RbcL and Raf1 in E. coli, again contained four Raf1 dimers bound 
to RbcL8 (Supplementary Fig. 8). The EM density of the T. elonga-
tus RbcL8–Raf14 complex was closely similar to that of S. elongatus  
(cross-correlation coefficient of 0.9742) (Fig. 6i), although its central 
pore was slightly wider (Fig. 6j).
Together the cross-linking data and the EM reconstructions sup-
port a model in which Raf1 brackets the RbcL antiparallel dimer, thus 
stabilizing it in a state competent for assembly to higher oligomers 
up to RbcL8–Raf14.
DISCUSSION
Assembly of oligomeric protein complexes is widely considered to 
be a spontaneous process, and relatively little is known about the 
machineries that support the formation of specific multiprotein com-
plexes. The biogenesis of hexadecameric Rubisco has emerged as a 
paradigm of assisted assembly30,31. Here we analyzed the structure 
Figure 6 Negative-stain EM and 3D reconstructions of RbcL8–Raf14 complex. (a) Micrograph of negatively stained complexes of S. elongatus RbcL8 
and Syn7942-Raf1 complex. (b) Class averages of the complexes derived from multivariate statistical analysis (MSA) in IMAGIC (upper row) and 
corresponding reprojections (bottom rows) of the initial 3D reconstruction. Each class average contains ~30 particles. (c) Class averages of the 
complexes from two-dimensional classification in RELION-1.3. (d) Eigenimages derived from MSA of top views in IMAGIC. (e) Rigid-body domain fitting 
of S. elongatus RbcL8 into the final 3D reconstruction of RbcL8–Raf14. Side and top views are shown. RbcL subunits are in gray and black. (f) Rigid-
body domain fitting of S. elongatus RbcL8 and the Syn7942-Raf1 α- and β-domains into the final 3D reconstruction of RbcL8–Raf14. Side and top 
views are shown in stereo views. Gray and black, RbcL subunits; purple, Raf1α; orange, Raf1β. (g) Negative-stain EM density of S. elongatus RbcL8–
Raf14 (dark mesh) overlaid on EM density of the same cross-linked complex (dark gray surface) in top view; the contour level is set to enclose 740 kDa. 
(h) Structural model of RbcL8 and the Syn7942-Raf1 α- and β-domains docked into the cross-linked S. elongatus RbcL8–Raf14 EM map shown as in f. 
(i) Negative-stain EM density of S. elongatus RbcL8–Raf14 (dark mesh) overlaid on EM density of the T. elongatus RbcL8–Raf14 complex (white surface) 
in top view. (j) Structural model of RbcL8 and the Syn7942-Raf1 α- and β-domains docked into the T. elongatus RbcL8–Raf14 EM map shown as in f.
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and mechanism of the Rubisco-assembly chaperone Raf1 (ref. 24). 
Our results demonstrate that the dimeric Raf1 functions down-
stream of RbcL-subunit folding by the GroEL–ES chaperonin system. 
The major intermediate populated during assembly is a complex 
in which Raf1 brackets the antiparallel RbcL dimer (Fig. 7), thus 
preventing rebinding of the structurally labile RbcL to GroEL. It is 
also possible that Raf1 brings RbcL subunits into proximity, thereby 
promoting dimer formation. The RbcL2–Raf1 complex is competent 
for assembly into higher oligomeric states, with the RbcL8–Raf14  
complex as the endpoint (Fig. 7). Finally, binding of RbcS displaces 
Raf1 and completes assembly of the holoenzyme.
Like the structurally unrelated Rubisco-assembly chaperone 
RbcX16,32,33, Raf1 is dimeric and engages in bivalent interactions 
with RbcL, a principle that probably relates to the antiparallel RbcL 
dimer being the building block of the RbcL8 complex. As shown 
by X-ray crystallographic analysis, Raf1 consists of an N-terminal 
α-domain, a flexible linker segment and a C-terminal β-sheet domain 
that mediates dimerization. Both domains expose conserved interac-
tion surfaces. From crystal structures, biochemical analysis, chemical 
cross-linking and negative-stain EM reconstruction, we propose a 
model of the RbcL8–Raf14 assembly intermediate. In this model, the 
α-domains mediate the majority of functionally important contacts 
with RbcL by bracketing each RbcL dimer at the top and bottom, and 
the β-domain dimers are positioned coaxially in front of the RbcL2 
units. Because the α-domain alone is essentially inactive, dimeriza-
tion is critical for Raf1 to achieve the necessary avidity for complex 
formation with RbcL assembly intermediates. At the same time, the 
interaction must remain dynamic in order to allow RbcS binding, 
because the Raf1 α-domain and RbcS have overlapping binding sites 
on RbcL.
Interestingly, the structurally distinct Raf1 and RbcX assembly pro-
teins perform the same function, but they do so by using different 
interaction sites on RbcL. The boomerang-shaped RbcX dimer binds 
the C-terminal peptide tail of one RbcL subunit in a central cleft and 
contacts the N-terminal domain of the adjacent RbcL subunit via a 
peripheral region16,22. In contrast, the Raf1-RbcL interaction sur-
face appears to be more extensive. An interesting question therefore 
concerns whether Raf1 and RbcX act in parallel assembly pathways 
or functionally cooperate in vivo to achieve efficient assembly at a 
biologically relevant timescale. Taking into consideration that the 
binding sites for RbcX and RbcS have little if any overlap22, the pre-
viously described RbcL8–RbcX8 complex14,22 may be an additional 
assembly intermediate, especially when insufficient RbcS is present. 
A cooperation of Raf1 and RbcX, rather than mere functional redun-
dancy, would be consistent with the strict co-occurrence of the two 
factors in photosynthetic organisms. Given that the RbcL subunits 
of all form I Rubiscos are highly homologous, it is surprising that the 
Rubisco of higher plants has so far been refractory to reconstitution 
in E. coli or in vitro. Perhaps additional factors are required for the 
assembly of the plant enzyme24,34,35.
The chaperone requirement for the folding and assembly of hexa-
decameric (form I) Rubisco is remarkably complex, thus raising the 
question of why such an important and abundant enzyme has failed 
to evolve a more robust biogenesis pathway. Form I Rubisco evolved 
from the simpler dimeric form II enzyme about 2.5 billion years 
ago to adapt to the increasing levels of oxygen36. Both the form I 
and form II RbcL subunits require the GroEL–ES chaperonin for 
folding, like many other TIM-barrel proteins37,38. However, only the 
RbcL of form I Rubisco remains structurally labile after folding and 
tends to rebind to chaperonin rather than to spontaneously assemble. 
The dependence on assembly chaperones, in turn, is likely to have 
slowed the evolution of form I Rubisco. Recent attempts to improve 
the enzymatic properties of the enzyme by directed evolution have 
shown that although the chaperonin tends to increase the number 
of permissible mutations, the assembly chaperone RbcX retards 
evolvability11. It remains to be seen whether Raf1 confers similar 
evolutionary constraints.
METHODS
Methods and any associated references are available in the online 
version of the paper.
Accession codes. Coordinates for the structural domains of the pro-
tein Raf1.2 from A. thaliana have been deposited in the Protein Data 
Bank under accession codes 4WT3, 4WT4 and 4WT5. Negative-stain 
EM maps of the S. elongatus and T. elongatus RbcL8–Raf14 complexes 
have been deposited in the Electron Microscopy Data Bank under 
accession codes EMD-3051 (T. elongatus RbcL8–Raf14), EMD-3052 
(cross-linked S. elongatus RbcL8–Raf14) and EMD-3053 (S. elongatus 
RbcL8–Raf14).
Note: Any Supplementary Information and Source Data files are available in the online 
version of the paper.
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ONLINE	METHODS
Cloning and plasmids. Open reading frames for Syn7942-Raf1, Syn7002-
Raf1, AtRaf1.1 and AtRaf1.2 were amplified by PCR from genomic DNA of 
S. elongatus PCC7942, Synechococcus sp. PCC7002 (ATCC no. 27264) and 
A. thaliana cDNA, respectively, and cloned between the SacII and SacI restriction 
sites of the pHue plasmid39, thus resulting in the following constructs: pHueSyn-
7942raf1, pHueSyn7002raf1, pHueAtraf1.1 and pHueAtraf1.2. The chloroplast 
transit peptides of AtRaf1.1 and AtRaf1.2 were predicted with TargetP (http://
www.cbs.dtu.dk/services/TargetP/) or adopted from the plant proteome database 
(http://ppdb.tc.cornell.edu/). The bicistronic plasmid pHueAtraf1.1raf1.2 was 
created by amplifying Atraf1.2 from pHueAtraf1.2 and inserting it into pHueAt-
raf1.1 with SacI and NotI restriction sites. The respective primer sequences are 
listed in Supplementary Table 1. SacII and SacI sites in the protein-coding regions 
were removed with whole-plasmid site-directed mutagenesis. The sequences for 
the N-terminal (Raf1α) and C-terminal (Raf1β) Raf1 domains were analogously 
cloned into pHue. T. elongatus BP-1 genes encoding RbcL and Raf1, and were 
synthesized (Life Technologies) and cloned between the NcoI and NotI and NdeI 
and XhoI restriction sites of the bicistronic pCDF-Duet-1 plasmid, respectively 
(Novagen). Raf1 was synthesized to contain a TEV protease–cleavable N-terminal 
His-tag (MGSSHHHHHHENLYFQG). For FLAG-tagged constructs, the sequence 
encoding the FLAG tag (MDYKDDDDKAG) was inserted upstream of the 
respective start codon (as described above). Point mutants were produced by 
PCR-based mutagenesis. All plasmid inserts were verified by DNA sequencing.
Protein expression and purification. All purification steps were performed at 
4 °C, and protein concentrations were determined spectrophotometrically at 
280 nm. Raf1 proteins were expressed as N-terminal His6-ubiquitin fusion 
proteins in E. coli BL21(DE3) cells containing the given pHue expression plasmid. 
Cells were grown to an OD600 of 0.5 at 37 °C in Luria-Bertani medium; this was 
followed by induction for 16 h with 0.5 mM isopropyl β-d-thiogalactoside at 
23 °C. Cells were lysed in 50 mM Tris-HCl, pH 8.0, 20 mM NaCl, 1 mM EDTA, 
0.5 mg mL−1 lysozyme and 5 mM phenylmethylsulfonyl fluoride for 30 min 
on ice, and this was followed by ultrasonication (Misonix Sonicator 3000). The 
supernatant obtained after high-speed centrifugation (48,000g, 40 min, 4 °C) was 
applied to an Ni-IMAC column (GE Biotech) to capture the His6-ubiquitin-Raf1 
fusion protein. This was followed by overnight cleavage of the His6-ubiquitin 
moiety at 23 °C with the deubiquitinating enzyme Usp2 (ref. 40). The protein-
containing fraction was dialyzed against buffer A (20 mM Tris-HCl, pH 8.0, and 
50 mM NaCl) and applied to a MonoQ (GE Biotech) column equilibrated with 
buffer A. Proteins were eluted with a linear salt gradient to 1 M NaCl. Fractions 
containing Raf1 were combined and concentrated, 5% glycerol was added, 
and fractions were flash frozen in liquid nitrogen and stored at −80 °C. Raf1 for 
X-ray crystallographic studies was purified further by Superdex200 (GE Biotech) 
size-exclusion chromatography in buffer A.
T. elongatus RbcL–Raf1 complex was expressed and purified essentially as 
described for Raf1 proteins. After purification with an Ni-IMAC column, the 
complex was dialyzed against buffer A. This was followed by purification with 
an ion-exchange column (MonoQ) and a final size-exclusion-chromatography 
step in buffer A (Superdex200). Fractions containing the HMW T. elongatus 
RbcL–Raf1 complex were combined and concentrated, 5% glycerol was added, 
and fractions were flash frozen in liquid nitrogen and stored at −80 °C.
S. elongatus 6301 (Syn6301) RbcL8S8, RbcL8 and RbcS, as well as unassembled 
RbcL, were purified as previously described14,16. The Rubisco proteins of Syn6301 
and Syn7942 are 100% identical in sequence (UniProt P00880, Q31NB3, P04716 
and Q31NB2). Rabbit antibodies against S. elongatus RbcL (ref. 14), Syn7942-Raf1 
and AtRaf1.2 were produced with standard procedures (Supplementary Data 
Set 2). The E. coli chaperonins GroEL and GroES were purified as described 
previously41.
Rubisco reconstitution. GroEL–ES–mediated RbcL folding was performed as 
in ref. 14, with modifications. Denatured S. elongatus RbcL was diluted 200-fold 
from 6 M GuHCl (final concentration 0.5 µM) into ice-cold buffer B (20 mM 
MOPS-KOH, pH 7.5, 100 mM KCl, and 5 mM MgOAc2) containing 5 mM DTT, 
1 mg mL−1 BSA and 1 µM GroEL, and was incubated on ice and then centrifuged to 
remove any aggregated protein. GroES (2 µM), S. elongatus RbcS (5 µM) and Raf1 
were added to the supernatant containing GroEL-bound RbcL when indicated in 
figure legends. Folding and assembly was initiated by addition of 4 mM ATP and 
incubation at 25 °C. Reactions were stopped at the indicated times by addition of 
apyrase (Sigma) to a final concentration of 0.25 U µl−1 to inhibit GroEL–ES activity. 
(Apyrase hydrolyzes ATP and ADP to AMP.) Formation of assembled complexes 
was analyzed by continuous Tris-acetate native-PAGE gradient gels (5–15%  
acrylamide) and immunoblotting with anti-RbcL and anti-Raf1 antibodies.
For measurement of Rubisco enzymatic activity, aliquots of the folding assay 
were supplemented with 5 µM S. elongatus RbcS when it had not previously been 
present in the reaction, and RbcL8S8 assembly was allowed to proceed for 15 min 
at 25 °C. Rubisco carboxylation activity was determined after incubation at 25 °C 
for 10 min in 50 mM Tris-HCl, pH 8.0, 10 mM MgCl2, and 30 mM NaH14CO3 
(25 Bq/nmol), and the amount of fixed carbon was quantified as described previ-
ously41. Activities are expressed as a percentage of purified S. elongatus RbcL8 
standard supplemented with S. elongatus RbcS (control).
Interaction of Raf1 with preformed RbcL8 complexes. Purified RbcL8 and 
RbcL8S8 complexes were incubated with Raf1 for 15 min at 25 °C in buffer B 
containing 5 mM DTT. Formation of assembled complexes was analyzed by con-
tinuous Tris-acetate native PAGE (5–15% acrylamide) and immunoblotting with 
anti-RbcL and anti-Raf1 antibodies and by SEC-MALS and native MS.
Size-exclusion chromatography coupled to multi-angle static light scattering 
(SEC-MALS). Protein samples (~30 to 60 µg) were analyzed with static and 
dynamic light scattering by autoinjection of the sample onto a SEC column 
(5 µm, 7.8 × 300 mm column, Wyatt Technology WTC-030N5) at a flow rate of 
0.2 mL min−1 in buffer C (25 mM Tris-HCl, pH 8.0, and 50 mM NaCl) at 25 °C 
or at a flow rate of 0.15 mL min−1 in buffer B for analysis of the RbcL8–Raf1 
complexes in solution. The column is inline with the following detectors: a vari-
able UV-absorbance detector set at 280 nm (Agilent 1100 series), a DAWN EOS 
MALS detector (Wyatt Technology, 690-nm laser) and an Optilab rEX refractive-
index detector (Wyatt Technology, 690-nm laser)42. Masses were calculated with 
ASTRA (Wyatt Technology) with the dn/dc value set to 0.185 mL g−1. Bovine 
serum albumin (Thermo) was used as the calibration standard.
Native mass spectrometry. The purified S. elongatus RbcL8 (1.25 µM oligomer), 
Syn7942-Raf1 (5 µM dimer) and the binding reaction (15 min at 25 °C) of 
Syn7942-Raf1 (5 µM dimer) to RbcL8 (1.25 µM oligomer) in buffer D (20 mM 
MOPS-KOH, pH 7.5, 50 mM KCl, and 5 mM MgOAc2) containing 5 mM DTT 
were buffer-exchanged into 100 mM ammonium acetate, pH 7.5–8.0 (Fluka, 
Sigma) with Micro Bio-Spin 6 chromatography columns (Bio-Rad). The puri-
fied T. elongatus RbcL–Raf1 complex (~8 µM) was buffer-exchanged as above. 
Native-MS analyses were performed in positive-ion mode on an electrospray ioni-
zation quadrupole time-of-flight (ESI-TOF) hybrid mass spectrometer (Synapt 
G2-Si, Waters) equipped with a Z-spray nano-ESI source. Gold-plated 10-µm 
nano-ESI pipettes (Mascom) were used as capillaries. Optimized capillary and 
sample cone voltages were 1–1.6 kV and 100–150 V, respectively. Spectra were 
calibrated with 30 mg mL−1 cesium iodide dissolved in 1:1 acetonitrile/water.
Electron microscopy (EM) and 3D reconstruction. RbcL8–Raf14 complex 
(~50 µg mL−1) in buffer B containing 5 mM DTT was applied to freshly plasma-
cleaned, carbon-coated grids (Quantifoil) and was negative stained with 2% (w/v) 
uranyl acetate. Images were digitally recorded on a Philips CM200 FEG electron 
microscope equipped with a TemCam F415MP 4k at a nominal magnification of 
50,000×, with a pixel size of 2.16 Å/pixel at specimen level and defocus ranging 
from 300 to 1,500 nm. The microscope was operated under low-dose condi-
tions at 160 kV. The defocus and astigmatism of the images were determined 
with CTFFIND4 (ref. 43) in RELION-1.3 (ref. 44). A total of 62, 49 and 90 
micrographs were selected for image processing of the S. elongatus RbcL8–Raf14, 
the cross-linked S. elongatus RbcL8–Raf14 and the T. elongatus RbcL8–Raf14  
complexes, respectively. Manual particle selection with RELION-1.3 yielded a 
final data set of 5,183 particles for the cross-linked S. elongatus RbcL8–Raf14 
complex and 5,471 particles for the T. elongatus RbcL8–Raf14 complex. For 
the native S. elongatus RbcL8–Raf14 complex, a total of 1,057 particles from 13 
micrographs were manually selected with RELION-1.3 to generate references 
for automatic particle picking. After automatic particle selection in RELION-1.3 
and manual cleaning of the data set on the basis of z-score characteristics, a stack 
of 7,602 particles was obtained. The extracted particle data set was subjected to 
2D classification in RELION-1.3, and classes showing erroneously picked features 
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and aggregates were discarded, thus resulting in 6,191 particles in the final data 
set. Initial 3D reconstruction of the S. elongatus RbcL8–Raf14 complex and the 
T. elongatus RbcL8–Raf14 complex were generated with IMAGIC-5 (ref. 45). 
Particle images were band-pass-filtered between 250 and 10 Å, normalized and 
centered by iterative alignment to their rotationally averaged sum. Initial class 
averages containing ~30 particles were obtained by two rounds of classification on 
the basis of multivariate statistical analysis (MSA) and subsequent multireference 
alignment with homogenous classes as new references. For symmetry analysis, 
top views of the complexes were extracted, randomly rotated and subjected to 
MSA. A density map with imposed dihedral four-fold symmetry was created 
by angular reconstitution. 3D refinement of the initial model was carried out in 
RELION-1.3 with application of four-fold symmetry and no mask. The resolution 
of the final refinement by gold-standard Fourier shell correlation (FSC) at cutoffs 
of 0.143 and 0.5 is shown in Supplementary Figure 7a. The PDB structures of 
RbcL8 (from the Rubisco crystal structure28) and Raf1 domains were fitted manu-
ally as rigid bodies with UCSF Chimera29.
Cross-linking coupled to mass spectrometry (CXMS). Purified RbcL8 (1.25 µM 
oligomer) was incubated with Raf1 (10 µM) in buffer D for 15 min at 25 °C. 
This was followed by addition of 2 mM of a 1:1 isotopic mixture of H12 and D12 
disuccinimidylsuberate, H12/D12-DSS (Creative Molecules) for 30 min 
(Supplementary Fig. 6). Reactions were quenched by addition of 150 mM 
NH4HCO3. (CXMS) with the bifunctional lysine-specific cross-linker 
disuccinimidylsuberate (DSS). Cross-linking during reconstitution was 
performed with N-terminally FLAG-tagged Raf1; this was followed by isola-
tion of cross-linked Raf1 by anti-FLAG immunoprecipitation (anti-FLAG beads, 
Sigma). Cross-linked complexes were separated on 4–12% Bis-Tris SDS-PAGE 
(Life Technologies) and visualized by Coomassie staining. Excision of gel bands, 
reduction, alkylation, in-gel digestion and desalting were performed as previ-
ously described46,47. Desalted peptides were dissolved in 5% formic acid and 
analyzed on an Easy-nLC 1000 UPLC system (Thermo) connected to a Q-Exactive 
Orbitrap mass spectrometer (Thermo). Peptides were separated on nanospray 
columns (ID 75 µm, 20 cm long with 8-µm tip opening, New Objective) contain-
ing 1.9-µm C18 beads (Reprosil-Pur C18-AQ, Dr. Maisch) on a 60-min gradient 
with buffers (0.2% formic acid in water and 0.2% formic acid in acetonitrile). 
Sample loading to the column was performed by the Thermo Easy-nLC 1000 
autosampler without a trap column, at a flow rate of 0.5 µl per min. The UPLC 
flow rate during sample analysis was set to 0.2 µl/min. MS2 analysis was per-
formed with standard data-dependent mode settings, with alternation between 
one high-resolution (resolution 70,000) MS1 scan (m/z of 400–1,750) and ten 
MS2 scans (resolution 17,500) of the ten most intense ions with charge states of 
three or more, as run on Thermo Xcalibur software.
For data analysis, Thermo Xcalibur .raw files were converted to .mgf (Mascot 
generic file) format, with Proteome Discoverer 1.4 (Thermo). To identify cross-
linked peptides, the .mgf files were analyzed on StavroX 3.1.19 (ref. 48) with the 
following parameters: MS1 tolerance of 3 p.p.m.; MS2 tolerance of 0.8 Da; missed 
cleavages for lysine and arginine of 3 and 1, respectively; signal-to-noise ratio ≥2; 
and fixed and variable modifications of cysteine carbamidomethylation and 
methionine oxidation, respectively. The potential cross-linking sites for DSS are 
lysine residues and the free amino group at the N terminus. All the identified 
linked peptides were validated manually for b- and y-ion assignment and were 
included in the final list only if precursors of the respective peptides contained 
doublets with mass difference of 12.0753 Da (mass difference between H12-DSS 
and D12-DSS). The cross-linked peptides were identified from two independent 
experiments for each Raf1 protein.
Small-angle X-ray scattering (SAXS). SAXS measurements were performed at 
beamline BM29 of the European Synchrotron Radiation Source (ESRF), Grenoble, 
France. Protein samples at three different concentrations in 50 mM Tris-HCl, pH 8.0, 
50 mM NaCl and 5% (v/v) glycerol were exposed for 1 s. Scattering data from ten 
repeats were averaged. Buffer background was subtracted. The protein scattering 
data were processed with Primus49,50. Radii of gyration were determined with the 
Guinier approximation. Scattering curves were fitted with GNOM51. An ensemble 
model of the AtRaf1.2 structure was generated with EOM 2.0 (refs. 52,53).
Crystallization. Initial crystals of AtRaf1.2α were obtained by the sitting-drop 
vapor-diffusion method at 18 °C, with mixture of equal volumes of AtRaf1.2(62–449) 
(18 mg mL−1 in buffer C) with a precipitant containing 0.1 M MES-NaOH, 
pH 6.0, and 20% (w/v) PEG 6000 (Qiagen pHClear Suite condition D3. 
Crystals of AtRaf1.2α(62–274) were obtained at 20 °C with 0.1 M MES-NaOH, 
pH 6.0, and 26% (w/v) PEG-6000 as a precipitant. For cryoprotection, crystals 
were transferred stepwise into 0.1 M MES-NaOH, pH 6.0, 26% (w/v) PEG 6000 
and 15% (v/v) glycerol before being flash frozen in liquid nitrogen.
Orthorhombic crystals of AtRaf1.2β were obtained by the sitting-drop vapor-
diffusion method at 4 °C, with mixture of equal volumes of AtRaf1.2(62–449) 
(17 mg mL−1 in buffer C) with a precipitant containing 20% PEG 6000, 50 mM 
K2HPO4 and 200 mM KH2PO4. Monoclinic crystals of AtRaf1.2β(281–449) 
were obtained with 10% PEG3350 as a precipitant.
Structure determination. Diffraction data were collected at beamlines X10SA 
and X06DA of the Swiss Light Source (SLS) in Villigen, Switzerland. The data 
were processed with XDS54 and transferred into the CCP4 format with Pointless55, 
Scala56 and Truncate57. The structures of AtRaf1.2α and monoclinic AtRaf1.2β 
were solved by SIRAS with crystals soaked with 1 mM K2[PtCl4] and sodium p-
(hydroxymercuri)benzoate (HMBA), respectively. Two platinum and six mercury 
sites were found with SHELXD58, as implemented in HKL2MAP59, for AtRaf1.2α 
and AtRaf1.2β, respectively. These solutions were further refined with Sharp60. 
Density modification was subsequently carried out with Resolve61. A prelimi-
nary model for AtRaf1.2α was manually built in the resulting map with Coot62. 
For final model building and refinement, a nearly isomorphous native data of 
AtRaf1.2α(62–274) was used. Buccaneer63 built a partial model of AtRaf1.2β, 
which was completed manually with Coot. Orthorhombic AtRaf1.2β was solved 
by molecular replacement with Molrep64. The models were improved by iterative 
cycles of refinement with Refmac65, as implemented in the CCP4 interface66, and 
this was followed by manual model building. The final refinement of AtRaf1.2α 
was carried out with phenix.refine67. Nonglycine residues facing solvent channels 
without discernible side chain density were modeled as alanines.
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Supplementary Figure 1 
Alignment of Raf1 sequences. 
Amino acid sequences of a representative set of Raf1 homologs were aligned using the EBI Clustal-Ω server. Secondary structure 
elements for Raf1.2 from Arabidopsis thaliana are indicated above the sequences. The Raf1 domain structure is indicated by purple 
and orange coloring of secondary structure elements in the Raf1 and Raf1 domains, respectively. The sequences from plants (1), 
green algae (2) and cyanobacteria (3) are grouped separately. Similar residues are shown in red and identical residues in white on a 
red background. Blue frames indicate homologous regions. The consensus sequence is shown at the bottom. The chloroplast signal 
sequences are not shown. Asterisks below the sequence indicate mutations in Syn7942-Raf1 analyzed in this study (Fig. 4). The 
Uniprot accession codes for the sequences are: Q9SR19, Arabidopsis thaliana Raf1.2; Q9LKR8, Arabidopsis thaliana Raf1.1; B4FR29, 
Zea mays; I0YJW5, Coccomyxa subellipsoidea C-169; E1ZGR5, Chlorella variabilis; Cre06.g308450.t1.2, Chlamydomonas reinhardtii; 
Q00S02, Ostreococcus tauri; C1FI81, Micromonas sp. (strain RCC299 / NOUM17); B4VSU9, Coleofasciculus chthonoplastes 
PCC7420; Q31Q05, Synechococcus elongatus PCC7942; Q5N472, Synechococcus elongatus PCC6301; B1XK11, Synechococcus sp. 
PCC7002. 
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Supplementary Figure 2 
Functional analysis of Raf1 homologs. 
(a) Purified full-length Raf1 proteins and the respective - and-domains of Syn7942, Syn7002 and A. thaliana. AtRaf1.1/1.2 is a 
complex of AtRaf1.1 and AtRaf1.2 produced from a biscistronic plasmid. (b) Native-PAGE analysis of Rubisco reconstitution reactions 
as in Fig. 1b, containing the Raf1 proteins indicated. (c) Rubisco activities in reactions shown in (b) after supplementation with RbcS as 
described in Fig. 1d. Error bars, s.d. (n = 3 independent experiments). (d) Displacement of Raf1 from RbcL8 by RbcS. Purified S. 
elongatus RbcL8 was incubated with Syn7942-Raf1 as in Fig. 2a, followed by addition of RbcS (5 M) and analysis by native-PAGE and 
immunoblotting with anti-RbcL (left) and anti-Raf1 (right). S. elongatus RbcL8 and RbcL8S8 were used as standards. (e) Stoichiometry 
of RbcL and Raf1 in RbcL* complexes. RbcL* was excised from native-PAGE and separated by SDS-PAGE followed by Coomassie 
staining and quantitation by densitometry. Top, molar ratios of RbcL and Raf1 standards as quantified by extinction coefficients. 
Bottom, ratios of RbcL to Raf1 stain intensities are indicated as averages ±S.D from four measurements. The molar ratio of RbcL to 
Raf1 in RbcL* is close 1:1. Shown is a representative Coomassie stained gel. (f) Dependence of Rubisco assembly on Raf1 
concentration. Reconstitution reactions were performed as in Fig. 1e at increasing concentrations of Raf1 and the Rubisco activities 
obtained after 60 min are indicated as percentage of control. Error bars, s.d. (n = 3 independent experiments). 
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Supplementary Figure 3 
SEC-MALS and SAXS analysis of Raf1 proteins. 
(a) SEC-MALS analysis of purified Raf1 domains from Syn7942, Syn7002 and A. thaliana. Data showing measurements for ~30 g of 
the respective proteins. Horizontal lines across the peaks indicate molar mass and homogeneity of the sample. Calculated molar 
masses and hydrodynamic radii are indicated. (b) Representative X-ray scattering curves of AtRaf1.2 (red), AtRaf1.2 (blue) and 
AtRaf1.2 (green) and Syn7942-Raf1 (black). The curves represent background-corrected averages of ten measurements. The GNOM-
fitted
51
 curves are overlaid. (c) Density distributions for AtRaf1.2 (red), AtRaf1.2 (blue), AtRaf1.2 (green) and Syn7942-Raf1 (black) 
calculated with GNOM. AtRaf1.2 and AtRaf1.2 appear rod-shaped and globular, respectively. The curves for AtRaf1.2 and Syn7942-
Raf1 suggests flexibly linked domains.(d) Parameters from SAXS data analysis. Radii of gyration were determined using the Guinier 
approximation. Scattering curves were fitted with GNOM. (e) Ensemble model for the AtRaf1.2 dimer. Two perpendicular views are 
shown. The backbones are represented as coils. A subset of five models matching the experimental scattering curve (Chi value 3.978) 
was picked from a library of 10,000 conformations by a genetic algorithm implemented in the program EOM 2.0
52,53
. The position of the 
dimeric -domain (orange) was fixed at the dyad symmetry axis. The -domains are represented in purple; the flexible termini and inter-
domain linkers are shown in gray. 
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Supplementary Figure 4 
Functional analysis of Raf1 homologs. 
(a) Native-PAGE analysis of Rubisco reconstitution reactions as in Fig. 1b, containing purified full-length Raf1 and the - and -
domains from Syn7942 and A. thaliana. RbcS was present when indicated. (b) Rubisco activities in reactions shown in (a) after 
supplementation with RbcS when absent, as described in Fig. 1d. Error bars, s.d. (n = 3 independent experiments). 
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Supplementary Figure 5 
Crystal structures of AtRaf1.2 domains. 
(a,b) Experimental electron density maps for AtRaf1.2 and AtRaf1.2. Representative regions are shown. The meshwork represents 
the isocontour surface at 1.0  level. The nominal resolutions of the AtRaf1.2 Pt-SIRAS and AtRaf1.2 Hg-SIRAS maps are 2.75 and 
3.0 Å, respectively. Panel B shows a contact between two AtRaf1.2 dimers. (c) Surface properties of AtRaf1.2 The same views as in 
Fig. 3c are shown. Positively and negatively charged groups are shown in blue and red, respectively. Yellow color signifies hydrophobic 
sidechains. (d) Superposition of three crystallographically independent copies of the AtRaf1.2 dimer. The models are represented as 
C traces. The orientation corresponds to the top-view in Fig. 3d.(e) Domain swapping in the P212121 crystal lattice of AtRaf1.2. In this 
lattice the long F-G connecting loops reach across between adjacent dimers, making contacts to a hydrophobic pit. In the C2 crystal 
form, the hydrophobic residues at the loop apex fold back onto the respective hydrophobic area of the same chain, realizing an 
analogous intramolecular contact. Outside of the crystal lattice the conformation observed in the C2 crystal form should be strongly 
favored. (f) Topology of the secondary structure in the AtRaf1.2 dimer. -Helices and -strands are represented by cylinders and 
arrows, using the same color scheme as in the main text. The monomer shown in orange differs from the second by insertion of helix 
12. (g) Features of the AtRaf1.2 dimer interface. On the left, the surface properties of the area facing the RbcL dimer are show using 
the same representation as in in panel c. On the right, one monomer is shown as backbone ribbon, the other in surface representation 
to reveal the AtRaf1.2 dimer interface. Yellow color signifies hydrophobic sidechains. 
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Supplementary Figure 6 
Cross-linking coupled to mass spectrometry (CXMS). 
(a) Structure of the bifunctional crosslinker disuccinimidylsuberate (DSS). The crosslinker is a 1:1 mixture of unlabeled (light; H12) and 
deuterium labeled (heavy; D12) compounds with a mass difference of 12.0753 Da. (b) Workflow for analysis of crosslinked protein 
bands marked and numbered in (c) by in-gel trypsin digestion, followed by LC–MS. (c) Crosslinking products of individual proteins S. 
elongatus RbcL8, Syn7942-Raf1 and Syn7002-Raf1. The purified proteins (1.25 M RbcL8 and 10 M of the respective Raf1 proteins) 
were incubated with H12:D12–DSS (2 mM) for 30 min at 25
o
C, followed by quenching of the crosslinking reaction with NH4HCO3 (150 
mM) and analysis by SDS-PAGE. (d) Crosslinking products of RbcL8 (1.25 M) with Syn7942-Raf1 or Syn7002-Raf1 (10 M each). 
Boxed areas were analyzed as in (b). (e) Representative MS/MS spectra for the crosslinks RbcL–RbcL (Lys15–Lys460), Raf1–RbcL 
(Lys344–Lys336) and Raf1–Raf1 (Lys344–Lys188). 
Nature Structural & Molecular Biology: doi:10.1038/nsmb.3062
 
 
 
 
Supplementary Figure 7 
Negative-stain EM analysis. 
(a) Fourier Shell Correlation (FSC) curves of S. elongatus (Se) RbcL8–Raf14, crosslinked SeRbcL8–Raf14, and T. elongatus (Te) 
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RbcL8–Raf14 as determined by gold standard FSC procedure in RELION-1.3. The resolution of the maps estimated by FSC with 0.5 
and 0.143 correlation cut-off and no masking are given. (b) Comparison of the RbcL8–Raf14 models derived from CXMS distance 
restraints (Fig. 5g,h) and EM reconstruction (Fig. 6f,h,j) (assuming the C-terminal 65 residues of RbcL are structured). The backbones 
are represented by C traces. Raf1 and RbcL in the CXMS model are shown in magenta and white, respectively. Raf1 and RbcL in the 
EM reconstruction are shown in cyan and gray, respectively. (c) Rigid body domain fitting of SeRaf1- and -domains and RbcL8 
missing the C-terminal 65 amino acids into the 3D reconstruction of SeRbcL8–Raf14. RbcL subunits in gray and black; Raf1 in purple 
and Raf1 in orange. Side- and top-views are shown. (d,e) Negative stain electron micrograph of crosslinked SeRbcL8–Raf14 (d) and of 
TeRbcL8–Raf14 (e). Exemplary class averages of the respective complexes obtained from 2D classification in RELION-1.3 are shown in 
the insets. 
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Supplementary Figure 8 
Characterization of the RbcL–Raf1 complex of the thermophilic cyanobacterium T. elongatus. 
T. elongatus RbcL and Raf1 proteins were coexpressed in E. coli and purified as a high molecular weight complex. (a) SEC-MALS 
analysis of RbcL-Raf1 complex in solution (~40 g). The horizontal line across the peak indicates the calculated molar mass. Note that 
the sample contained a small amount of aggregated protein which leads to a higher average molar mass (~828 kDa) than expected for 
the RbcL8–Raf14 complex (~740 kDa). (b) nano-ESI native MS spectra of RbcL–Raf1 complex (~8 M), Symbols indicate the charge 
state distributions with the charge states shown for some peaks; the calculated mass around the m/z values of the respective protein 
complexes is indicated. S.D. refers to the accuracy of mass values calculated from the different m/z peaks. The theoretical masses for 
RbcL8–Raf14 and RbcL2 are 741628.8 Da and 106265.4 Da, respectively. 
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 SUPPLEMENTARY TABLES 
Supplementary Table 1. PCR Primer Sequences for Cloning of Raf1 Constructs. The SacI 
(GAGCTC), SacII (CCGCGG) and NotI (GCGGCCGC) restriction sites are underlined, and the 
start codons are italicized. 
Plasmid   Oligos 
Syn7942raf1 
Syn7942Raf1: 5’ CCGCGGTGGTATGCGTGAGTTCACCCCCAC 
Syn7942Raf1: 3’ GAGCTCCTATTCTTCAAACTGCCAAGGTG 
Syn7002raf1 
Syn7002Raf1: 5’ CCGCGGTGGTATGATTGGACAACCGCAATCTCC 
Syn7002Raf1: 3’ GAGCTCTTAATCGTCCATTTGCCAGGGTTCC 
Atraf1.1      
(52-434) 
AtRaf1.1: 5’ CCGCGGTGGTCAACAACTCTATCAACCATTCCG 
AtRaf1.1: 3’ GAGCTCCTAATCCCAATCTTCATCATTTATC 
Atraf1.2      
(62-449) 
AtRaf1.2: 5’ CCGCGGTGGTCAACAGCTCTACCAACCGTTCCG 
AtRaf1.2: 3’ GAGCTCTCAGTCCCAGTTCTGATGACTTG 
Atraf1.1/1.2
AtRaf1.1/1.2: 5’ 
GAGCTCAAGCTTAGATCCGGCTGCTAACAAAGCC
CGTAAGAAGGAGATATACCATGCAACAGCTCTACC
AACCGTTC 
AtRaf1.1/1.2: 3’ 
GCGGCCGCTCAGTCCCAGTTCTGATGACTTGTCTG
C 
Syn7942raf1???
(1-192) 
Syn7942Raf1?: 5’ CCGCGGTGGTATGCGTGAGTTCACC 
Syn7942Raf1?: 3’ GAGCTCTTAATCTAGCAGCAATGCTTCGATGAGG 
Syn7942raf1?
(194-356) 
Syn7942Raf1?: 5’ CCGCGGTGGTCCGATGCTGCCGATCTATCGACTG 
Syn7942Raf1?: 3’ GAGCTCCTATTCTTCAAACTGCCAAGGTGTTG 
Syn7002raf1? 
(1-195) 
Syn7002Raf1 ?: 5’ CCGCGGTGGTATGATTGGACAACCGCAATCTCC 
Syn7002Raf1 ?: 3’ GAGCTCTTAGTCACTGAGGAGTTGCTCGAT 
Syn7002raf1? 
(197-359) 
Syn7002Raf1 ?: 5’ CCGCGGTGGTCCGCTCCTCCCCCTCTACCGTTAC 
Syn7002Raf1 ?: 3’ GAGCTCTTAATCGTCCATTTGCCAGGG 
Atraf1.2?         
(62-274) 
AtRaf1.2?: 5’ CCGCGGTGGTCAACAGCTCTACCAACCGTTCCG 
AtRaf1.2?: 3’ GAGCTCTCACTTCTCCTTCTCTGCTTCCTTGTC 
Atraf1.2?         
(281-449) 
AtRaf1.2?: 5’ CCGCGGTGGTGAGGAAGTCAAAGCTATTCGGATTC
C 
AtRaf1.2?: 3’ GAGCTCTCAGTCCCAGTTCTGATGACTTG 
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Supplementary Data Set 1  DSS crosslinks identified in the complex of S. elongatus RbcL8 and 
Raf1 (a) S. elongatus RbcL8 and Syn7942-Raf1 complex. Protein band refers to the band number 
on SDS-PAGE in Supplementary Fig. 6d; A, experiment 1; B, experiment 2. m/z, mass over 
charge. The crosslinked peptides, as well as their detected and calculated mass, and the positions 
of the crosslinked residues are indicated. m, denotes oxidized methionine. Note that the N-
terminal amino acid of a protein can be crosslinked with DSS. See Online Methods and 
Supplementary Fig. 6 for details. (b) Consolidated list of crosslink sites from Supplementary 
Data Set 1a. Domain categories: N, N-terminal residues 1–11 in Syn7942-Raf1 and residues 1–
147 in S. elongatus RbcL; TIM, TIM-barrel residues 148–410 in S. elongatus RbcL; C, C-
terminal residues 411–472 in S. elongatus RbcL; ?, ?-domain residues 12–192 in Syn7942-
Raf1; ?, ?-domain residues 202–342 in Syn7942-Raf1; linker, residues 193–201 in Syn7942-
Raf1. Crosslink distances between RbcL residues indicate the intra- or intermolecular distance in 
RbcL2 in context of the RbcL8 core complex. Crosslink distances between RbcL and Raf1 
residues refer to the distances of the respective residues in the structural model derived from 
crosslinking data (assuming the C-terminal 65 residues of RbcL are structured) or EM 
reconstruction (assuming the C-terminal 65 residues of the RbcL subunit are either structured or 
disordered). Distances of Raf1 to the adjacent RbcL and the next closest RbcL are reported. 
Crosslink distances between Raf1 residues indicate the intra- or intermolecular distance in the 
Raf1 dimer in the structural models derived from crosslinking data (assuming the C-terminal 65 
residues of RbcL are structured) or EM reconstruction (assuming the C-terminal 65 residues of 
the RbcL subunit are either structured or disordered). 1, RbcL residues in the flexible N- or C-
terminal sequence precluding distance assignment. 2, Raf1 residues in the flexible N-terminal 
sequence and interdomain linker precluding distance assignment. *, denotes a crosslink between 
Raf1 ?-domains that cannot occur in the context of the structural models of the RbcL8Raf14 
complex and must be due to the dynamic nature of the interaction. (c) S. elongatus RbcL8 and 
Syn7002-Raf1 complex. Protein band refers to the band number on SDS-PAGE in 
Supplementary Fig. 6d; A, experiment 1; B, experiment 2. m/z, mass over charge. The 
crosslinked peptides, as well as their detected and calculated mass, and the positions of the 
crosslinked residues are indicated. m, denotes oxidized methionine. Note that the N-terminal 
amino acid of a protein can be crosslinked with DSS. See Online Methods and Supplementary 
Fig. 6 for details. (d) Consolidated list of crosslink sites from Supplementary Data Set 1c. 
Domain categories: N, N-terminal residues 1–14 in Syn7002-Raf1 and residues 1–147 in S.
elongatus RbcL; TIM, TIM-barrel residues 148–410 in S. elongatus RbcL; C, C-terminal 
residues 411–472 in S. elongatus RbcL; ?, ?-domain residues 15–195 in Syn7002-Raf1; ?, ?-
domain residues 205–345 in Syn7002-Raf1; linker, residues 196–204 in Syn7002-Raf1. 
Crosslink distances between RbcL residues indicate the intra- or intermolecular distance in 
RbcL2 in context of the RbcL8 core complex. Intermolecular distances of RbcL to the next 
closest RbcL of a RbcL2 are also reported. Crosslink distances between RbcL and Raf1 residues 
refer to the distances of the respective residues in the structural model derived from crosslinking 
data (assuming the C-terminal 65 residues of RbcL are structured). Distances of Raf1 to the 
adjacent RbcL and the next closest RbcL are reported. Crosslink distances between Raf1 residues 
indicate the intra- or intermolecular distance in the Raf1 dimer in the structural model derived 
from crosslinking data (assuming the C-terminal 65 residues of RbcL are structured). 1, RbcL 
residues in the flexible N- or C-terminal sequence precluding distance assignment. 2, Raf1 
EMENTARY NOTE
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 residues in the flexible N-terminal sequence and interdomain linker precluding distance 
assignment. (e) Reconstitution of SeRbcL in the presence Syn7942-Raf1. Protein band refers to 
the band number on SDS-PAGE. A, experiment 1; B, experiment 2. m/z, mass over charge. The 
crosslinked peptides, as well as their detected and calculated mass, and the positions of the 
crosslinked residues are indicated. m, denotes oxidized methionine. Note that the N-terminal 
amino acid of a protein can be crosslinked with DSS. See Online Methods and Supplementary 
Fig. 6 for details. (f) Consolidated list of crosslink sites from Supplementary Data Set 1e. 
Domain categories: N, N-terminal residues 1–14 in Syn7002-Raf1 and residues 1–147 in S.
elongatus RbcL; TIM, TIM-barrel residues 148–410 in S. elongatus RbcL; ?, ?-domain residues 
15–195 in Syn7002-Raf1; ?, ?-domain residues 205–345 in Syn7002-Raf1; linker, residues 196–
204 in Syn7002-Raf1. Crosslink distances between RbcL residues indicate the intra- or 
intermolecular distance in RbcL2 in context of the RbcL8 core complex. Crosslink distances 
between RbcL and Raf1 residues refer to the distances of the respective residues in the structural 
model derived from crosslinking data (assuming the C-terminal 65 residues of RbcL are 
structured). Crosslink distances between Raf1 residues indicate the intramolecular distance in the 
Raf1 dimer in the structural model derived from crosslinking data (assuming the C-terminal 65 
residues of RbcL are structured). 2, Raf1 residues in the flexible interdomain linker precluding 
distance assignment.
Nature Structural & Molecular Biology: doi:10.1038/nsmb.3062
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3.4 Article 4 - Mechanism of Enzyme Repair by the AAA+ 
Chaperone Rubisco Activase 
Rubisco is a highly inefficient enzyme fixing only ~3-10 CO2 molecules per second. It is 
also prone to inhibition by premature RuBP binding and binding of misfire products 
(XuBP, PDBP). Rubisco activase (Rca) is a AAA+ protein that conformationally remodels 
Rubisco and rescues it from the inhibited state126. In this study, we have characterized in 
detail how red-type Rca from Rhodobacter sphaeroides repairs the corresponding Rubisco 
enzyme by using hydrogen/deuterium exchange coupled to mass spectrometry, chemical 
crosslinking coupled to mass spectrometry, cryo-electron microscopy and biochemical 
assays. The results of our experiments show that Rca binds transiently to the corner of 
inhibited Rubisco, contacting both large and small Rubisco subunits. Rca exerts its 
remodelling action locally on Rubisco’s multi-layered active site consisting of the ‘60s loop 
of the N-terminal domain of RbcL, loop 6 of the C-terminal domain of the adjacent RbcL 
subunit, and the extended C-terminal tail of RbcL. Rca repairs the active site by pulling the 
C-terminal tail thereby breaking the C-terminal latch. This opens the active site and 
releases the inhibitor. Conformational remodelling by Rca is limited to the catalytic site, 
avoiding global destabilization of Rubisco complex. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Publications 
124 
 
Molecular Cell (2017)170 
Bhat J, Miličić G, Thieulin-Pardo G, Bracher A, Maxwell A, Ciniawsky S, Mueller-Cajar O, 
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Thieulin-Pardo, Andreas Bracher, Andrew Maxwell, Susane Ciniawsky, Oliver Mueller 
Cajar, John Engen and Petra Wendler. I was involved in analysis and single particle cryo-
EM 3D reconstruction of the Rubisco and Rubisco-Rca complex. I also performed the 
structural analysis of the Rubisco-Rca complex. 
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http://dx.doi.org/10.1016/j.molcel.2017.07.004SUMMARY
How AAA+ chaperones conformationally remodel
specific target proteins in an ATP-dependentmanner
is not well understood. Here, we investigated the
mechanism of the AAA+ protein Rubisco activase
(Rca) in metabolic repair of the photosynthetic
enzyme Rubisco, a complex of eight large (RbcL)
and eight small (RbcS) subunits containing eight
catalytic sites. Rubisco is prone to inhibition by
tight-binding sugar phosphates, whose removal is
catalyzed by Rca. We engineered a stable Rca hex-
amer ring and analyzed its functional interaction
with Rubisco. Hydrogen/deuterium exchange and
chemical crosslinking showed that Rca structurally
destabilizes elements of the Rubisco active site
with remarkable selectivity. Cryo-electron micro-
scopy revealed that Rca docks onto Rubisco over
one active site at a time, positioning the C-terminal
strand of RbcL, which stabilizes the catalytic center,
for access to the Rca hexamer pore. The pulling force
of Rca is fine-tuned to avoid global destabilization
and allow for precise enzyme repair.
INTRODUCTION
Members of the AAA+ (ATPases associated with various cellular
activities) family of molecular chaperones are involved in a wide
range of functions in which the energy of ATP is used to unfold,
disassemble, or conformationally remodel various substrate
proteins (Olivares et al., 2016; Snider et al., 2008). These hex-
americ ring complexes exert mechanical force by pulling
extended sequences or loop segments into their central pore.
How they recognize their clients and apply conformational force
to effect a specific outcome is not well understood. The AAA+
protein Rubisco activase (Rca) has emerged as an important
paradigm to understand these mechanisms (Bhat et al., 2017;744 Molecular Cell 67, 744–756, September 7, 2017 ª 2017 ElsevierBracher et al., 2017; Hauser et al., 2015). Rca is required for
the metabolic repair of ribulose-1,5-bisphosphate carboxylase/
oxygenase (Rubisco), the most abundant enzyme in nature.
Rubisco mediates the fixation of carbon dioxide from the
atmosphere into organic carbon during photosynthesis by
catalyzing the carboxylation of the five-carbon sugar, ribulose-
1,5-bisphosphate (RuBP). This reaction is directly or indirectly
responsible for the production of all biomass. The most common
form of Rubisco (form 1) is highly conserved from photosynthetic
bacteria to algae and plants. It consist of eight large (RbcL) and
eight small (RbcS) subunits, forming a hexadecameric cylindrical
complex of550 kDa (Figure 1A). RbcL consists of an N-terminal
a+b domain of 150 residues and a C-terminal domain of 325
residues, which contains a b8a8 triosephosphate isomerase
(TIM)-barrel domain of 310 residues and a flexible C-terminal
tail of 15 residues (Figure 1A). This C-terminal tail is extended
to 24 residues in the so-called red-type Rubiscos of red algae
and certain photosynthetic bacteria, such as Rhodobacter
sphaeroides (Bhat et al., 2017; Bracher et al., 2017; Hauser
et al., 2015). The RbcL subunits are arranged as a tetramer of
antiparallel dimers with two catalytic centers located at the inter-
face of each dimer between the N-terminal domain of one sub-
unit and the b8a8 domain of the other subunit (Andersson and
Backlund, 2008) (Figure 1A). Catalysis requires the active site
to adopt a closed, solvent-inaccessible state (Duff et al., 2000).
While the structural features of the RbcL subunits are highly
conserved, the RbcS subunits are more diverse. The common
core structure of the RbcS subunit is a four-stranded anti-parallel
b sheet covered on one side by two helices (Andersson and
Backlund, 2008). The variation among RbcS subunits is mainly
in the loops between b strands A and B and at the C terminus,
resulting in more or less extensive interactions with the RbcL
subunits. Although the RbcS subunits do not participate directly
in the formation of the active site, they are required for catalytic
activity through long-range effects (Bracher et al., 2011).
Despite its pivotal role, Rubisco is remarkably inefficient as an
enzyme: its catalytic rate is only two to ten CO2 molecules fixed
persecond (Bracher et al., 2017).Moreover, themultistep reaction
of carboxylation is error prone, producing sugar by-products,
such as xylulose-1,5-bisphosphate (XuBP), that bind tightly toInc.
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Figure 1. Structural and Functional Characterization of RcaCC
(A) Crystal structure of Rubisco (from spinach) (PDB: 1RCX) shown in side view. Subunits of one antiparallel RbcL dimer (RbcL and RbcL’) are shown in dark and
light green, respectively, in ribbon representation, with the substrate RuBP (red) in space-filling representation. Other subunits are depicted as molecular sur-
faces, with RbcL in gray and RbcS in beige. The structure of the RbcL monomer is shown on the right, with the N-terminal domain in cyan and the C-terminal TIM-
barrel domain in green.
(B) Structure of the hexamer of RsRca double-cysteine mutant L49C/A263C (RcaCC) modeled based on the structure of RsRca (Mueller-Cajar et al., 2011). A top
view is shown with alternating subunits in teal and light blue. The right panel zooms in on residues C49 and C263, with cysteine side chains in space-filling
representation.
(C) RcaCC in oxidized (Ox.) and reduced (Red.) states analyzed by non-reducing SDS-PAGE. Asterisk indicates incompletely oxidized RcaCC.
(D) Native MS spectrum of oxidized RcaCC. The low-intensity charge states of mass/charge (m/z) values of 4,000–5,000 belong to a minor contaminant
of 70 kDa (possibly, the chaperone DnaK).
(E) ATPase rates of oxidized RcaCC and wild-type RsRca, determined in the absence or presence of sugar phosphate ligands, as indicated, and in the presence
of non-carbamylated (E) or carbamylated (ECM) Rubisco from R. sphaeroides. 0.83 mM WTRca or RcaCC (hexamer) and 0.375 mM non-carbamylated (E) or
carbamylated (ECM) Rubisco (hexadecamer) were used.
(F and G) Reactivation of inhibited Rubisco by RcaCC. CO2 fixation assays were performed with ECM or E-RuBP (F) or E-CABP (G) Rubisco (0.02 mM
hexadecamer or 0.15 mM RbcL protomer) in the absence or presence of RsRca or RcaCC (0.67 mM hexamer). See STAR Methods for details.
All SDs are from at least three independent experiments.the active site and inhibit Rubisco function (Hauser et al., 2015;
Parry et al., 2008). Inhibition ofRubisco canalso occur as a conse-
quenceof thecomplex reaction that is necessary for catalytic acti-vation of the enzyme. Prior to the binding of its substrates, RuBP
andCO2, Rubiscomust be carbamylated by a non-substrate CO2
molecule at the active-site lysine and bind Mg2+ ion as a cofactorMolecular Cell 67, 744–756, September 7, 2017 745
(Bracher et al., 2017). Upon binding of RuBP, themobile loop 6 re-
gionof the TIMbarrel and themovableC-terminal RbcL sequence
formamulti-layered lid that ‘‘closes’’ the active site. Togetherwith
a loop sequence from residues 59 to 82 (tobacco numbering) in
the N-terminal domain of the adjacent subunit (the so-called
‘‘60s loop’’) (Duff et al., 2000), this generates the physical environ-
ment required for electrophilic attack of RuBP by CO2 or O2. Pre-
mature binding of RuBP to non-carbamylatedRubisco results in a
closed, inhibitedenzyme (Parryet al., 2008).Reactivationof the in-
hibited Rubisco is mediated by Rca (Bhat et al., 2017; Bracher
et al., 2017; Hauser et al., 2015). Deletion of Rca in the plant Ara-
bidopsis thaliana and the proteobacteriumR. sphaeroides results
in severe photoautotrophic growth defects (Bracher et al., 2017).
Recent structural and biochemical studies show that Rca pro-
teins from different organisms are type 1 AAA+ chaperones
(Bhat et al., 2017). They all share the AAA+ domain architecture,
consisting of an N-terminal a/b nucleotide-binding subdomain
and a C-terminal a-helical subdomain, and function as hexamers
with a central pore (Bhat et al., 2017). Residues in the central
pore loops have been shown to be required for Rubisco re-
modeling and, in the case of red-type Rubiscos, have been impli-
cated in exerting a pulling force on the extended C-terminal tail of
the RbcL subunits (Loganathan et al., 2016; Mueller-Cajar et al.,
2011; Stotz et al., 2011). The extent of conformational remodeling
resulting fromthisactionandhow it causes the releaseof inhibitory
sugar phosphate remains to be elucidated. Two geometries of
Rubisco-Rca interactions have been envisioned: a ‘‘top-on’’
model of Rca involving substantial molecular contacts with the
RbcS subunits of Rubisco and a ‘‘side-on’’ model with the Rca
hexamer binding so that its central pore is centered over the
2-fold rotational axis of the RbcL antiparallel dimer (Wachter
et al., 2013).
We engineered the Rca from the photosynthetic proteobacte-
rium R. sphaeroides to form a stable, fully functional hexamer
andusedahybridapproachof three techniques toanalyze its tran-
sient interaction with cognate Rubisco. Hydrogen/deuterium ex-
change (H/DX) mass spectrometry (MS) is a biophysical method
that provides information on protein structural dynamics (Harrison
and Engen, 2016), while the combination of chemical crosslinking
(coupled toMS) andcryo-electronmicroscopywith single-particle
reconstruction (Leitner et al., 2016) was used to provide structural
information on protein-protein interactions. All three methods
showed that the conformational changes in Rubisco effected by
Rca are precisely restricted to the catalytic site and its close vicin-
ity.Wefind thatRca interactswith the cube-shapedRubisco side-
on,with the conserved topsurfaceof thehexamer contactingboth
RbcL and RbcS subunits. This topology positions the C-terminal
tail ofRbcLso that it can transientlybepulled into theRcahexamer
pore, therebycatalyzing theopeningof theactive site. Importantly,
this interaction preserves the structural integrity of the Rubisco
complex, allowingRca to repair the inhibited enzymewithminimal
structural perturbation.
RESULTS
Stable Rca Hexamers
Rca from R. sphaeroides (RsRca) functions as a hexamer in the
presence of ATP and RuBP but forms amorphous oligomers in746 Molecular Cell 67, 744–756, September 7, 2017the apo-state or fibrillar structures with ATP alone (Mueller-Cajar
et al., 2011). RuBP, the substrate of the target protein Rubisco,
binds to Rca as an allosteric effector of hexamer formation. To
stabilize the RsRca in the hexamer state, we introduced cysteine
residues at positions Leu49 and Ala263 (forming RcaCC) so as
to allow inter-subunit disulfide bond formation (Figure 1B).
Purified recombinant RcaCC was incubated with ATP and
RuBP, followed by oxidation with copper chloride. Oxidized
RcaCC migrated as a high-molecular-weight complex on non-
reducing SDS-PAGE (Figure 1C). A small amount of a faster
migrating species was also detected (Figure 1C), probably repre-
senting incompletely oxidized RcaCC. Size exclusion chroma-
tography of oxidized RcaCC demonstrated a homogeneous
molecule distribution consistent with that of hexamers, whereas
reduced RcaCC and wild-type Rca (WTRca) populated a range
of oliogomeric states (Figure S1A). Native MS determined a
mass of the oxidized RcaCC of 210 kDa, 1.7 kDa greater
than the calculated hexamer mass (208,117 Da) (Figure 1D), sug-
gesting the presence of bound adenine nucleotide and/or RuBP.
Henceforth, RcaCC refers to the oxidized hexamer complex.
RcaCC showed basal ATPase activity (7 min1) in the
absence of RuBP, consistent with the oxidized protein being
independent of the allosteric effector for hexamer formation
(Figure 1E). Importantly, this basal activity was stimulated by
inhibited Rubisco enzyme (E-RuBP; non-carbamylated Rubisco
with bound RuBP) to 20 min1. In the presence of excess free
RuBP, the ATPase activity of RcaCC increased to 40 min1,
equivalent to the ATPase activity of WTRca (Figure 1E). Indeed,
RcaCC was fully functional in reactivating E-RuBP (Figure 1F)
and preserved functional activity upon reduction of the disulfide
bonds (Figure S1B). Active Rubisco enzyme (ECM, for enzyme
with bound CO2 at the active lysine and bound Mg
2+) with or
without RuBP stimulated the ATPase of RcaCC to a lower level
(10–20 min1) than the inactive Rubisco (E-RuBP) (Figure 1E).
The ATPase activity of RcaCC was also stimulated to high levels
when the tight-binding synthetic inhibitor 2-carboxyarabinitol-
1,5-bisphosphate (CABP) (Schloss, 1988) was bound to inhibited
or active Rubisco enzyme (E-CABP or ECM-CABP, respectively)
(Figure 1E). Note that CABP is not able to replace RuBP as
allosteric effector of Rca hexamer formation, explaining why
E-CABP failed to stimulate the ATPase of WTRca (Figure 1E).
However, reactivation of E-CABP (measured in presence of
excess RuBP) occurred only with low efficiency (Figure 1G),
consistent with the much higher affinity of CABP for Rubisco
(KD, 1011 M) compared to RuBP (KD, 106 M) (Brooks and
Portis, 1988; Pierce et al., 1980; Wang and Tabita, 1992)
(see STAR Methods for details). Thus, CABP is an effective
competitive inhibitor, resulting in Rca interacting continuously
with Rubisco. In conclusion, RcaCC is fully active as a stable
hexamer, facilitating structural and functional analysis.
Remodeling of Inhibited Rubisco by Rca
To obtain insight into the conformational changes that occur in
Rubisco during remodeling by Rca, we first performed H/DX
coupled to MS of intact Rubisco (Figure 2A). The RbcL of
ECM incorporated 78 ± 1 deuterons (17% of 463 possible
deuteration sites) during a 60s D2O pulse, while the RbcL from
inactive E-RuBP incorporated only 57 ± 1 deuterons (Figure 2B),
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Figure 2. RcaCC-Mediated Remodeling of Inhibited Rubisco Moni-
tored by H/DX-MS Analysis
(A) Schematic of the global H/DX-MS pulse experiment. After 30 s of re-
activation of inhibited Rubisco (E-RuBP) with 8-fold excess of RcaCC
(hexamer) over Rubisco catalytic sites, proteins were pulse-labeled with D2O
buffer for 60 s, followed by acid quenching and LC-MS analysis. See STAR
Methods for details. H, hydrogen; D, deuterium.
(B and C) Mass spectra showing deuterium uptake in RbcL (B) and RbcLD4 (C)
from reactions containing RcaCC or RcaCC Y114A and ATP or AMP-PNP
(10 mM) as indicated. The positions of RbcL from the carbamylated Rubisco
(ECM; ED4CM) and inhibited Rubisco (E-RuBP; ED4-RuBP) are indicated by
red and green dotted lines, respectively. E-RuBP and ED4-RuBP not sub-
jected to D2O pulse are shown as controls. Mass values are averages of five
independent experiments.consistent with active Rubisco being more dynamic than the in-
hibited enzyme. After reactivation of E-RuBPwith excess RcaCC
in the presence of ATP, the RbcL showed essentially the same
deuterium incorporation as the active ECM state (Figure 2B),
indicating that Rca does not increase the flexibility of the RbcLsubunit beyond that in the functional enzyme. Remodeling of
E-RuBP was not observed in the presence of the non-hydrolys-
able ATP analog, AMP-PNP, or with the RcaCCpore loopmutant
Y114A (Mueller-Cajar et al., 2011) (Figure 2B), confirming that
ATP hydrolysis and the central pore of the hexamer are critical
for Rca function. Similar results were obtained when Rubisco
was inhibited with the misfire product XuBP (Bracher et al.,
2015) (Figure S1C). In contrast, no significant increase in
deuterium uptake was observed when CABP-bound Rubisco
(E-CABP) was incubated with RcaCC and ATP (Figure S1D),
consistent with the low efficiency of reactivation in the presence
of CABP (Figure 1G).
We previously found that deletion of the four C-terminal resi-
dues from R. sphaeroides RbcL (RbcLD4) rendered the inhibited
Rubisco non-activatable by Rca, while removal of the last two
residues reduced reactivation by 80% (Mueller-Cajar et al.,
2011). In its active state, the RbcLD4 (ED4CM) incorporated
77 ± 3 deuterons (17% of 460 possible deuteration sites),
and the inhibited ED4-RuBP incorporated 60 ± 2 deuterons (Fig-
ure 2C), similar to wild-type RbcL. No shift in deuterium incorpo-
ration of ED4-RuBP occurred in the presence of RcaCC and ATP
(Figure 2C), confirming that remodeling requires Rca to engage
the extreme C terminus of RbcL (Mueller-Cajar et al., 2011). As
expected, RcaCC failed to reactivate ED4-RuBP (Figure S1E).
H/DX analysis of the RbcS subunits showed incorporation of
17 ± 1 deuterons (14% of 120 possible deuteration sites),
and no difference in deuterium incorporation between the active,
inactive, and reactivated states was detected (Figure S1F). This
suggests that remodeling by Rca either is restricted to the RbcL
subunit or involves only flexible regions of RbcS.
Remodeling Is Restricted to the Rubisco Active Site
To identify the regions on RbcL that undergo time-dependent
conformational changes during reactivation by Rca, we next
monitored H/DX protection at peptide resolution. E-RuBP was
incubated with RcaCC at a ratio, for Rubisco catalytic sites to
RcaCC, of 1:2.5. After different times (10 s to 7 min), the reac-
tions were labeled with a short D2O pulse of 10 s, sufficient to
label regions with low or no structure but not long enough to label
structured regions (Engen and Wales, 2015). Further exchange
was then inhibited by acid quench, followed by pepsin digest
and analysis of peptides by liquid chromatography-tandem
mass spectrometry (LC-MS/MS) (Figure 3A). Pepsin digestion
produced 73 unique and overlapping peptides of RbcL and 22
peptides of RbcS, corresponding to 86% and 91.5% sequence
coverage, respectively (Figures S2A and S2B). All the peptides
analyzed showed unimodal exchange kinetics (i.e., a single bino-
mial isotope distribution; Figure S2C), which is consistent with a
single population of protein molecules (Engen and Smith, 2001).
Observation of unimodal exchange kinetics indicates that the
proteins do not undergo large folding-unfolding transitions
during the deuterium pulse. Such transitions would result in
a bimodal isotope pattern. Pulse labeling of E-RuBP in the
absence of RcaCC resulted mainly in deuteration of N- and
C-terminal peptides of RbcL (Figure S3A). Incubation with
RcaCC and ATP resulted in additional deuterium incorporation
in a time-dependent manner, as shown in a difference plot (Fig-
ure 3B). Saturation of exchange was reached after 2–7 min ofMolecular Cell 67, 744–756, September 7, 2017 747
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Figure 3. Deuterium Uptake into RbcL Peptides during Rubisco Activation by RcaCC
(A) Schematic of H/DX pulse experiment at peptide resolution. E-RuBP was reactivated by a 2.5-fold excess of RcaCC (hexamer) over Rubisco catalytic sites for
10 s to 7 min, followed by a 10-s D2O pulse, acid quench, pepsin digestion, and LC-MS/MS. See STAR Methods for details. H, hydrogen; D, deuterium.
(B and C) Difference plots showing deuterium incorporation into RbcL peptides after reactivation of E-RuBP by RcaCC for the times indicated (B) and upon
incubation of ECM in the absence of RcaCC (C). Deuterium incorporation measured for E-RuBP alone is subtracted. Changes in deuteration >0.5 Da are
meaningful. All H/DX-MS data represent averages of four to six independent experiments (also, see related Figure S4).
(D) Time course of RbcL remodeling by RcaCC. The difference in deuterium uptake into RbcL peptides shown in (B) was mapped onto a homology model of the
RbcL antiparallel dimer based on the crystal structure of CABP-bound Rubisco fromGaldieria partita (PDB: 1BWV). A color gradient from pale yellow (no change
in deuterium uptake relative to E-RuBP) to magenta (high relative deuterium uptake) indicates time-dependent remodeling, with the end state having deuteration
(legend continued on next page)
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activation, dependent on the specific peptide analyzed (Fig-
ure S4), with the end state having the same H/DX properties of
RbcL as in the active enzyme (Figures 3C, 3D, and S3B).
Remarkably, increased deuterium incorporation during activa-
tion by RcaCC occurred exclusively in peptides that mapped
to the solvent-accessible face of the Rubisco active site: in the
N domain, the flexible N terminus (1–19), helix a1 (residues
20–24), residues of the so-called 60s loop (residues 68–79),
and helix a4 to strand b4 (residues 119–139); in the C domain,
loop 6 (residues 319–346), residues 373–394 and 399–427 of
the TIMbarrel, and theC terminus (residues 459–469) (Figure 3B).
Mapping these regions on the RbcL2 unit illustrates the time-
dependent deprotection during activation (Figures 3D and 3E).
Mobilization of loop 6, the C-terminal lid, and the 60s loop would
reflect the opening of the active site (Figure 3E). Notably, pep-
tides of the central solvent channel (RbcL residues 253–294) of
the Rubisco complex remained protected to deuterium incorpo-
ration during reactivation (Figure 3B).
The deuteration properties of RbcLD4 Rubisco were the same
as for the wild-type enzyme when the active (ED4CM-RuBP) and
inactive (ED4-RuBP) forms were compared (Figures 3C and
S3C). However, no additional deuterium incorporation was
observed upon incubation of the inactive ED4-RuBPwith RcaCC
and ATP (Figure S3D), confirming that engagement of the RbcL
C terminus is critical for remodeling. RbcS peptides did not show
significant changes in deuteration between the active and inac-
tive states of Rubisco (data not shown), consistent with the H/DX
analysis of the intact protein (Figure S1F).
These results indicate that the remodeling of RbcL by Rca is
restricted to active-site regions that are conformationally dy-
namic during the functional open-to-closed transition of the
enzyme (Duff et al., 2000). Thus, Rca faithfully restores the in-
hibited Rubisco to a state identical in structural dynamics to
that of the active enzyme, avoiding global destabilization of
RbcL in the process.
Analysis of the Rubisco-Rca Interface
Having established the conformational changes in Rubisco that
are associated with Rca-mediated reactivation, we next used
chemical crosslinking coupled to MS (CXMS) to analyze the in-
teracting regions of Rubisco and Rca. We added the lysine-spe-
cific crosslinker disuccinimidyl suberate (DSS) to reactions con-
taining RcaCC and Rubisco inhibited with CABP (ECM-CABP),
with or without ATP and RuBP. CABP was used as inhibitor
in these experiments because it cannot be metabolized
by Rubisco; thus, RcaCC continuously works on Rubisco,
increasing the probability of capturing the transient RcaCC-
Rubisco interaction. Crosslinking was stopped after 10–30 min,
and crosslinked products were visualized by native-PAGE anal-
ysis (Figure 4A). Three discrete high-molecular-weight (HMW)
bands representing crosslinked complexes were detected only
in the presence of ATP (asterisks in Figure 4A, lanes 6 and 7).properties of the active, carbamylated Rubisco (ECM) (shown as control). Regions
in cyan, using space-filling representation. Positions of the N and C termini are i
(E) The boxed area in (D) is magnified to demonstrate that deuterium uptake by
pocket, including the 60s loop, loop 6, and the flexible C-terminal lid.
See also Figure S4.Note that ECM-CABP and RcaCC migrate on native PAGE at
the same position in the absence of DSS (Figure 4A, lanes 1, 3,
and 5), although they are very different in mass. When treated
with DSS, ECM-CABP migrates faster and RcaCC runs slower,
as lysine modification will change the charge property of the pro-
tein (Figure 4A, lanes 2 and 4).
Next, we analyzed the crosslinking reactions by native MS.
The mass of ECM-CABP alone when incubated with DSS
was 555 kDa and that of RcaCC was 212 kDa (Figure 4B).
The crosslinking reaction of RcaCC and Rubisco in the presence
of ATP contained additional complexes of 768, 978,
and 1,223 kDa, corresponding to Rubisco with one, two, or
three RcaCC hexamers bound, respectively (Figure 4B). These
complexeswerenotobserved in theabsenceofATP (FigureS5A),
consistent with the observation by native PAGE (Figure 4A).
To identify the crosslink sites between Rubisco and RcaCC,
we used a 1:1 H12 and D12 isotopic mixture of DSS, which pro-
duces peptide doublets of near-equal intensity separated by a
mass of 12 Da in MS (Figure S5B). The crosslinked HMW protein
complexes containing one, two, or three RcaCC hexamers
bound to Rubisco were excised from native PAGE, subjected
to in-gel digestion, and analyzed by LC-MS/MS (Figures S5C
and S5D) (Sinz, 2006). We identified 57 unique crosslinked pep-
tide pairs from two independent experiments (Tables S1A and
S1B): 23 intra- and intermolecular crosslinks for RcaCC, 7 for
RbcL, and 1 for RbcS; 19 intermolecular crosslinks for RbcL-
RcaCC; and 7 for RbcS-RcaCC. Based on the hexameric struc-
tural model of RsRca (Mueller-Cajar et al., 2011) and a structural
model of the R. sphaeroides RbcL8S8 holoenzyme, crosslinks
within RcaCC and within Rubisco generally satisfied the plau-
sible Ca-Ca distance spanned by DSS (14–36 A˚) (Leitner
et al., 2016) (Table S1B).
Multiple RbcL-RcaCC and RbcS-RcaCC crosslinks were
identified at least twice (Figure 4C; Table S1B), suggesting that
Rca contacts both RbcL and RbcS subunits of the inhibited
Rubisco. Lysines 99, 123, and 127 of each RcaCC subunit, which
form a charge cluster on the top surface of the hexamer, cross-
linked with residues in both RbcL and RbcS (Figure 4C). The
amino-group of Met1 at the flexible N terminus of RcaCC also
made crosslinks to RbcL and RbcS. Lysines 123 and 127 are
conserved and belong to the polar face of helix a5 of Rca (Fig-
ure 4C). The corresponding crosslinked residues in Rubisco
located to the N-terminal domain (K4, K9, K15, K20, and K133)
and the C-terminal domain (K306) of RbcL, as well as to the
adjoining RbcS subunits (K62 and K73) (Figure 4C). Note that
the RbcS sequence contains only these two lysines. Similar
crosslink pairs were identified, regardless of whether complexes
containing one, two, or three RcaCChexamers per Rubiscowere
analyzed (Figure S5D; Table S1B). Overall, the crosslinking foot-
print suggests that the RsRca hexamer docks onto Rubisco
side-on over one or both active sites of an antiparallel RbcL
dimer, making extensive contacts with RbcL and RbcS. Thisfor which no peptide coverage was obtained are shown in gray. RuBP is shown
ndicated.
RbcL during reactivation occurs in peptide regions close to the catalytic site
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Figure 4. Analysis of the Rubisco-RcaCC Interface by Chemical Crosslinking
(A) Rubisco with bound inhibitor CABP (ECM-CABP) was preincubated for 1 min with RcaCC/RuBP and ATP when indicated. RuBP was present in all reactions.
Reactions were then incubated for 30 min with or without DSS crosslinker, followed by analysis by native PAGE. High-molecular-weight complexes representing
crosslinked species are marked with asterisks. See STAR Methods for details.
(B) Nano-ESI native-MS spectra of DSS-crosslinked (10 min at 25C) ECM-CABP and RcaCC/RuBP/ATP and of ECM-CABP/RcaCC complexes obtained in the
presence of RuBP and ATP. Symbols indicate charge-state distributions. Calculated mass around m/z values and accuracy of mass values are indicated. The
charge state distributions marked with green, magenta, and blue symbols in the bottom panel represent ECM-CABP complexed to one, two, or three RcaCC
hexamers, respectively. Nano-ESI, nano-electrospray ionization.
(C) Crosslinks from RcaCC to Rubisco RbcL and RbcS subunits. Crosslinks are shown schematically along the protein sequences on the left. Crosslinked amino
acids are indicated (see Table S1B). The locations of crosslinking sites in the 3D structures are shown on the right. Protein complexes are shown in outline; one
subunit of Rca and a dimer of RbcL (RbcL is indicated in olive green; RbcL’ is indicated in light green) with twoRbcS subunits (orange) bound are shown in cartoon
representation (homology model based on the G. partita Rubisco structure; PDB: 1BWV); helices are represented as cylinders. Ca atoms of crosslinked Lys
residues are indicated by magenta spheres, and the N-terminal Met is indicated in dark blue. Disordered residues are indicated by dotted lines. For clarity,
crosslinked residues are shown only in one half of the RbcL dimer. The C-terminal peptide of RbcL is shown in red, and bound CABP is shown in yellow.
See also Table S1B.
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Figure 5. Cryo-EM and 3D Reconstructions of R. sphaeroides Rubisco
(A) 3D reconstruction of ECM-CABP complexes at 3.4-A˚ resolution shown as end and side views. D4 symmetry was applied during 3D reconstruction. Densities
for RbcL and RbcS subunits are indicated in green and orange, respectively.
(B) 15-A˚ slice through the ECM-CABP complex with D4 symmetry with the sequences of R. sphaeroides RbcL and RbcS fitted into the electron density. The EM
reconstruction is shown as transparent surface, and the model is colored as in (A).
(C and D) Cryo-EM density of the catalytic site pocket of Rubisco, showing density for CABP and carbamylated Lys 203 (C) and the interactions of the C-terminal
strand with the body of the closed enzyme (D). Interacting residues are shown in stick representation in pink (Trp463 interacts with Trp68 and Thr69 of the 60s
loop; Phe468 interacts with Trp68 of the 60s loop and Gly334 and Lys335 of loop 6; Tyr470 interacts with Lys130; Thr473 interacts with Arg304; Asp474 interacts
with Arg136 and Glu337; Asp477 interacts with Arg43 and Lys306; Phe477 interacts with Pro93, Phe100, Phe364, and Leu359).topology is in agreement with the conformational changes
observed in the active-site region by H/DX analysis. Amajor con-
tact region on RsRca is helix a5, consistent with mutation K123A
resulting in an 80% loss of activase function (Mueller-Cajar
et al., 2011).
EM Analysis of Rubisco and Rubisco-Rca Complex
To obtain additional structural information on the interaction be-
tween Rubisco and Rca, we performed negative-stain electron
microscopy (EM) and cryo-EM with single-particle image anal-
ysis. In preliminary experiments, we failed to detect significant
numbers of Rubisco-RcaCC complexes in the presence of ATP
and/or ATP analog, consistent with the transient nature of the
interaction (apparent Kd = 3.1 mM ± 0.8 mM) (Mueller-Cajar
et al., 2011). To capture the interaction, reactions containing
ECM-CABP, RcaCC, and ATP were incubated with the cross-
linker glutaraldehyde (GA), which has a shorter crosslinkingdistance than DSS. Crosslinked HMW complexes, similar to
those observed with DSS (Figures 4A and S6A), were enriched
by size exclusion chromatography (Figure S6B). 2D class aver-
ages of the negatively stained complexes (Figure S6B, fraction
12) showed either one or two RcaCC hexamers bound to
Rubisco (60% and 40% of particles, respectively) (Figures
S6C and S6D). The two Rcas were bound to either adjacent or
opposing surfaces of Rubisco (Figure S6D). In rare cases,
up to three RcaCC hexamers were bound, as indicated by
native-MS analysis (Figure 4B).
Structure of Inhibited Rubisco
Next, we performed cryo-EM analysis of fraction 13 from the size
exclusion chromatography (Figure S6B), which contained free
Rubisco and complexes with mainly one RcaCC bound (Fig-
ureS6E). Thedatasetwas subdividedaccordingly basedon visual
identification of 2D class averages (Figures S6F and S6G). ToMolecular Cell 67, 744–756, September 7, 2017 751
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Figure 6. Attachment of RbcL C-Terminal
Strand to the Body of Rubisco
(A) Carboxylation activity of activated RsRubisco
(ECM) of wild-type (WT) and mutants D474N,
D477N, and D474N/D477N, as well as reactivation
of inhibited WT and mutant Rubisco (E-RuBP) with
or without RsRca. Carboxylation and reactivation
assays were performed as in Figures 1F and 1G.
(B) ATPase activities of Rca upon incubation with
mutant or WT Rubisco are indicated. ATPase
assays were performed as in Figure 1E.
All SDs are from at least three independent
experiments.obtain insight into the structure of inhibitor-bound R. sphaeroides
Rubisco,wefirst solved thestructureofRubiscowithboundCABP
at a resolution of 3.4 A˚, applying D4 symmetry, and at 3.5 A˚,
without imposing symmetry (Figures 5A and S7A–S7C). The
sequences ofR. sphaeroidesRbcL and RbcSweremanually built
into the B-factor sharpened electron density, starting from the
crystal structure of the highly homologous red-type Rubisco of
Galdieria partita with bound CABP (PDB: 1BWV; see STAR
Methods for details). Overall, the structure is closely similar to
known crystal structures of other red-type Rubiscos, with root-
mean-square deviations (RMSDs) of 0.683–0.800 A˚ for RbcL
and 0.624–0.873 A˚ for RbcS, indicating that GA crosslinking did
not result in structural distortions.
The model encompasses residues 13–479 of the 486-residue
RbcL and the complete sequence (residues 1–129) of RbcS.
Amino-acid side chains are generally well resolved, with the
exception of residues 13–17 and 462–479 at the N and C termini
of RbcL, respectively (Figures 5B and S7C). A close-up of the
active site shows that Lys203 is carbamylated and that density
for bound CABP is clearly discernible (Figure 5C). The C-terminal
strand (residues 462–479) that pins down loop 6 over the
catalytic site appears to be dynamic, exhibiting higher B factors
(Figure S7D). B-factor and refinement statistics suggest an
atomic occupancy of 40% for the C-terminal residues in the
closed conformation (see STAR Methods), mediated by a series
of van der Waals, electrostatic, and hydrogen-bond contacts
from residues Trp463, Phe468, Tyr470, Thr473, Asp474,
Asp477, and Phe478 (Figure 5D). Asp474 is conserved in all
form I Rubiscos and is positioned to form a salt bridge with
Arg136 and van der Waals contacts with Glu337. These interac-
tions are thought to provide amajor anchor point for the C-termi-
nal strand (Figure 5D) (Duff et al., 2000). Interestingly, the
extended C-terminal sequence of red-type Rubisco has an addi-
tional conserved Asp-Phe motif (residues 477 and 478), which
contributes to stabilizing the C-terminal strand in the closed
state. Asp477 makes electrostatic contacts with Arg43 and
Lys306, while Phe478 engages in extensive van der Waals or
p-p stacking interactions with Pro93, Phe100, Leu359, and
Phe364 (Figure 5D). The ultimate C-terminal residues 480–486
are disordered and are not included in the structural model.
These residues are critical for Rca-mediated remodeling (Figures
2C and S3D).752 Molecular Cell 67, 744–756, September 7, 2017To investigate whether anchoring the C-terminal strand of
RbcL to the body of the enzyme is critical for Rca to engage
the RbcL C terminus, we mutated residues Asp474 and
Asp477 to asparagine individually and in combination. The three
Rubisco mutants had an 30%–60% reduced CO2 fixation ac-
tivity compared to wild-type Rubisco (Figure 6A), consistent
with destabilization of the closed state of the enzyme. This is
supported by an increase in spontaneous reactivation of the in-
hibitedmutant enzymes reaching50%of full activity compared
to only 10% for wild-type Rubisco (Figure 6A). Strikingly,
no significant increase in reactivation by WTRca was observed
for any of the mutants (Figure 6A). Moreover, the Rubisco
mutants only partially stimulated the ATPase activity of Rca (Fig-
ure 6B), to a value similar to that observed upon deletion of the
two C-terminal residues of RbcL (Mueller-Cajar et al., 2011).
These results suggest that an anchored C-terminal strand is
required for engagement of the RbcL C terminus by Rca.
Structure of Rubisco in Complex with Rca
The structure of the Rubisco-RcaCC complex was resolved to
7.6 A˚, with the Rca hexamer ring bound at one corner of the
cube-shaped Rubisco (Figures 7A and S7A). The RcaCC density
has a height of 43 A˚, similar to the unbound hexamer (EMDB:
1932; PDB: 3ZUH), but its diameter exceeds that of the free hex-
amer (147 A˚ versus110 A˚) (Figure 7A). Accordingly, rigid-body
docking of the RsRca hexamer model from the crystal structure
resulted in unoccupied density in the periphery and also showed
RsRca protruding from the density in several places (Figure 7A).
This suggests that the Rubisco-crosslinked RcaCC represents
an average of somewhat different topologies, which could not
be separated by classifications. Structural heterogeneity can
occur within the substrate-engaged ATPase ring and by slightly
varying attachment points of RcaCC on the Rubisco complex.
The vast majority of complexes adopts a binding mode where
the central pore of the hexamer is positioned over the last C-ter-
minal helix of RbcL (helix a17), from which the flexible C-terminal
tail that covers the active site emanates (Figure 7B). This position
may represent the end state of Rca action after the central pore
has engaged the C-terminal tail. Determination of the local reso-
lution of the map reveals lower resolution of structural elements
adjacent to the contact area between both subcomplexes (Fig-
ure S7E), suggesting structural re-arrangements.
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Figure 7. Cryo-EM and 3D Reconstructions
of Rubisco-RcaCC Complex
(A) 3D reconstruction of the complex of inactive
Rubisco (ECM-CABP) with RcaCC hexamer
bound at 7.6-A˚ resolution shown as side view,
with RsRubisco and RsRca (PDB: 3ZUH) fitted as
rigid bodies.
(B) End view of RcaCC bound to Rubisco as shown
in (A). The C-terminal helix a17 of RbcL shown in
green is visible through the central pore of RcaCC.
(C) Close-up view of the RbcL and RbcS subunits
proximal to RcaCC. For clarity, the density map of
RcaCC is removed. The flexible residues at the N
and C termini of the RbcL and RbcL’ subunits, not
resolved in the 3.4-A˚ structure of Rubisco (Fig-
ure 5), are indicated by dashed lines. Structural
elements outside the density map, representing
regions that are conformationally destabilized by
Rca, are labeled. Residues that crosslinked to
RcaCC are indicated either in ball-and-stick rep-
resentation or as a black circle in the unstructured
N terminus of RbcL’. The positions of Asp474 and
Asp477 that anchor the C-terminal strand to the
body of the enzyme are shown in magenta. Arrow
denotes transient pulling by Rca on the RbcL C
terminus.The Rubisco structure determined as described earlier (Fig-
ure 5A) was well accommodated by the electron density of
the Rubisco-RcaCC complex, except for the regions of
the RbcL dimer interacting with RcaCC (Figures 7A and 7C).
Interestingly, at the interaction site, density for the 50 C-ter-
minal residues (encompassing helices a16, a17, and residues
462–486 of the C-terminal tail) and residues 332–339 of loop
6 that covers the active site in the closed state is missing in
one of the RbcL subunits (Figure 7C). In the adjacent subunit,
density for the N-terminal residues 1–23, 67–76 (60s loop),
44–51, and 130–133 is missing (Figure 7C). The 60s loop forms
the major interface between the N-terminal domain of one
RbcL subunit and the a/b TIM-barrel domain of the adjacent
RbcL subunit and is involved in stabilizing the closed state of
the catalytic site (Duff et al., 2000). The same regions were
observed to undergo increased deuterium uptake in the H/DX
analysis of Rubisco during reactivation by Rca (Figure 3). More-
over, the residues of RbcL that crosslinked with RcaCC are
located within this destabilized interface (Figures 4C and 7C;
Table S1B). The observed destabilization suggests that, in
the RbcL dimer, the catalytic site proximal to RcaCC is in the
open state. Such destabilization is not observed in the other
catalytic sites of the Rubisco-Rca complex, indicating that
Rca remodels one site at a time. The single-particle reconstruc-
tion also showed missing density in helices a1 and a2 of theMoleculatwo neighboring RbcS subunits (Fig-
ure 7C), consistent with the observed
RbcS-RcaCC crosslinks (Figure 4C;
Table S1B). Weakening the RbcL-RbcS
interface would contribute to mobilizing
the 60s loop and, hence, destabilize
the catalytic center (Bracher et al., 2011).To obtain a higher resolution structure of the Rubisco-RcaCC
complex, we masked the outer parts of the RcaCC density dur-
ing refinement. This resulted in a reconstruction at 6.0-A˚ reso-
lution (Figures S7A and S7F). We again observed destabilization
of the same regions in RbcL and RbcS (Figure S7G) as for the
lower resolution map (Figure 7C), confirming that the catalytic
site is in the open conformation.
DISCUSSION
To understand how force generation by AAA+ chaperones can
be utilized to perform specific tasks, we have analyzed the func-
tion of the AAA+ protein Rca in metabolic repair of the photosyn-
thetic key enzyme Rubisco. H/DX and chemical crosslinking
were used to define the regions of Rubisco that are conforma-
tionally remodeled by Rca and determine the sites that Rca con-
tacts on the Rubisco complex. Cryo-EM of Rubisco in complex
with Rca provided a snapshot of Rca in action. This integrated
approach offered detailed insight into the mechanism by which
Rca performs enzyme repair avoiding global destabilization of
the Rubisco complex.
Rubisco Remodeling by Rca
Perhaps the most striking result of this study is how precisely the
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catalytic site, as demonstrated by the H/DX analysis. This con-
trasts with the ability of structurally similar AAA+ proteins, such
as bacterial ClpX, to mediate global protein unfolding (Sauer
and Baker, 2011). In the cryo-EM structure of the Rubisco-Rca
complex, the Rca hexamer ring is associated at one corner of
Rubisco in a tilted manner, contacting the N domain of one
RbcL subunit and the C domain of the adjacent RbcL of the
dimer, with the catalytic site located at the inter-subunit inter-
face. The central pore of the hexamer is positioned over the
last C-terminal helix of RbcL (helix a17), from which the C-termi-
nal tail that covers the catalytic site emanates (Figure 7B). As
shown by crosslinking, a major contact region on the flat surface
of the Rca ring is helix a5, containing the functionally critical
lysine residue 123 (Mueller-Cajar et al., 2011) (Figure 4C).
Rca makes additional crosslink contacts to the two proximal
RbcS subunits—specifically, their helices a1 and a2 (Figure 4C),
which are destabilized as indicated by missing EM density in the
complex (Figure 7C).
Remodeling of the closed catalytic site likely involves transient
pulling on the C-terminal RbcL tail by Rca (Figure 7C). Mobiliza-
tion of the tail region is supported by the H/DX data (Figure 3) and
is consistent with the finding that truncation of the C-terminal two
to four amino acids renders inhibited Rubisco non-activatable.
The pulling force necessary to mobilize the C-terminal tail
appears to be limited, considering that, in the inhibitor-bound
enzyme, the C-terminal strand is already relatively dynamic (Fig-
ures 5 and S7D). This would be in line with the proposal that,
when closed, the C-terminal strand is maintained under tension
(Duff et al., 2000). Our structural analysis suggests that Asp474,
Asp477, and Phe478, which are conserved in red-type Rubiscos,
form a triad that is important in attaching the C-terminal strand in
a latch-like manner over the catalytic site. Breaking this interac-
tion might, therefore, lead to retraction of the C-terminal strand.
Mutation of Asp474 and Asp477 reduced Rubisco activity and
prohibited reactivation of inhibited Rubisco by Rca, suggesting
that anchoring the C-terminal strand to the body of the enzyme
is a prerequisite for the central pore of Rca to productively
engage the RbcLC terminus. Interaction of Rcawith the C-termi-
nal strand would trigger a sequence of coupled conformational
changes that ultimately lead to release of the inhibitory sugar
phosphate. During initial recognition of the C terminus, the
central pore of Rca is likely positioned closer to the equator of
Rubisco than observed in the cryo-EM reconstruction of the
complex. We, therefore, suggest that, as the C-terminal strand
is being detached from the body of the enzyme and its anchor
points are released, Rca moves from a side-on to a tilted posi-
tion. This movement may be coupled to destabilizing the
RbcS-RbcL interface that contributes to structuring residues
72–78 of the 60s loop (Bracher et al., 2011). Detachment of the
C-terminal strand and destabilization of the 60s loop results in
the retraction of loop 6 and opening of the catalytic site.
Limited Remodeling Versus Global Destabilization
What are the functional properties underlying Rca’s ability to
perform precise conformational remodeling and avoid global un-
folding? It would appear that Rca interacts only transiently with
its target substrate, in contrast to AAA+ unfoldases like ClpX,
which act in a highly processive manner (Olivares et al., 2016).754 Molecular Cell 67, 744–756, September 7, 2017Whereas the unfoldases interact with a broad range of sub-
strates, binding of Rca to Rubisco is specific and requires both
the central pore and contacts of the hexamer ring surface with
RbcL and RbcS. The grip strength of AAA+ proteins depends
on their pore loop structure and on how pore loop movement
is coupled to the ATPase cycle of the AAA+ module (Olivares
et al., 2016; Rodriguez-Aliaga et al., 2016). The pulling force of
Rca is likely lower than that of AAA+ unfoldases, consistent
with the ATPase rate of RsRca in the presence of substrate
being about 7-fold lower than that of ClpX (Burton et al.,
2003; Mueller-Cajar et al., 2011).
AAA+ proteins with Rca function exist in prokaryotic and
eukaryotic photosynthetic organisms (Bhat et al., 2017; Bracher
et al., 2017). The divergence in primary sequence of these pro-
teins suggests that a process of convergent evolution underlies
the use of the common AAA+ module in the Rubisco repair
mechanism. Moreover, Rubiscos have coevolved with their
cognate activases, as exemplified by the C-terminal extension
in red-type RbcL. Accordingly, Rca from R. sphaeroides cannot
activate plant Rubisco, and, conversely, plant Rca is unable to
activate RsRubisco. It will be interesting to understand the
mechanisms of client-specific recognition and repair by this
important group of AAA+ proteins.
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STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Chemicals, Peptides, and Recombinant Proteins
2-carboxyarabinitol-1,5-bisphosphate (CABP) Custom synthesized Pierce et al., 1980
Cesium iodide Sigma Cat#21655
Creatine P-kinase Sigma Cat#C3755
Deuterium oxide Euriso-top Cat#D216L
Disuccinimidyl suberate (DSS) Thermo Scientific Cat#21655
Disuccinimidly suberate (DSS) d0/d12 Creative Molecules Cat # 001S
Glu-fibrinopeptide Waters, USA Cat#700008842-2
Glutaraldehyde (GA) Sigma Cat#G5882
Glyceraldehyde-3-phosphate dehydrogenase Sigma Cat#G0763
Glycerophosphate dehydrogenase-
triosephosphate isomerase
Sigma Cat#G1881
Lactate dehydrogenase/pyruvate kinase Sigma Cat#P0294
NADH Sigma Cat#N6785
NuPAGE 3%–8% Tris-acetate Native gel Life Technologies Cat#EA03755BOX
Phosphocreatine Roche Cat#14662432
Phosphoenol pyruvate Roche Cat#13516325
Phosphoglycerate kinase Sigma Cat#P7634
ReproSil C18-AQ Dr. Maisch, Germany Cat#r13.aq
Ribulose-1,5-bisphosphate (RuBP) Sigma Cat#R0878
Sodium bicarbonate (Na14HCO3) PerkinElmer Cat#NEC086H005MC
TCEP Thermo Scientific Cat#20491
Xylulose-1,5-bisphospahte (XuBP) Custom synthesized Bracher et al., 2015
Deposited Data
RsRubisco structure with CABP, derived from
EMD-3699
This study PDB: 5NV3
RsRubisco map with CABP, D4 This study EMD-3699
RsRubisco map with CABP, C1 This study EMD-3700
RsRubisco map with CABP and RcaCC This study EMD-3701
RsRubisco with CABP and RcaCC masked This study EMD-3702
Mendeley Data This study http://dx.doi.org/10.17632/vnt5ck2kbz.1
Recombinant DNA
pET30b-RsRbcLS Previous study Mueller-Cajar et al., 2011
pET30b-RsRbcLD4S Previous study Mueller-Cajar et al., 2011
pHue-RsRca Previous study Mueller-Cajar et al., 2011
pHue-RsRcaCC This study N/A
pHue-RsRcaCC Y114A This study N/A
pET30b-RsRbcL D474N This study N/A
pET30b -RsRbcL D477N This study N/A
pET30b-RsRbcL D474N/D477N This study N/A
Software and Algorithms
Chimera Pettersen et al., 2004 http://www.cgl.ucsf.edu/chimera
Coot Emsley et al., 2010 https://www2.mrc-lmb.cam.ac.uk/personal/
pemsley/coot/
CTFFIND3 Mindell and Grigorieff, 2003 http://grigoriefflab.janelia.org/ctf
(Continued on next page)
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REAGENT or RESOURCE SOURCE IDENTIFIER
CTFFIND4 Rohou and Grigorieff, 2015 http://grigoriefflab.janelia.org/ctf
Cytoscape 3.4.0 Shannon et al., 2003 http://www.cytoscape.org/
DynamX 3.0 Waters, USA
IMAGIC-5 van Heel et al., 1996 https://www.imagescience.de/imagic.html
MassLynx 4.1 Waters, USA
Mass Matrix Data File Conversion Tools v.3.9 http://www.massmatrix.net
ModBase Pieper et al., 2011 https://salilab.org/modeller
ProteinLynx Global Server 2.4 Waters, USA N/A
PyMOL 0.99 or 1.3 N/A http://www.pymol.org
REFMAC Brown et al., 2015 https://www2.mrc-lmb.cam.ac.uk/groups/
murshudov/content/refmac/refmac.html
RELION 1.3 or 1.4 Scheres, 2015 http://www2.mrc-lmb.cam.ac.uk/relion
Ring v.2.0.1 Piovesan et al., 2016 http://protein.bio.unipd.it/ring/
SPIDER Frank et al., 1996 https://spider.wadsworth.org/spider_doc/spider/
docs/spider.html
StavroX 3.6.0.1 Go¨tze et al., 2012 http://www.stavrox.com
SWISS-MODEL Kiefer et al., 2009 https://swissmodel.expasy.org
Thermo Xcalibur Thermo Scientific N/A
Unblur Grant and Grigorieff, 2015 http://grigoriefflab.janelia.org/unblur
Ximdisp Crowther et al., 1996 http://www2.mrc-lmb.cam.ac.uk/research/
locally-developed-software/image-
processing-software
Other
ACQUITY UPLC C18 BEH analytical column Waters, USA Cat#186002346
ACQUITY UPLC C18 BEH VanGuard pre-column Waters, USA Cat#186003975
Micro Bio-spin 6 column Bio-Rad Cat#732-6221
Nano-ESI pipettes, gold plated Mascom, Bremen Cat#MC-10-10u
POROS-20 AL beads Applied Biosystems Cat#1-6028-10
Quantifoil R3/3 holey carbon grids with 2nm carbon Quantifoil Micro Tools, Germany N/A
Reprosil Gold 300 C4, 3 mm (10 3 1 mm) column Dr. Maisch, Germany Cat#r33.4g.t0101
Reprosil Gold 300 C4, 3 mm (125 3 1 mm) column Dr. Maisch, Germany Cat#r33.4g.s1201
Restek HPLC column Restek, USA Cat#25119
Superdex 200 PC 3.2/30 column GE Healthcare Life Sciences Cat#29-0362-31CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to the Lead Contact M. Hayer-Hartl (mhartl@
biochem.mpg.de).
METHOD DETAILS
Proteins
R. sphaeroides wild-type Rubisco, mutant Rubisco with deletion of the four C-terminal residues from RbcL (ED4) and the activase
(RsRca) were purified as previously described (Mueller-Cajar et al., 2011). The mutants Rca L49C/A263C (RcaCC), RcaCC
Y114A, RsRbcL D474N, RsRbcL D477N, and RsRbcL D474N/D477N were generated by QuikChange mutagenesis (Strategene)
and recombinantly expressed and purified (Mueller-Cajar et al., 2011), except that DTT (2-5 mM) was present during purification
and storage of RcaCC proteins.
Preparation of Oxidized RcaCC
Purified RcaCC was buffer exchanged into 50 mM Tris-HCl pH 8.0/50 mM NaCl and incubated with 4 mM ATP, 10 mM MgCl2 and
0.5mMRuBP. Oxidation was initiated by addition of 50 mMCuCl2 for 15min at 25
Cand stoppedwith 50mMEDTA. The reactionwase2 Molecular Cell 67, 744–756.e1–e6, September 7, 2017
applied to a size-exclusion chromatography column (Superdex 200 10/30; GE Healthcare) equilibrated with buffer A (20 mM Tris-HCl
pH 8.0/50 mM NaCl) and the fractions containing hexameric RcaCC were pooled, concentrated, supplemented with 10% glycerol,
flash frozen in liquid N2 and stored at 80C.
Size-Exclusion Chromatography
Size-exclusion chromatography was performed on a Superdex 200 3.2/300 column attached to an AKTA Basic HPLC system with a
flow rate of 80 mL min1 (GE Healthcare). RcaCC (50 mL of 4.0 mM hexamer) with ATP/RuBP (1 mM each) was injected into the
column equilibrated with buffer A or buffer A containing 3 mM DTT for non-reducing and reducing conditions, respectively. The
elution of the protein was monitored at 280 nm.
ATPase Assay
ECM, ECM-CABP, ED4CM, E-RuBP, E-CABP, E-XuBP and ED4-RuBP were prepared as previously described (Bracher et al., 2015;
Mueller-Cajar et al., 2011). Briefly, active carbamylated Rubisco (ECM or ED4CM; 25-50 mMactive sites) was prepared by incubation
in buffer A/40 mM NaHCO3/10 mM MgCl2 for 10 min at 25
C. The inhibited non-carbamylated Rubisco (E-RuBP or ED4-RuBP;
25-50 mM active sites) was prepared by incubation in buffer A/4 mM EDTA for 10 min followed by addition of 0.8 mM RuBP and in-
cubation for 10 min. The inhibited enzymes ECM-CABP, E-CABP or E-XuBP, were first incubated for10 min in the respective buffers
described above, followed by incubation for 10 min in the presence of 0.8 mM carboxypentitol bisphosphate (a 1:1 mixture of the
inhibitor CABP and its lower affinity stereoisomer carboxyribitol-1,5-bisphosphate) (Pierce et al., 1980) or 0.5 mM XuBP. ATPase
activity was measured spectrophotometrically by monitoring NADH oxidation in a coupled enzymatic assay (Mueller-Cajar,
2011 #15). ATPase assays were performed at 25C with active or inhibited Rubisco (0.375 mM hexadecamer) in the presence of
wild-type Rca or RcaCC (0.83 mM hexamer) in buffer (50 mM Bis-Tris pH 7.5/50 mM NaCl/100 mM KCl/10 mM MgCl2/ 2 mM
phosphoenol pyruvate/1 mM ATP/0.5 mM NADH and ATP regenerating enzymes (2.5 U pyruvate kinase and 3.5 U lactate dehydro-
genase). RuBP (1 mM) was included when indicated.
Rubisco Activity Assay
Rubisco CO2 fixation assays were measured spectrophotometrically in a coupled enzymatic assay monitoring NADH oxidation as a
function of CO2 uptake and 3-PGA release (Kubien et al., 2011; Tsai et al., 2015). Reactions with wild-type Rubisco (0.15 mM active
sites or 0.02 mMhexadecamer) in the presence or absence of Rca or RcaCC (0.67 mMhexamer) in buffer (0.1M Tricine-NaOH pH 8.0/
5 mM MgCl2/coupling enzymes (2.5 U creatine P-kinase, 2.5 U glyceraldehyde-3-P-dehydrogenase, 2.5 U 3-phosphoglycerate
kinase, 20 U triose-P-isomerase and 2 U glycerol-3-P-dehydrogenase)/0.5 mM NADH/10 mM phosphocreatine/20 mM NaHCO3/
1 mM RuBP/1 mM ATP) were performed at 25C. Activity assays of ECM-CABP or E-CABP also contained 5 mM carboxypentitol
bisphosphate, as a result of diluting the stock solutions of inhibited Rubisco (see above) into the enzyme reaction. Buffers used for
measurements under reducing conditions contained 3 mM DTT.
Chemical Crosslinking Coupled to Mass Spectrometry
Prior to chemical crosslinking, proteins were buffer exchanged into 20 mM HEPES pH 7.5/50 mM NaCl using Micro BioSpin
6 columns (BioRad). Reactions containing Rubisco (ECM-CABP; 1.25 mM hexadecamer) and RcaCC (3.33 mM hexamer) either alone
or together were incubated with 10 mM ATP/20 mM MgCl2/1 mM RuBP for 1 min at 25
C. Crosslinking was initiated by addition of
1 mM of an isotopic mixture of H12/D12 (1:1) disuccinimidyl suberate (Creative Molecules) and the reaction allowed to proceed for
30 min, before quenching with NH4HCO3 (150 mM). Crosslinked proteins were resolved on a NuPAGE 3%–8% Tris-acetate
native gel (Life Technologies). The high molecular weight (HMW) crosslinked bands were excised and subjected to in-gel trypsin-
digestion and desalted as described previously (Shevchenko et al., 2006). Desalted peptides in 5% formic acid were analyzed on
nanoACQUITY UPLC system (Waters Corp., USA) connected to LTQ-Orbitrap (Thermo). Peptide separation was performed on
home-made nanoLC columns (ID 100 mm, length 20 cm with 15 mm tip opening, New Objective), packed with 3 mm C18 beads
(Reprosil-Pur C18-AQ, Dr. Maisch GmbH) using a 120min gradient from 0.2% formic acid in water to 0.2% formic acid in acetonitrile.
Sample loading to the column (0.5 ml/min) was performed with a nanoACQUITY UPLC autosampler (Waters Corp., USA) without a
trap column, with the UPLC flow rate during sample analysis maintained at 0.4 mL per min. MS analysis, using Thermo Xcalibur soft-
ware, was performed in a standard data dependent mode of 1 high resolution 60000 FWHMMS1 scan (m/z 330- 1700) followed by
MS2 scans of 8 most intense ions, with charge states 1 and 2 excluded.
Identification of Crosslinks
To identify the crosslinked peptides, Thermo Xcalibur raw files were converted to Mascot generic file (mgf) format, using Mass
Matrix Data File Conversion tools v 3.9 (http://www.massmatrix.net). Analysis of the mgf files was performed on StavroX 3.6.0.1
(http://www.stavrox.com/Download_StavroX_Win.htm) (Go¨tze et al., 2012) with the following filters: FDR cut off% 5%, MS1 toler-
ance = 3 ppm, MS2 tolerance = 0.3 Da, missed cleavages for K and R = 3 and 1, respectively, signal to noise ratio R 2, fixed
and variable modifications = Cys-carbamidomethylation and Met-oxidation, respectively, minimum length of each of the two cross-
linked peptides = 5 amino acids, crosslinks with terminal lysines excluded. Lysine and N-termini were considered as potential cross-
linking sites for DSS. Manual validation of all identified crosslinked peptides included the assignment of b- and y-ion and presence ofMolecular Cell 67, 744–756.e1–e6, September 7, 2017 e3
MS1 doublets separated by 12.0753 Damass for DSS-H12/D12. Crosslink sites (Table S1B) were only considered when identified in at
least two experiments.
Native Mass Spectrometry
Crosslinking was performed as described above except that the DSS (Pierce) did not contain the D12 heavy isotope and the cross-
linking was quenched after 10 min. Crosslinked proteins (1.25 mM ECM-CABP hexadecamer, 3.33 mM RcaCC hexamer and ECM-
CABP/RcaCC complex) were buffer exchanged into 100 mM ammonium acetate (Sigma) pH 8.0, using Micro Bio-Spin 6 columns
(BioRad). For native-MS analysis of non-crosslinked RcaCC (Figure 1D), the protein (2.5 mM hexamer) was buffer exchanged as
described above. Native-MS analysis was performed on quadrupole IM time-of-flight hybrid mass spectrometer with a Z-spray
nano-ESI source (Synapt G2-Si, Waters Corp., USA) in positive ion mode, using 10 mm gold-platted nano-ESI pipettes (Mascom,
Bremen) as capillaries. Optimized capillary and sample cone voltages were 1-1.5 kV and 150 V respectively, at a source temperature
of 30C. The instrument was calibrated with acetonitrile: water solution of 30 mg mL1 cesium iodide.
Hydrogen-deuterium Exchange (H/DX) and Mass Spectrometry
Intact Protein H/DX MS Analysis
In remodeling experiments of inhibited Rubisco, RcaCC (20 mM hexamer) was incubated with E-RuBP, E-XuBP, ECM-CABP or ED4-
RuBP (2.5 mM catalytic sites each) in buffer C (25 mM Tris-HCl pH 7.5/20 mMMgCl2/10 mM ATP) containing 1 mM RuBP for 30 s at
25C (Figures 2 and S1). Hydrogen-deuterium exchangewas initiated by addition of 14-fold excess of 99.9%D2O buffer (25mMTris-
HCl pD 7.5) for 60 s, followed by shifting the pH to 2.5 with ice cold quench buffer (200 mM phosphate buffer pH 2.2/3 M GuHCl/
150 mM TCEP). Hydrogen-deuterium exchange was initiated by addition of 14-fold excess of 99.9% D2O buffer (25 mM MOPS pD
7.8/5mMKCl) for 60 s, followed by shifting the pH to2.5 with ice cold quench buffer. The samples ECM, E-RuBP, E-XuBP, ED4CM,
ED4-RuBP and ECM-CABP in the absence of RcaCCwere incubated, labeled, and quenched as described above in either buffer C or
D. Quenched samples (50 ml) were injected into a nanoACQUITYUPLCHD/Xmanager (Waters Corp., USA) housing reverse phaseC4
desalting (10 3 1 mm) and analytical (125 3 1 mm) columns (ReproSil Gold 300 C4, 3 mm, Dr. Maisch GmbH, Germany). Samples
were desalted for 3 min at a flow rate of 100 ml min1 and separated on an analytical column at a flow rate of 40 ml min1 using a
8 min gradient from 0.1% formic acid/15% acetonitrile to 0.1% formic acid/85% acetonitrile. To minimize back exchange, all chro-
matographic steps were performed at 0C and pH 2.5 (Zhang and Smith, 1993). The proteins were directly eluted into a Synapt G1
or G2-Si mass spectrometer (Waters Corp., USA) equipped with a standard electrospray interface. Mass accuracy of < 20 ppm
was confirmed using horse heart myoglobin as a standard. Experiments were repeated 3-5 times, allowing comparison of relative
deuterium uptake levels. The averaged masses as relative deuterium uptake levels were not corrected for back exchange (Wales
and Engen, 2006). Protein mass spectra were deconvoluted using MassLynx 4.1 (Waters Corp., USA).
Peptide Level HD/X MS Analysis
H/DX reactions were performed essentially as above, except that the concentration of Rubisco catalytic sites was 6 mM and RcaCC
2.5 mM (hexamer). Deuterium labeling was performed for 10 s after incubating inactive Rubisco (E-RuBP) from 10 s to 7 min in the
presence of RcaCC and ATP (10 mM), followed by acid quenching at 0C. Quenched samples (15 pmoles) were injected into a
nanoACQUITY UPLC HD/X manager and digested on an in-line stainless steel column of 2.1 mm inner diameter and 50 mm length
(Restek Corporation, USA), self-packed with immobilized pepsin (Wang et al., 2002) on POROS-20AL beads (Applied Biosystems) at
a flow rate of 100 ml min1 at 20C. The peptic peptides were trapped and desalted on a ACQUITY UPLC C18 BEH VanGuard pre-
column (2.13 5 mm,Waters Corp., USA) containing 1.7 mmC18 beads for 3 min at a flow rate of 100 ml min1 and separated in 6 min
using a 8%–40%gradient of acetonitrile in 0.1% formic acid pH 2.5 on a ACQUITY UPLC BEHC18 analytical column (1.03 100mm,
1.7 mm, Waters Corp., USA). Both pre- and analytical columns were maintained in the nanoACQUITY UPLC HD/X manager main-
tained at 0C. The use of protonated solvents during UPLC allowed exchange of deuterium from side chains and amino/carboxyl
termini with hydrogen that exchange faster than backbone amides. The eluted peptic peptides were directly analyzed on a Synapt
G2-Si mass spectrometer equipped with a standard ESI source (Waters Corp., USA) over a mass range of 50-1700 m/z. Glu-fibri-
nopeptide (Sigma) was continuously sprayed through the lock mass channel to maintain calibration at < 3 ppm. The mass spectrom-
eter was run in MSE and ion mobility mode with the following settings: ESI positive ion mode; capillary voltage, 3000 V; cone voltage,
40 V; desolvation temperature, 175C; source temperature, 80C; nitrogen desolvation gas flow, 600 l hr1; scan rate, 0.23 scans s-1.
Step wave settings used were as described (Guttman et al., 2016). Peptic fragment identification was performed with IdentityE soft-
ware implemented in the ProteinLynx Global Server 2.4 (Waters Corp., USA) from 4-5 MSE analyzed replicates (Plumb et al., 2006).
MSE was performed by a series of low-high collision energies ramping from 5–30 V, ensuring proper fragmentation of the peptic
peptides. Deuterium exchange levels were determined by DynamX 3.0 software (Waters Corp., USA) by identifying the isotopic dis-
tribution (from +1 to +6 charge state, depending on the peptide). Isotope distribution and peak selection was verified manually for all
peptides. The relative deuterium incorporation was calculated by subtracting the centroid of the isotopic distribution for peptide ions
of the unlabeled reference from the centroid of the isotopic distribution for peptide ions from each deuterated sample. All the exper-
iments were performed under identical experimental conditions and hence, deuterium levels are uncorrected for back exchange and
are reported as relative uptake levels (Wales and Engen, 2006). Experiments were repeated 3-5 times.e4 Molecular Cell 67, 744–756.e1–e6, September 7, 2017
Electron Microscopy (EM) and Data Processing
Negative-Stain EM
Crosslinked ECM-CABP-RcaCC complexes were prepared bymixing RcaCC (20 mMmonomer) with E.C.M-CABP (10 mMmonomer)
in a reaction containing 20 mM HEPES pH 7.5, 50 mM NaCl, 10 mM MgCl2, 10 mM ATP and 1mM RuBP, for 1 min at 25
C prior to
addition of 0.125% of glutaraldehyde (GA). After 10min the reaction was quenched by addition of 0.1M Tris-HCl pH 8 followed by gel
filtration on a Superdex 200 PC 3.2/30 column (GE Healthcare). The fractions were eluted in buffer A and analyzed on a 6%native gel.
Fractions 12 and 13 (Figure S6B) containing HMW complexes with the least amount of free Rubisco were chosen for negative-stain
and cryo-EM, respectively. The crosslinked ECM-CABP-RcaCC complexes were diluted to 30-35mgmL1 in 20mM Tris-HCl pH 8.0,
50 mM NaCl, 1 mM ATP, 1 mM ATPgS and 1 mM RuBP, and negative staining performed using 2% uranyl acetate. Images for 2D
class averages were taken on a Tecnai G2 Spirit transmission electron microscope, operating at 120 kV, using a FEI 2,0483 2,048-
pixel CCD camera. The pictures were taken at a nominal magnification of 90,600 x resulting in a pixel size of 3.1 A˚ at the specimen
level with the defocus varying between 350 nm and 1000 nm. The defocus and astigmatism of micrographs were determined using
CTFFIND3 (Mindell and Grigorieff, 2003) and CTF correction was done in SPIDER (Frank et al., 1996; Shaikh et al., 2008). A total of
1191 particles were manually selected using the MRC program Ximdisp (Crowther et al., 1996). Boxed particles were analyzed using
IMAGIC-5 (van Heel et al., 1996). Single particles were normalized and band-pass filtered between 200 and 10 A˚ and centered by
iterative alignments to their rotationally averaged sum. Resulting class averages (8 particles/class) served as input for one round
of competitive alignment to separate the dataset into classes having either one or two RcaCC bound per Rubisco based on multi-
variate statistical analysis followed by multi-reference alignment.
Cryo-EM
Using a FEI Vitrobot Mark VI, 3.5 ml GA crosslinked ECM-CABP-RcaCC complexes (120 mg mL1) prepared as above were applied
on glow discharged Quantifoil R3/3 holey carbon grids with 2 nm carbon support film for 45 s at 4C and 100% humidity before
blotting for 2 s and vitrification. Cryo-EM images were acquired under low-dose conditions at 300 keV on a Titan Krios transmission
electronmicroscope equippedwith a Falcon II detector at the Netherlands Center for Electron Nanoscopy (NeCEN) financed by iNext
(Instruct). A total of 4824 micrographs were collected at a nominal magnification of 134615 with defocus ranging from 200
to 3600 nm and sampled at 1.04 A˚ per pixel at the specimen level. 22 frames were recorded over 1.25 s giving an accumulated
dose of 50 e-/A˚2. All image processing and 3D reconstruction was performed using RELION-1.3 or 1.4 (Scheres, 2015). Contrast
transfer functions were determined by CTFFIND4 (Rohou and Grigorieff, 2015) and movie frame alignment was performed using
Unblur (Grant and Grigorieff, 2015). Micrographs recorded with strong astigmatism, at overfocus, very low defocus or with broken
ice or strong ice contamination were discarded, yielding 4239 micrographs for further processing steps. 528 manually selected par-
ticles were 2D-classified and a 2D class average of ECM-CABP with RcaCC bound was used as template for semi-automated par-
ticle selection (Scheres, 2015) resulting in an initial dataset of 862590 particles. The dataset was cleaned and sorted using the z-score
function and iterative 2D classifications in RELION-1.3, resulting in a sub-dataset of ECM-CABP of 333122 particles and a sub-data-
set of ECM-CABP-RcaCC of 333711 particles. One third of the ECM-CABP dataset was selected for a first 3D refinement using a
homology model of R. sphaeroides Rubisco based on the crystal structure of Alcaligenes eutrophus Rubisco (pdb: 1BXN) filtered
to 50 A˚ resolution as reference. The resulting (initial) 3D reconstruction was filtered to 20 A˚ resolution and used for 3D refinement
of the aligned movie frame averages of the ECM-CABP dataset in RELION-1.3. Auto-refinement without mask resulted in a 3.4 A˚
and 3.8 A˚ reconstruction for ECM-CABP with applied D4 symmetry and without symmetry, respectively.
3D refinement of a smaller dataset of the Rubisco-RcaCC complex of 37500 particles, using the down filtered ECM-CABP D4
reconstruction as input model, generated an initial reconstruction for the complex. The initial reconstruction was filtered to 20 A˚ res-
olution and used for 3D refinement of the entire ECM-CABP-RcaCC dataset. Different masks were applied during 3D refinement,
yielding ECM-CABP reconstructions with a) the full RcaCC density at 7.56 A˚ resolution, and b) only the central density of the hex-
americ RcaCC ring at 6.05 A˚ resolution. Movie frame weighting was performed in RELION-1.4 using all movie frames. Subsequent
3D refinement of the weighted movie dataset resulted in a 3.4 A˚ symmetrized ECM-CABP reconstruction and a 3.5 A˚ reconstruction
without applied symmetry. Auto-refinement of the weighted movie ECM-CABP-RcaCC dataset did not improve the reconstruction.
The dataset of ECM-CABP-RcaCC was also 3D-classified into 2 classes using the initial 3D reconstruction filtered to 20 A˚ as a refer-
ence and the resulting classes showed no difference in the binding mode of RcaCC. All refinements used gold standard Fourier shell
correlation (FSC) calculations and reported resolutions are based on the FSC= 0.143 criterion ofmask-corrected FSC curves. All final
maps were masked and sharpened using automatically determined negative B-factors.
Modeling
The RbcL and RbcS subunit structures ofR. sphaeroides Rubisco were initially modeled with SWISS-MODEL (Kiefer et al., 2009) and
ModBase (Pieper et al., 2011). The sequences of RsRbcL and RsRbcS were manually built into the B-factor sharpened electron
density using the program Coot (Emsley et al., 2010), based on the crystal structure of the highly homologous red-type Rubisco
of Galdieria partita with bound CABP (pdb: 1BWV). A B-factor of 200 A˚2 was applied to sharpen the electron density map for visu-
alization. For reciprocal-space refinement of the model with REFMAC5 (Brown et al., 2015) in the EM mode, the RELION map was
converted first into a pseudo-diffraction dataset mtz file using REFMAC5 (Brown et al., 2015). During refinement, the weight for the
model geometry versus the X-ray target was adjusted for plausible stereochemistry. The final model has one outlier (RbcS Val116)
and 94.5% in the favored regions in the Ramachandran plot, according to the criteria of MolProbity (Chen et al., 2010). Occupancies
0.2, 0.4, 0.5, 0.6 and 0.8 were tested for residues 462-479 in REFMAC5 refinement, because of high B-factors in this segment at fullMolecular Cell 67, 744–756.e1–e6, September 7, 2017 e5
occupancy. At occupancy 0.4, the C-terminal strand had B-factors similar to residues contacting the C-terminal tail (290-396 A˚2) and
the corresponding model the best refinement statistics (R-factor 0.3511, average Fourier shell correlation 0.8138). The Rubisco
model and the hexameric model of RsRca were docked into the cryo-EM maps as rigid bodies using the Chimera fit (Pettersen
et al., 2004) in map function by simulating maps from atomic coordinates at the resolution of the EM maps and optimizing map in
map correlation. The models were then refined by molecular dynamics flexible fitting (Trabuco et al., 2008). Visualization of cryo-
EM maps and models was performed using Chimera (Pettersen et al., 2004) and PyMOL 0.99.
Analysis of Amino Acid Residue Interaction Network
The analysis of interacting amino acid residues in structural model of RsRubiscowas performedwith the Residue Interaction Network
Generator (RING) v2.0.1 web server (Piovesan et al., 2016). All possible interactions were taken into account (covalent, salt bridges,
hydrogen bonds, van der Waals interactions, pp stacking, p cation) with distance threshold set to either strict or relaxed (for com-
parison) and network policy to closest. Per residue pair multiple interaction types were determined. The interaction network was visu-
alized with PyMOL 0.99 and Cytoscape 3.4.0 (Shannon et al., 2003).
DATA AVAILABILITY
Data Resources
The EM density maps for the complexes RsRubisco D4; RsRubisco C1; ECM-CABP-RcaCC and ECM-CABP-RcaCC masked have
been deposited to the Electron Microscopy Data (EMD) Bank under accession codes EMD: 3699, 3700, 3701, and 3702, respec-
tively. The accession number for the Rubisco structural model reported in this paper is PDB: 5NV3. The full gels of Figures 1C,
4A, S5, and S6 can be viewed at Mendeley Data (URL: http://dx.doi.org/10.17632/vnt5ck2kbz.1).e6 Molecular Cell 67, 744–756.e1–e6, September 7, 2017
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Figure S1.  RcaCC-mediated Remodeling of Inhibited Rubisco, Related to Figures 1 and 2 
(A) Size exclusion chromatography of WTRca, oxidized RcaCC and reduced RcaCC on a 
Superdex 200 3.2/300 column in presence of ATP/RuBP. See Star Methods for details. (B) 
Reactivation of inhibited Rubisco by reduced RcaCC. CO2 fixation assays were performed with 
active (ECM) or inhibited (E-RuBP) Rubisco as in Figure 1F in the absence or presence of 
WTRca or RcaCC under reducing conditions (3 mM DTT). SDs are from at least three 
independent experiments. (C-D) Remodeling of inhibited Rubisco monitored by global H/DX-
MS analysis. Mass spectra showing deuterium uptake in RbcL from Rubisco inhibited with 
XuBP (A) or CABP (B). Measurements were performed as in Figure 2. (E) Inability of WTRca 
and RcaCC to reactivate Rubisco containing C-terminally truncated RbcL (E4-RuBP). 
Activation assays were performed as in Figure 1F. SDs are from at least three independent 
experiments. (F) Remodeling of inhibited Rubisco monitored by global H/DX-MS analysis. Mass 
spectra showing deuterium uptake in RbcS from Rubisco inhibited with RuBP in comparison to 
the carbamylated active form. Measurements were performed as in Figure 2. See Star Methods 
for details. 
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Figure S2.  H/DX-MS Analysis of Rubisco Reactivation at Peptide Resolution, Related to 
Figure 3 
(A-B) Sequence coverage in H/DX measurements. Peptic peptides (black double-headed arrows) 
of RbcL (A) and RbcS (B) analyzed in H/DX-MS measurements of Figure 3 are mapped on the 
amino acid sequences. -Helices and β-strands are shown in red on top of the sequences as 
helices and arrows, respectively. (C) Mass spectra showing deuterium incorporation into 
representative peptides of RbcL during the time course of reactivation of E-RuBP by RcaCC (see 
Figures 3B and S4). Mass and charge state are shown for each peptide. Deuterium uptake by 
ECM and spectra of unlabeled E-RuBP are included as reference. 
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Figure S3.  Deuterium Uptake into RbcL Peptides, Related to Figure 3 
(A-B) The relative deuterium incorporation into RbcL peptides of inhibited Rubisco (E-RuBP) 
(A) and active Rubisco (ECM) (B) is mapped onto a homology model of the RbcL antiparallel 
dimer and shown as a color gradient from pale yellow (low relative deuterium uptake) to magenta 
(high relative deuterium uptake). Regions for which no peptide coverage was obtained are in 
grey. RuBP is shown in cyan using space-filling representation. Positions of the N- and C-termini 
are indicated. See Figure 3 and Star Methods for details. (C-D) Difference plots showing 
deuterium incorporation into RbcL peptides upon incubation of E4CM in the absence of RcaCC 
(C) and upon incubation of E4-RuBP with RcaCC (D) over a time course of 10 s to 7 min of 
reactivation. Deuterium incorporation measured with E4-RuBP alone is subtracted. Changes in 
deuteration >0.5 Da are meaningful. H/DX-MS data represents averages of 4-6 independent 
experiments per time point. 
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Figure S4.  Relative Deuterium Uptake into RbcL Peptides during Rubisco Reactivation, 
Related to Figure 3 
Time-dependent deuterium incorporation into representative RbcL peptic peptides spanning the 
RbcL sequence during incubation of E-RuBP with RcaCC (black) and of ECM (red) and E-RuBP 
(cyan) in the absence of RcaCC. Shown are the raw data (4-6 replicates per time-point) after 
DynamX analysis of each peptide in all charge states followed by manual inspection and 
validation. D, deuterium. See Star Methods for details. 
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Figure S5.  Chemical Crosslinking Coupled to MS (CXMS) Analysis of E.C.M.-
CABP/RcaCC Complexes, Related to Figure 4 
(A) Nano-ESI native-MS spectra of DSS crosslinking reaction (10 min at 25°C) of ECM-CABP 
and RcaCC in the presence of RuBP but absence of ATP. Symbols indicate charge-state 
distributions. The calculated mass around the m/z values of the respective protein complexes and 
the accuracy of mass values calculated from the different m/z peaks are indicated. (B) Structure 
of the bifunctional crosslinker disuccinimidyl suberate (DSS). The crosslinker is a 1:1 mixture of 
protonated (light; H12) and deuterated (heavy; D12) isotopes with a mass difference of 12.0753 
Da. (C) Workflow for crosslinking and analysis of crosslinked peptides by in-gel trypsin 
digestion and LC-MS/MS. (D) Crosslink products of the ECM-CABP and RcaCC reaction as in 
(C). The proteins (10 μM ECM-CABP and 20 μM RcaCC) were incubated with 10 mM ATP/20 
mM MgCl2/1 mM RuBP for 1 min at 25°C, followed by crosslinking by addition of H12:D12–DSS 
(1 mM) for 30 min at 25°C. The crosslinking reaction was quenched with NH4HCO3 (150 mM) 
and analyzed by native-PAGE. High molecular weight crosslinked bands A1-A3 (Experiment 1) 
and B1-B3 (Experiment 2) were subjected to in-gel trypsin digestion and LC-MS/MS analysis 
(Table S1). 
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Figure S6.  Analysis of Glutaraldehyde Crosslinked E.C.M.-CABP/RcaCC complexes by 
Negative-stain and Cryo-Electron Microscopy, Related to Figures 6 and 7 
(A) Rubisco with the tightly bound inhibitor CABP (ECM-CABP) was preincubated for 1 min 
with RcaCC and ATP as indicated. RuBP was present in all reactions. Reactions were then 
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incubated for 10 min with or without glutaraldehyde (GA), followed by analysis by native-
PAGE. High molecular weight complexes representing crosslinked species are marked with 
asterisks. See Star Methods for details. (B) Fractions of the ECM-CABP/RcaCC GA crosslinking 
reaction obtained by size-exclusion chromatography (Superdex 200 PC 3.2/30; GE Healthcare) 
were analyzed by native-PAGE. Fraction 13 containing mainly the high molecular weight 
complexes were used for EM analysis. See Star Methods for details. LS, RbcL8S8; X, GA 
crosslinking reaction prior to size-exclusion chromatography. (C) Negative stain electron 
micrograph of ECM-CABP/RcaCC complexes (30-35µg ml-1) in the presence of 1 mM ATP and 
ATPγS. Exemplary ECM-CABP/RcaCC complexes with one, two or three RcaCC rings bound 
are encircled. (D) Class averages of ECM-CABP/RcaCC complexes derived from reference free 
multivariate statistical analysis (MSA) of negatively stained images in IMAGIC. Each class 
average contains five to ten images. ECM-CABP bound with either one (upper panel) or two 
(lower panel) RcaCC complexes are shown. (E) Micrographs of ECM-CABP/RcaCC complexes 
(~120 µg ml-1) in the presence of 1 mM ATP and ATPγS taken under low dose cryo conditions. 
(F) Representative reference free 2D class averages of ECM-CABP derived from cryo-EM 
images in RELION-1.3. (G) Representative reference free 2D class averages of ECM-
CABP/RcaCC complexes in the presence of 1 mM ATP and ATPγS, derived from cryo-EM 
images in RELION-1.3. 
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Figure S7.  Cryo-EM Structural Analysis of Rubisco and Rubisco-RcaCC complexes, 
Related to Figures 6 and 7 
(A) Mask- corrected Fourier shell correlation (FSC) curves of ECM-CABP and ECM-
CABP/RcaCC complexes as determined by gold standard FSC procedure in RELION-1.4. All 
maps were masked and sharpened using automatically determined negative B-factors. (B) 3D 
reconstruction of ECM-CABP complexes at 3.5 Å resolution shown as top and side views. No 
symmetry was applied during 3D reconstruction. RbcL and RbcS subunits are colored in green 
and orange, respectively. (C) 15 Å slice through the ECM-CABP complex with no symmetry 
applied and with the sequences of R. sphaeroides RbcL and RbcS fitted into the electron density. 
The EM reconstruction is shown as transparent surface and the model is colored as in (B). (D) B-
factors of the refined R. sphaeroides Rubisco D4-symmetric model. A backbone trace is shown; 
CABP is depicted in space-filling mode. B-factors from 214 to 496 Å2 are shown as a rainbow 
gradient from blue to red. The average B-factor is 277 Å2. Residues 13-17 and 465-474 of RbcL 
are the most mobile parts (B-factor > 370 Å2). (E) Representative slices through the Rubisco-
RcaCC complex colored according to ResMap results. The color bar indicates local resolution 
between 6 and 15 Å. (F) 3D reconstruction of the ECM-CABP/RcaCC complex at ~6.0 Å 
resolution shown as side view with RsRubisco and RsRca (pdb: 3ZUH) fitted as rigid bodies. (G) 
Close up view of the RbcL and RbcS subunits proximal to RcaCC. For clarity, the density map of 
RcaCC is removed. Flexible residues at the N- and C-termini of the RbcL subunits not resolved 
in the 3.4 Å structure of Rubisco (Figure 5) are indicated by dashed lines. Structural elements 
outside the density map are labeled. Residues that were identified to crosslink to RcaCC are 
shown either in ball and stick representation or as black circles in the flexible N-terminus of 
RbcL. CABP is shown as space-filling model in red. 
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4 Discussion and Outlook 
4.1 Article 1 - Active Cage Mechanism of Chaperonin-Assisted 
Protein Folding Demonstrated at Single-Molecule Level 
It has been suggested that GroEL/ES accelerates protein folding by preventing reversible 
aggregation of its substrates84. In such an interpretation the GroEL/ES system would 
perform a passive role, functioning merely as an aggregation prevention device with no 
active contribution to the folding process. Our experiments on a single molecule level at 
DM-MBP concentrations of 100 pM, where the probability of two DM-MBP molecules to 
interact is <1%, allowed us to effectively exclude any influence of reversible aggregation 
on measured folding rates. We confirmed the absence of aggregates by FCS and dcFCCS 
measurements. Under such conditions and using smFRET, we compared the spontaneous 
folding rate of DM-MBP with the rate of GroEL/ES assisted folding and observed a 4-8 fold 
acceleration of the DM-MBP folding rate in presence of GroEL/ES. This finding 
demonstrated the active role of GroEL/ES system in the folding process. We went further 
and asked which part of the system is the active principle: the ATP dependent cycling of 
the chaperonin (repeated binding, stretching and release) as stated by the iterative 
annealing model88,145 or the properties of the GroEL cavity that influence the folding of 
encapsulated substrate91,100? By using the single-ring version of GroEL (SR1-EL) which 
does not cycle and undergoes only one round of encapsulation89 we measured a similar 
increase in DM-MBP folding rate and full yield of folding. It is possible, however, that one 
round of binding and stretching, followed by release into the cavity partitions the 
substrate on a productive folding pathway. Our SR1-EL gel filtration experiments also 
excluded any kind of substrate escape96,146 from the cavity. PET-FCS measurements on a 
cycling GroEL/ES system showed further that the non-native DM-MBP spends ~80% of 
the cycle in the GroEL cavity, demonstrating that it is the GroEL cavity itself that is 
important for folding of the DM-MBP. This is in contrast to the statement posited by the 
iterative annealing model85,88, which does not ascribe any specific role to the inner 
environment of the GroEL cavity and presumes that the substrate can be released either 
into the cavity or into free solution for folding. Further into detail on how the GroEL cavity 
influences the encapsulated substrate, we employed PET-FCS and measured the chain 
dynamics of the DM-MBP intermediate during spontaneous and GroEL/ES assisted 
folding. Comparison of the DM-MBP intermediate chain dynamics, which is reflected in 
the relaxation time (τR) of free (τR = 40±3 µs) and encapsulated (τR = 99±1 µs) protein, 
revealed a restriction in the flexibility of the DM-MBP chain upon encapsulation. A similar 
τR was measured for DM-MBP when stably encapsulated in SR1-EL. PET-FCS experiments 
allowed for the first time a direct observation of chain entropy for substrate within the 
GroEL cavity. Experimental results corroborated earlier predictions that the GroEL cavity 
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restricts conformational entropy of the encapsulated chain by steric confinement which 
accelerates folding90,91,147. However, confinement is not the sole factor contributing to 
acceleration of substrate folding. Another property of the GroEL cavity that has a crucial 
role is the net negative charge (-42) of the inner wall. Negative charges are clustered into 
two circular layers at the level of the apical domains. Experiments with the GroEL KKK2 
mutant, where the second layer of negatively charged amino acid residues was mutated 
to positive charge (D359K, D361K, E363K), changing a net negative charge (-42) of the 
cavity to net neutral charge (0), showed no acceleration of DM-MBP folding, despite steric 
confinement. Similarly, stable encapsulation by SR1-EL KKK2 showed no increase in DM-
MBP folding rates. Additionally, our PET-FCS measurements showed that DM-MBP 
intermediate chain dynamics within GroEL KKK2 is not restricted anymore and is similar 
in behaviour to a highly dynamic intermediate found free in solution. The GroEL cavity 
clearly plays a dual role. It allows proteins to fold in isolation and thereby prevents any 
unwanted interactions with other molecules that might result in formation of aggregates. 
On the other hand, the cavity also serves as a structural framework for correct positioning 
of the charged residues on the cavity wall, that upon substrate encapsulation point into 
the cavity and influence protein folding. It is interesting to note that GroEL mutants with 
a net neutral charge, albeit with different mutations, do not show the same defect in 
assisted protein folding, pointing to a specific role of the second charge cluster91,100. How 
clusters of charged residues influence folding of an encapsulated substrate remains to be 
determined. 
One way in which the GroEL cavity may influence protein folding is that the charge 
clusters would accumulate water molecules in their vicinity, thus inducing a water 
structuring effect100. A layer of structured water molecules between exposed hydrophobic 
residues on the encapsulated substrate intermediate and charged residues on the GroEL 
cavity wall would experience a high degree of entropy restriction, thus resulting in an 
enhanced hydrophobic effect. This would result in more efficient burial of hydrophobic 
residues and accelerated folding of the encapsulated substrate. To date only one 
experimental study101 has been conducted to measure the structuring of water inside the 
GroEL cavity. The authors were not able to find any water structuring effect upon 
GroEL/ES complex formation. This could be due to sensitivity of the method, unfortunate 
choice of the residue (top of the inner side of GroES) around which water structuring 
effect was measured, or the absence of encapsulated substrate. A more promising 
approach of how to measure water structure (or water mobility), would be to specifically 
introduce cysteine residues for labelling on the inner wall at positions along the vertical 
axis of GroEL. The positions for introducing cysteines should not differ substantially 
between apo and complex states of GroEL, thus excluding the influence of a 
conformational change on the measurement. The introduced cysteines could then be 
labelled with a fluorescent probe and by measuring the fluorescence lifetime at different 
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wavelengths one could obtain information on solvation dynamics on a nanosecond 
timescale148. Another option would be to introduce tryptophans instead of cysteines and 
perform femtosecond fluorescence spectroscopy, which gives information on solvation 
dynamics at picosecond timescale149. It would be necessary to perform these experiments 
in the absence and presence of the encapsulated protein. The biggest challenge would be 
to measure how water structure within GroEL changes as the substrates folds. One could 
achieve this by combining either of the two above mentioned fluorescent approaches with 
stopped-flow measurements. 
A second potential role for the GroEL charge cluster might be direct interaction with 
encapsulated substrate protein. In this case, the net charge of the substrate protein would 
also be important since the GroEL cavity might then attract or repel substrate99. This 
could be the reason for observed differences in folding rate enhancements for different 
substrates91. To identify residues that interact with the substrate during folding, one 
could use an approach whereby the transient interactions would be crosslinked and 
subsequently analysed by hydrogen/deuterium exchange coupled to mass spectrometry 
or NMR. To simplify matters one would have to use a slowly folding substrate such as DM-
MBP or Rubisco. In the case of fast folding substrates, for example DapA or MetF, one could 
then use quenched flow approach to follow interactions on shorter time scales.  
It is also of potential significance that the two negative charge clusters are located at the 
level of the GroEL apical domains, which undergo the largest conformational changes 
during the GroEL cycle. Apical domain movements are important for the remodelling of 
the bound substrate and subsequent controlled release into the cavity. In the case of 
GroEL KKK2, the conformational cycle may be perturbed and impair stretching of the 
substrate. Thus, it may upon release into the cavity form a kinetically trapped state. One 
could reanalyse the GroEL KKK2 conformational states during the ATP cycle by cryo-EM 
single particle analysis and compare them with GroEL. It would be of utmost interest to 
compare the conformational states of GroEL and GroEL KKK2 in the presence of a 
substrate protein. Comparison of the structures during the conformational cycle with 
substrate present would then give a definitive answer as to whether the inability of GroEL 
KKK2 to fold substrates lies in structural perturbations of the conformational cycle.  
Another GroEL feature that despite considerable efforts still remains unexplained are the 
unstructured C-terminal tails50. The C-terminal tails have four glycine-glycine-methionine 
repeats ending with an additional methionine. Interestingly, removal of the C-terminal 
tails did not result in any growth defects in E. coli150. It is possible that this modification 
would prove deleterious under a specific set of stress conditions. So far, the role for the C-
terminal tails has been proposed to be in: more efficient substrate encapsulation151, 
control of the GroEL ATPase activity152 and intercalation into the encapsulated substrate 
during folding91,153,154. One could envision a combined effect of these functions, such that 
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C-terminal tails would help bring the substrate into the cavity, sense that is indeed inside 
and relay this information to the ATPase active site to increase ATPase activity and speed 
up the cycle. Additionally, C-terminal tails may help fold the substrate and lastly, may play 
a role in substrate protein release. The latter might be controlled entropically: once the 
encapsulated protein reaches the folded state, the entropy of the complete system, 
GroEL/ES and the substrate, would be too low and not compensated anymore by 
favourable interactions of the hydrophobic C-terminal tail with now buried hydrophobic 
residues of the substrate. To increase entropy, folded substrate (low in entropy) would 
have to be expelled from the system and the new system, GroEL alone, would relax to a 
high entropy state due to the conformational freedom of the C-terminal tails155. A 
potential approach to observe GroEL C-terminal tails dynamics, and thereby infer their 
entropy, is by using PET-FCS. One could then measure the C-terminal chain dynamics 
during the GroEL cycle in the presence and absence of the substrate. 
All of the GroEL cavity features have to work in unison to realize the full potential of the 
GroEL/ES folding machinery. The GroEL cavity is necessary but not sufficient, charged 
clusters seem to have the biggest effect on folding, since their removal turns GroEL into a 
passive cage, and the C-terminal tails are implicated in a myriad of functions that remain 
to be understood. Taken together, the general mechanism by which GroEL folds proteins 
is still far from being fully explained. 
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4.2 Article 2 – Chaperonin-assisted protein folding: Relative 
population of asymmetric and symmetric GroEL:GroES 
complexes 
Recent experiments have suggested that the functional form in the GroEL/ES cycle is a 
symmetrically shaped complex with two GroES molecules bound on either side of GroEL. 
In these studies, however, GroEL was modified by introducing cysteines at the level of the 
apical domains86,141,142,156. The apical domain cysteines were used either for coupling to 
biotin in order to allow tethering to a streptavidin coated surface, or were labelled with a 
fluorophore to monitor the FRET signal between GroEL and GroES. Such GroEL 
modifications might have resulted in decreased allosteric coupling between the rings, or 
changes in binding affinity between GroEL and GroES. This might have caused the authors 
to overestimate the amount of symmetrical complexes. Our experimental approach used 
dual colour FCCS with differently labelled populations of GroES, and thereby 
circumvented any potential perturbation of the allosteric communication in the GroEL 
rings, or changes in binding affinities. This allowed for a more accurate determination of 
the relative ratio of asymmetric versus symmetric complexes. In contrast to previous 
studies, our data showed that symmetrical complexes do not form in the absence of a 
substrate or in presence of a foldable substrate. We have observed GroES binding to both 
sides of GroEL only in presence of non-foldable substrates, such as α-lactalbumin (α-LA) 
and α-casein. These substrates also stimulated the GroEL ATPase activity in the presence 
of GroES up to 2-fold. This suggested an explanation whereby non-foldable substrates 
allosterically uncouple the two GroEL rings and allow ATP to bind to both rings. This in 
turn preconditions GroEL to bind two GroES molecules. The mechanism by which non-
foldable substrates uncouple the two rings still has to be elucidated. It might be that, since 
non-foldable substrates are unable to effectively bury their hydrophobic residues, they 
‘over-interact’ with the C-terminal tails emanating from the GroEL equatorial domains. 
This may lead to an increased interaction surface area between the GroEL rings, 
effectively disabling allosteric pathways. In that sense, it would be interesting to see, by 
using our dcFCCS approach, whether the GroEL mutant without C-terminal tails (GroEL 
ΔC) can form symmetrical complexes in presence of non-foldable substrates. Moreover, a 
comparison of single particle cryoEM 3D reconstructions of the GroEL and GroEL ΔC in 
presence and absence of non-foldable substrates might provide a hint on any increase in 
distance or change in conformation between the two rings. It might also be that there is a 
change from a staggered to stacked conformation of GroEL rings, which predisposes the 
GroEL:GroES2 formation, again by a decrease in allosteric communication between the 
rings157. Along these lines of interplay between GroEL and the substrate, it is tempting to 
presume that a symmetrical complex might be more efficient in folding since it can fold 
the double amount of substrate in the same time. However, a recent native mass 
 
 
  Discussion and Outlook 
164 
 
spectrometry study158 showed that not all GroEL substrates can bind simultaneously to 
the apo state of GroEL. It is exactly for such substrates that it would be of benefit to have 
a free ring in an asymmetrical GroEL:GroES complex which allows for substrate binding 
and its solubilization. In the case of the symmetrical complex, the substrate binding site is 
occupied by GroES which would lead to aggregation of the substrate. Thus, the damage to 
the cell would be much greater than the benefit of simultaneous folding for some 
substrates. Of course, one has to take into consideration the actual number of substrates 
that can or cannot bind simultaneously to GroEL. Therefore, it would be of interest to find 
out the stoichiometry of binding for all GroEL substrates. This would provide a good 
indication of which form is favoured. Moreover, if GroEL really could function as a 
symmetrical machine, it is not clear what the trigger would be for the release of GroES 
and the substrate50. An additional interesting observation from our study was that at 
physiological ATP:ADP ratios (10:1) the population of symmetrical complexes was 
substantially decreased, even in the presence of non-foldable substrates. It has been 
previously observed that ADP is an allosteric regulator which increases the negative 
allostery between the rings such that they bind and hydrolyse ATP sequentially rather 
than simultaneously77. This hints that in physiological setting most probably the 
functional form is a GroEL:GroES asymmetric complex. To experimentally prove this 
hypothesis the best approach to use would be to employ recently developed method159 of 
focused ion beam (FIB) milling to open an E. coli cell and image the interior by cryo 
electron-tomography. One could then determine the relative populations of apo GroEL, 
GroEL:GroES and GroEL:GroES2 complexes inside the cell. Furthermore, such a study 
could then be extended further and investigate the influence of stress (heat, oxidation), 
starvation or different growth states on relative ratios of the aforementioned populations. 
The results of such a study would give a definite answer as to which form is functional 
and put an end to this long-standing debate. Going further, it is interesting to look at cycles 
of other group I chaperonins such a mitochondrial Hsp60 (mt-Hsp60) and group II 
chaperonins, for example thermosome or TRiC. It was shown for mt-Hsp60 that in 
presence of ATP and absence of substrate, complexes without Hsp10, single and doubly 
bound Hsp10 complexes and even single ring with and without Hsp10 were populated160. 
It seems that in this case the regulation of complex composition is not as strict as for the 
bacterial GroEL/ES system. This could be due to differences in interfaces between the 
rings, resulting in decreased allosteric communication, or it could be that 
dissociation/association kinetics are different and allow for intermediates to be detected. 
On the other hand, for group II chaperonins, it was proposed that both cavities function 
simultaneously, requiring a different mechanism for opening of the rings161. However, 
group II chaperonins have not been investigated in the presence of ATP using cryo 
electron microscopy. Such a study would show the distribution of population of open, 
single closed or double closed particles. The most appropriate group II chaperonin would 
be TRiC, because the resulting reconstructions could be compared to already published 
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structures of TRiC along the conformational cycle trapped by different nucleotide 
analogs161. It seems that during evolution the mechanistic cycle of chaperonin 
conformational states has simplified but on the other side the complexity of proteins that 
chaperonins have to handle has increased162. Of course, it is a pure speculation that there 
is any functional correlation between these two phenomena. Nevertheless, the study of 
the cycle, especially of group II chaperonins, still offers a very exciting field of research. 
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4.3 Article 3 – Structure and mechanism of the Rubisco 
assembly chaperone Raf1 
Rubisco is the most abundant enzyme in nature. It catalyses the incorporation of 
atmospheric CO2 into five carbon sugar ribulose-1,5-bisphosphate and is therefore 
directly or indirectly responsible for the production of all biomass. Form I Rubisco is the 
most common and it consists of eight large subunits (RbcL) and eight small subunits 
(RbcS). RbcL subunits are arranged as a tetramer of antiparallel dimers, forming barrel-
like structure which is capped on both ends by four RbcS subunits. Form I RbcL evolved 
from a simpler Form II RbcL163. RbcL of both forms needs assistance of chaperonins in 
order to fold. Form II RbcL is upon completion of assisted folding released from the 
chaperonin and can assemble into a functional dimer. On the other hand, form I RbcL, after 
completion of assisted refolding, remains in a structurally labile state which perpetually 
rebinds to chaperonin. As was shown for a cyanobacterial Form I RbcL from 
Synechococcus sp 6301 (Syn6301), it is the loop region in the TIM-barrel domain between 
β-sheet and α-helix with a rather hydrophobic motif (LGSTIKPKLGL) that is solvent 
exposed and thus facilitates rebinding to GroEL115. To be released and assembled RbcL 
needs assistance from additional factors. Assembly of the final RbcL8:RbcS8 is preceded 
by formation of the RbcL8 core, followed by docking of RbcS. When various cyanobacterial 
form I Rubiscos were expressed in heterologous host systems the level of functional 
enzyme reached only 0.1-10%164. Biogenesis of hexadecameric Rubisco has become a 
prime example of assisted assembly. The first described Rubisco assembly chaperone 
RbcX from cyanobacteria Anabaena sp. CA allowed for Syn6301 Rubisco reconstitution in 
the presence of GroEL/ES up to 40% yield115. The increased but still relatively low yield 
was due to high affinity of Anabaena sp. CA RbcX which allowed the release from GroEL 
but prevented the binding of RbcS. This finding suggested the existence of additional 
factors that drive Rubisco assembly to completion. Indeed, a recent photosynthetic 
mutant library screen in maize identified a gene, Raf1, responsible for the reduced amount 
of Rubisco holoenzyme despite unchanged levels in transcription and translation of RbcL 
and RbcS165. The RbcL subunit was found bound to GroEL suggesting that Raf1 acts 
downstream of the chaperonin.  
We have structurally and mechanistically described plant and cyanobacterial Rubisco 
accumulation factor 1 (Raf1), a Rubisco assembly chaperone. Our X-ray structure of 
Arabidopsis thaliana Raf1 showed that Raf1 dimerizes through its β-sheet dimerization 
domain and is flanked by α-domains. Our negative stain EM reconstruction of Syn6301-
RbcL8:Syn7942-Raf14 showed that the Raf1 dimer interacts with the Rubisco antiparallel 
dimer along the equator via its β-domains and that Raf1 α-domains bracket the RbcL2 
antiparallel dimer by embracing it at the top and bottom sides of RbcL2, overlapping with 
RbcS binding sites. In our low resolution EM reconstruction, parts of the missing density 
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at the interface of RbcL2 and Raf1 indicate that the complex is highly dynamic. It is exactly 
this dynamic nature of interaction that allows RbcS to displace Raf1 α-domains and form 
the final RbcL8:RbcS8 holoenzyme. Therefore, the RbcL8:Raf14 structure represents the 
last structural intermediate in the assembly process. Earlier in the assembly pathway, 
Raf1 is most probably involved in dimerization of RbcL which prevents rebinding to the 
chaperonin. The RbcL2:Raf1 complex is a major structural intermediate and precedes 
assembly of the RbcL8:Raf14 complex. As already discussed, Raf1 is not the sole assembly 
chaperone involved in Rubisco biogenesis. RbcX, described above, is a structurally 
unrelated, ~30 kDa ‘boomerang’ shaped dimer that binds to RbcL via a set of different 
interaction sites, forming a less extensive interaction surface than RbcL2:Raf1115. The 
different sites of interaction define a different mode of action for RbcX, which binds the C-
terminal tail of one RbcL subunit and N-terminal domain of adjacent RbcL subunit, thus 
functioning as a molecular clamp that brings together two RbcL subunits. This leads to 
assembly of an RbcL8:RbcX8 complex. Raf1 performs essentially the same function as 
RbcX, which immediately raises the question whether the two assembly chaperones 
functionally cooperate or are redundant and thus function in parallel pathways. In 
contrast to Raf1, RbcX binding sites do not overlap with RbcS and thus the RbcL8:RbcX8 
complex may be an additional assembly intermediate which keeps the RbcL core in an 
assembly competent state when protein levels of RbcS are high enough to complete the 
last step. Moreover, genetic studies showed strict co-occurrence of RbcX and Raf1 in 
photosynthetic organisms with green-type Form I Rubsico, providing another clue for a 
functional cooperation of the two chaperones. 
However, not all Form I Rubsico enzymes depend on assembly chaperones. It was recently 
shown for a red-type Form I Rubisco from a proteobacterium Rhodobacter sphaeroides 
that RbcS alone is sufficient for assembly to the RbcL8:RbcS8 complex166. The red-type 
RbcS subunit has an additional C-terminal loop that has a role in Rubisco assembly. 
Interestingly, red type large subunits were not found to be bound to GroEL after refolding 
in the absence of RbcS. This suggests that red type RbcL are less prone to rebinding to 
GroEL and easily dimerize. Moreover, a homology search did not reveal any homologous 
green type assembly chaperones in prokaryotic or eukaryotic organisms with red type 
Rubsico. This led to the conclusion that the assembly processes evolved in different ways. 
There is an additional difference between green-type and red-type organisms; in non-
green algae RbcS are expressed in chloroplasts whereas in green algae and plants RbcS is 
encoded in nuclear genome and has to be imported into cholorplasts167. This might 
explain the need for assembly chaperones in green-type organisms so that Raf1 would be 
involved in the assembly of the RbcL8 core and RbcX would stabilize it until RbcS is 
imported into chloroplast. It is interesting to note that such an important enzyme as 
Rubisco depends on many factors for its biogenesis rather than having developed a more 
robust folding process. 
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The dependence on the assembly chaperone RbcX imposes a limit on the mutational space 
that Rubisco can explore, thus keeping it trapped in a form that is not enzymatically 
optimal168. On the other hand, the upstream chaperonin was shown to buffer mutations 
and thus allow further Rubisco evolution. The exact role of Raf1 is still to be determined. 
The ability to mutate and evolve plant Rubisco to a better enzyme, either in terms of its 
catalytic turnover or increased specificity for CO2 over O2 without disrupting its structure 
is of great interest for agriculture since such genetic manipulations would result in 
increased crop production. Unfortunately, to date no one has been able to reconstitute 
plant Rubisco in a heterologous system or in vitro. This suggest that additional factors for 
plant Rubisco assembly still await to be discovered. 
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4.4 Article 4 – Mechanism of Enzyme Repair by the AAA+ 
Chaperone Rubisco Activase 
In addition to being a very inefficient enzyme, Rubisco is also error-prone in its multi-step 
carboxylation reaction105. Sugars that form as mis-fire products, such as xylulose-1,5-
bisphosphate (XuBP), can bind tightly to the active site of Rubisco and inhibit its catalytic 
action. Rubisco inhibition can also occur due to premature binding of RuBP117. To release 
the inhibitor from the active site and allow for re-activation of Rubisco on a biologically 
relevant time scale, many photosynthetic organisms need help of a Rubisco activase 
(Rca)105. Rca belongs to a diverse family of AAA+ proteins which are involved in 
remodelling, disassembly or unfolding of proteins in the cell118. Rca remodelling action on 
inhibited Rubisco, which leads to metabolic repair, has emerged as an important 
paradigm to understand these mechanisms126,127. We have studied the remodelling 
mechanism of Rca from a proteobacterium Rhodobacter sphaeroides (RsRca), which 
harbours a red-type Rubisco. To become functional, RsRca needs to hexamerize. 
Hexamerization occurs in the presence of ATP and the substrate RuBP. The RsRca ring-
like hexamer has a central pore with conserved pore loop residues (YIG) that are 
implicated in interaction with the RsRbcL C-terminal tail126. From our 
hydrogen/deuterium exchange (H/DX) experiments coupled to the mass-spectrometry 
(MS), we were able to identify RsRbcL regions that were remodelled by RsRca. It is 
astonishing that the action of RsRca is limited to a precisely defined region consisting of 
the C-terminal tail, loop 6 of C-terminal domain and ‘60s loop of the adjacent N-terminal 
domain of RbcL. These are the exact elements that build the multi-layered active site of 
Rubisco113. This finding argues in favour of a restricted region being remodelled as 
opposed to a global unfolding event. Such a mode of action is in contrast to ClpX, another 
AAA+ protein responsible for unfolding of substrates with an ssrA tag169. ClpX works in a 
highly processive manner, threading the substrate through its pore which in many cases 
leads to complete unfolding. 
Another feature of the RsRca interaction with Rubisco is its transient nature (cross linking 
with glutaraldehyde was required to trap the complex). It might be that a difference in 
interaction strength determines the specific mechanism of remodelling. Additionally, the 
ATPase activity of ClpX is stimulated to higher levels (7 fold) by the interacting substrate 
as compared to RsRca. Remarkably, the pore loop residues of ClpX (YVG) are similar to 
RsRca, which excludes them as a reason for the difference in remodelling action. Thus, one 
could envision RsRca working by a ‘kiss and run’ mechanism where the weak interaction 
and slow processivity of RsRca would allow only for a short remodelling action. This 
would disrupt the active site just enough to open it and release the bound inhibitor. Our 
single particle cryo-EM reconstruction showed in more detail that RsRca binds to a corner 
of the Rubisco complex and is in a tilted orientation, interacting with both RbcL and RbcS. 
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The RsRca pore is positioned above the C-terminal helix of RbcL (helix 17), which is the 
starting point of the C-terminal tail that covers the active site. Large regions of the active 
site are missing in density, confirming that the RbcL structure is locally disrupted. 
Additionally, our cryoEM structure shows destabilization of helices 1 and 2 of RbcS, which 
was not observed by the HDX/MS experiments. RsRca itself is missing density as well, 
which could be due to distortions by glutaraldehyde cross-linking or more probably due 
to movement of RsRca on Rubisco. It is tempting to speculate that the structure we 
reconstructed is a morph of Rca, bound side-on to Rubisco where it initially interacts with 
the C-terminal tail, and the end state is closer to the top of the complex. Such a movement 
would peel off the C-terminal tail from the body of the enzyme. Our 3D classification, 
however, was not able to identify such classes. It might be that the structural differences 
are too small to be effectively differentiated by the algorithm. Our crosslinking 
experiment showed that the major interaction site on Rca is helix 5, where the functionally 
critical lysine residue 123 is located. As mentioned above, RsRca engages with the RbcL 
C-terminal tail. Crucial for the interaction, as shown by mutational analysis, are the last 
four residues of the tail126. In addition, it was speculated that immobilisation of the 
otherwise highly dynamic C-terminal strand is another important factor for successful 
interaction with RsRca. We performed an in-depth structural analysis of the closed 
inhibited state and observed that Asp474, Asp477 and Phe478, which are conserved in 
red type Rubisco, form a triad that might be crucial in locking the C-terminal strand over 
the catalytic site in a latch-like manner. Indeed, mutation of these aspartates into 
asparagines resulted in decreased Rubisco activity and inability of RsRca to reactivate 
inhibited Rubisco. This confirmed that the C-terminal tail has to be properly positioned to 
the body of enzyme such that RsRca with its central pore is able to engage with the last 
four residues of the C-terminal tail. This suggests a model where RsRca-induced 
conformational remodelling is initiated by breaking the contacts formed by Asp474 and 
Asp477, thus triggering a sequence of conformational changes. This results in 
destabilization of the 60s loop, leading to retraction of loop 6 and finally opening of the 
active site release of the inhibitory sugar. Only one RsRca per Rubisco active site is 
involved in reactivation. However, we observed from our cross-linking experiments and 
from our cryoEM 2D class averages that up to three RsRca can be bound, albeit in different 
positions, indicating simultaneous remodelling of three active sites. 
It is still not clear, how RsRca differentiates between two closed states of Rubisco, namely 
the inhibited state, and the state where the productive carboxylation reaction is ongoing. 
It might be that the RsRca binding is kinetically controlled, meaning that when the enzyme 
is in active mode the transition between the open and the closed states is faster than when 
the enzyme is inhibited, thereby decreasing the time window in which RsRca can interact 
with Rubisco. It would therefore be of great interest to study the kinetics of opening of the 
active site. One would have to find appropriate positions for fluorophore labelling and try 
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to measure kinetics by FRET. Such an experimental setup would allow the mechanism of 
Rubisco catalysis to be probed in even greater detail under a variety of conditions. It 
would also be interesting to study the activation process from the perspective of RsRca. 
For example, how many ATP molecules does a single RsRca need to hydrolyse in order to 
open the active site? Further, are ATP molecules hydrolysed simultaneously or 
sequentially? Dissection of activase conformational changes along the ATP hydrolysis 
reaction coordinate while bound to Rubisco would also be of interest. This could be 
achieved by 3D reconstruction of activase:Rubisco complexes in the presence of ADP-BeFx 
(ATP bound state), ADP-AlFx (ATP hydrolysis state) and ADP-VO4 (post-hydrolysis state) 
given that the complexes are stable enough. Another unresolved question is the force that 
RsRca exerts on Rubisco, which could be experimentally approached using single-
molecule force spectroscopy. Also, how exactly do pore loop residues and the ATPase 
activity determine grip strength and processivity of RsRca? Would it be possible to mutate 
RsRca in such a way that it would interact with Rubisco and completely unfold it? 
It is bewildering how the different AAA+ proteins evolved to be specifically adapted to the 
needs of their cognate substrates. Along these lines, it has been shown that red-type 
activases cannot activate a green-type plant Rubisco and vice versa. How exactly the plant 
activase remodels plant Rubisco still remains to be answered. Plant activases have an 
additional N-terminal domain which was shown to be important for interaction with 
Rubisco105. Additionally it is not clear where the plant activase would pull the Rubisco in 
order to open the active site, since the C-terminal tail is shorter by ~10 residues as 
compared to red-type Rubisco113. Another interesting case are cyanobacterial Rubiscos, 
for which no inhibited forms have been described105. These organisms do, however, have 
Rca like proteins with an RbcS like domain. This points to yet another possible mode of 
interaction with Rubisco. The field of Rubisco activation still has many research 
challenges, and offers an alternative approach to engineering a better Rubisco by 
modulating the interaction and activity of its cognate activase. 
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6 Abbreviations 
2PG   2-phosphoglycolate 
3PG   3-phosphoglycerate 
AAA+   ATPases associated with various cellular activites 
Å   Ångstrom 
aa   amino acid 
ADP   adenosine 5’-diphosphate 
AFM   atomic force microscopy 
afRca1  Rubisco activase from Acidithiobacillus ferrooxidans 
ALS   amyotrophic lateral sclerosis 
At   Arabidopsis thaliana 
ATP   adenosine-5’-triphosphate 
Bis-ANS  4,4’-Dianilino-1,1’-binaphthyl-5,5’-disulfonic acid dipotassium salt 
C   carbon 
°C   degree Celsius 
Cα   chiral carbon atom 
CABP   2-carboxyarabinitol bisphosphate 
CA1P   carboxyarabibitol 1-phosphate 
CBB   Calvin-Benson-Bassham 
CD   circular dichroism 
cmRca   Rubisco activase from Cyanidioschyzon merolae 
CO2   carbon dioxide 
Cpn   chaperonin 
dcFCCS  dual colour fluorescence cross-correlation spectroscopy 
DapA   dihydrodipicolinate synthase 
DM-MBP  double mutant maltose binding protein 
DNA   deoxyribonucleic acid 
DnaJ   bacterial Hsp40 chaperone 
DnaK   bacterial Hsp70 chaperone 
E   non carbamylated Rubisco 
ECM   carbamylated and Mg2+ bound Rubisco 
ECMI   inhibited ECM form 
EI   sugar phosphate inhibited E form 
E.coli   Escherichia coli 
EM   electron microscopy 
ESI   electron spray ionization 
FCS   fluorescence correlation microscopy 
FIB   focused ion beam 
fL   femtoliter 
FRET   Förster resonance energy transfer 
GroE   GroEL/ES system 
GroEL   bacterial Hsp60 chaperonin 
GroES   bacterial Hsp10 co-chaperonin 
G3P   glyceraldehyde phosphate 
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hnRca   Rubisco activase from Halothiobacillus neapolitanus 
HDX   hydrogen deuterium exchange 
Hsp   heat shock protein 
K+   potassium ions 
KABP   3-ketoarabinitol-1,5-bisphosphate 
KD   dissociation constant 
kDa   kilodalton 
kon   association rate constant 
koff   dissociation rate constant 
ms   millisecond 
MS   mass spectrometry 
MD   molecular dynamics 
MDa   megadalton 
MDH   malate dehydrogenase 
MetK   S-adenosylmethionine synthase 
mg   milligrams 
Mg2+   magnesium ions 
ml   millilitres 
mRNA   messenger RNA 
N   nitrogen 
NAC   nascent chain associated complex 
NADPH  β-nicotinamide adenine dinucleotide 2’-phosphate 
NBD   nucleotide binding domain 
NEF   nucleotide exchange factor 
NHS   N-hydroxysuccinimide 
nm   nanometer 
nM   nanomolar 
NMR   nuclear magnetic resonance 
ntRca   Rubisco activase from Nicotiana tabacum 
O2   oxygen 
PDB   protein data bank 
PDBP   2,3-pentodiulose-1,5-bisphosphate 
PEP   phosphoenolpyruvate 
PET   photoinduced electron transfer 
PFD   prefoldin 
Pi   phosphate group 
pM   picomolar 
PPI   peptidyl prolyl isomerase 
R   relaxed 
RAC   ribosome-associated complex 
Raf1   Rubisco accumulation factor 1 
Raf2   Rubisco accumulation factor 2 
RbcL   Rubisco large subunit 
RbcS   Rubisco small subunit 
Rca   Rubisco activase 
Rs   Rhobobacter sphaeroides 
RsRca   Rubisco activase from Rhobobacter sphaeroides 
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Rubisco  Ribulose-1,5-bisphosphate carboxylase/oxygenase 
RuBP   Ribulose-1,5-bisphosphate 
RNA   ribonucleic acid 
s   seconds 
SAXS   small angle X-ray scattering 
SBD   substrate-binding domain 
SDS   sodium dodecyl sulphate 
SmFRET  single-molecule Förster resonance energy transfer 
SR1-EL  single ring version of GroEL 
Syn   Synechococcus 
T   tense 
TF   trigger factor 
TRiC/CCT  TCP-1 Ring Complex/Chaperonin containing TCP-1 
TCP-1   T-complex 1 
TIM   triose phosphate isomerase 
τR   relaxation time 
Trp   tryptophane 
Tyr   tyrosine 
µs   microsecond 
UPS   ubiquitin proteasome system 
UV   ultraviolet 
VWA   von Willebrand factor A 
XuBP   xylulose-1,5-bisphosphate 
 
